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Understanding the fate of active pharmaceutical compounds in waters receiving 
poorly or untreated sewage effluent for the development of a dedicated environmental 
risk assessment approach – Simone Bagnis 
The global increasing consumption and production of active pharmaceutical 
ingredients (APIs) is of a growing environmental concern. The inherently biological 
activity of APIs creates a concern of potential ecotoxicological effects even at very low 
concentrations. Such risk is particularly exacerbated in low and low-middle income 
countries (LLMICs) where it is common the practice of direct discharge of untreated 
wastewater (DDUW) into surface waters, which creates a heavily polluted area 
downstream, described as the “impact zone”. Little is known about the environmental 
fate of APIs in this area. Nevertheless, measured environmental concentrations (MECs) 
of LLMICs show higher concentrations than for high-income countries. Globally, the 
MECs for APIs in the “impact zone” are often above 0.01 µg L-1, which would be 
sufficient to trigger the environmental risk assessment (ERA) refinement phase. 
Environmental concentrations are calculated with a conservative default dilution factor 
(DF) of 10, but in many countries observations show a lower value. Additionally, the 
traditional ERA considers sorption on the wastewater sorbents in the wastewater 
treatment plant as removal process. This does not happen in the case of the DDUW, 
where instead the sorbent are released and diluted into the receiving waters. This peculiar 
widely spread environmental scenario translates in the necessity of a dedicated 
environmental risk assessment impact zone inclusive approach, and supports the 
generation of scientific robust data about the environmental behaviour of APIs along and 
beyond its boundaries. Such a situation is therefore giving rise to scientific questions 
such as the effects of dilution of the untreated wastewater on the distribution of APIs 
between water and sorbents, i.e. sorption and desorption; the effects of the dilution on 
the biodegradation of such molecules in the receiving compartment, e.i. the compound 
half-life; and the development of a scientific approach to model the boundaries of the 
impact zone and to predict the environmental concentrations within and beyond. 
With the aim of creating a framework for the generation of sound scientific 
information regarding such area a methodological approach was designed. A first phase 
of such methodology included laboratory studies about the most prominent occurring 
environmental fate processes, such as distribution and biodegradation. This information 
was used to propose a model for the determination of concentrations along and beyond 
the impact zone. In a subsequent phase it was conducted a fieldwork to both validate the 
first phase and to provide a real case for the modelling of environmental concentrations, 
and the inclusion of such methodology parallel to the traditional ERA. 
A first study was conducted to investigate the effect of DFs <10 on the distribution 
of APIs between wastewater sorbents and receiving waters. The sorption was consistent 
with the APIs chemical properties. Dilution increased desorption of the basic and neutral 
APIs and correlated with their lipophilicity (R2 >0.98). The data showed a clear trend in 
the desorption process of APIs that may lead to higher exposure risk than anticipated.  
xii 
 
A second study aimed at investigating low levels of dilution on the biodegradation 
of APIs. Also, the extent of the impact zone was modelled using the biochemical oxygen 
demand (BOD) as proxy. The degradation half-lives of acebutolol and diclofenac 
increased with increasing dilution and resulted in higher environmental persistence. The 
other APIs investigated were not degraded, but acetaminophen which was quickly lost 
from the solution (<24 h). The temporal end boundary of the impact zone was predicted 
as 24 h. Therefore, it was concluded that most of the investigated compounds would 
persist beyond the impact zone, as defined by BOD concentrations owing to the fact that 
they exhibited greater persistence than the DOM comprising the BOD within the 
samples.   
Thirdly, a sampling campaign of the Nairobi/Athi river catchment was performed 
to characterize the impact zone and the occurrence of APIs. The study showed a clear 
relationship with the DOM quality variation and the diffuse source areas of untreated 
wastewater within the city, as well as the occurrence of API trends. The study showed a 
first attempt of understanding the role of such an impact zone with respect to API source, 
occurrence and fate and furnishes pivotal information to further investigate such areas.  
In conclusion, from the results obtained by the laboratory studies and fieldwork it 
clearly results on the impact zone as an area of severe pollution which needs a dedicated 
ERA approach. Beyond its boundary the classical protocol of ERA can be applied, but to 
estimate the predicted environmental concentrations of APIs it is necessary to create a 
model to be applied to such area. Such model would output environmental concentrations 
beyond the end boundary of the impact zone that may be used for further risk assessment. 
Further studies are necessary to provide scientific robust endpoints useful to the 
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The increasing consumption and production of active pharmaceutical ingredients 
(APIs) in low and low-middle income countries (LLMICs) is of a growing environmental 
concern owing to potential ecotoxicological effects and antibiotic resistance. This is 
related to the practice of direct discharge of untreated wastewater (DDUW) into receiving 
waters, which creates a heavily polluted area downstream, named the “impact zone”. 
Little is known about the environmental fate of APIs in this area. Nevertheless, a few 
available measured environmental concentrations (MECs) in LLMICs show higher 
concentrations than for high-income countries with developed wastewater treatment 
infrastructures. Globally, the MECs of APIs in the “impact zone” are often above 0.01 
µg L-1, which would be sufficient to trigger the environmental fate refinement of the 
European Medicine Agency (EMA) environmental risk assessment (ERA). In the ERA 
predicted environmental concentration (PEC) calculation, a dilution factor (DF) of 10 is 
used as a default, but in at least 53 countries worldwide, the local predicted DF median 
value is less than this. There is no information available in the literature about the effects 
of low dilutions on the natural attenuation and resulting exposure of APIs, and especially 
in the specific case of DDUW. This study provides information about effects of the 
dilution of untreated wastewater on the partitioning – sorption and desorption – and 
biodegradation of APIs within the impact zone. Also, a sampling campaign for a real 
environmental catchment allowed an investigation into an actually field-based impact 
zone. This research provides pivotal information which will support the development of 








1.1.1. Pharmaceuticals in the environment 
Modern society largely depends on the use of chemicals that have the potential for 
adverse environmental effects. Public concern began with the publication of Rachel 
Carson’s “Silent spring” in 1962, which drew attention to the effects of pesticides on the 
environment and the consequent risks to humans. Although persistent organic pollutants, 
“POPs”, which are persistent, bioaccumulating and toxic (PBT) chemicals, have largely 
been regulated via global agreements such as the Stockholm Convention held in 2001 
(http://chm.pops.int/Home/tabid/2121/Default.aspx, 2017), new compounds are 
continually being created and employed in many applications. Some of these new 
substances are collectively classified under the name of “emerging contaminants”, which 
are defined as synthetic or natural chemicals detected and monitored in the environment 
and thought to pose a potential risk of harmful effects to human health or ecosystems 
(Sorensen et al., 2015). 
Due to improvements in analytical technology, many new compounds can be 
detected in environmental matrices at very low concentrations (< 1 ng L-1). Active 
pharmaceutical ingredients (APIs) have received attention, particularly since the studies 
by Purdom et al. (1994) and Sumpter and Jobling (1995) reported that nanograms per 
liter concentrations of 17α-ethinylestradiol (EE2) could cause feminization of river fish. 
Consequently, the perception of potential detrimental effects of APIs on the environment 
led to the creation of a dedicated area of study, named “Pharmaceuticals in the 
Environment” (PIE) (Daughton and Ternes, 1999). More recently, the near extinction of 
several vulture species in India caused by diclofenac toxicity provided further evidence 
of negative environmental impacts of some APIs (Swan et al., 2006). These findings 
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raised questions about the possibility of other APIs having similar disruptive effects in 
the environment (Fatta-Kassinos et al., 2011). The increased number of studies 
demonstrating API occurrence in surface and groundwater worldwide and evidence of 
ecotoxicological effects have further increased concern (Nikolaou et al. 2007; Brausch 
et al. 2012; Arnold et al. 2014; Backhaus 2014; Brodin et al. 2014; Brown et al. 2014; 
Gaw et al. 2014; Hutchinson et al. 2014; Kookona et al. 2014; Küster and Adler 2014; 
Lalone et al. 2014; Larsson 2014; Shore et al. 2014). In addition, the global 
pharmaceuticals market is expanding year on year and was valued at $1.072 trillion in 
2015, and a significant number of APIs have been detected in sewage effluents leading 
to concern about the ecosystem impact of these emerging contaminants (Comber et al., 
2018; Gardner et al., 2013, 2012). 
APIs comprise a large and diverse group of compounds used for the prevention, 
cure or treatment of diseases in humans and livestock. Currently, there are uncertainties 
associated with the environmental risk assessment of pharmaceuticals due to lack of 
knowledge concerning their fate in wastes and the environment, their uptake, metabolism 
and excretion (pharmacokinetics) in wildlife, and their target affinity and functional 
effects (pharmacodynamics) on non-target species (Arnold et al., 2014). The 
environmental threat is linked to some structural features, which may result in inter-alia, 
persistence to degradation, high bioavailability and high solubility. Furthermore, APIs 
are excreted after ingestion either as parent compounds or metabolic products, which can 
be, naturally or by wastewater treatment processes, converted to transformation products 
or back to the parent compound creating further uncertainty regarding environmental fate 
and ecotoxicological effects (Boxall et al., 2012). In fact, the metabolism of xenobiotic 
compounds in organisms plays a key role in reducing drugs toxicity, and fosters their 
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excretion through bile, faeces and urine. The main metabolic goal is to transform 
lipophilic compounds to more hydrophilic ones that can thus be more easily excreted 
(Hutchinson et al., 2014). API’s and xenobiotics are converted into metabolites by drug 
metabolizing enzymes, or excreted from cellular environments. The drug can be excreted 
as parent compound (up to 50-90% of the dose), which means it is chemically unchanged 
and in its pharmacologically active form; examples of this include amoxicillin and 
ciprofloxacin (Githinji et al., 2011). The trend in general, however, is that the metabolites 
in excretions are less bioactive than their parent compound form (Daughton and Ternes, 
1999). However, it is also necessary to consider the evidence that conjugates can be 
hydrolysed by bacteriological activity in sewerage works or in the environment, and 
retransformed to their parent compound form (Hirsch et al., 1999).  
1.1.2. Sources and fate of pharmaceuticals in the environment 
The introduction of APIs in the environment occurs chiefly from point sources and, 
despite some of them being highly degradable, continuous inputs can result in pseudo-
persistent behavior (Grenni et al. 2013). The principal source of APIs away from rural 
areas is via human excretion (private household and hospitals), and the consequent 
discharge of treated and untreated wastewater into the aquatic environment (Daughton 
and Ternes, 1999; Kookana et al., 2014; Malik et al., 2015). Industrial manufacturing 
plants are considered important point sources of pharmaceuticals to the environment 
(Cardoso et al. 2014; Larsson et al. 2015), as well as livestock farming and aquaculture 
in rural areas, which are regarded as additional significant sources of veterinary 
pharmaceuticals (Carmosini and Lee, 2009; Shimizu et al., 2013; Song and Guo, 2014).  
Also, improper disposal of expired medicinal products contributes to the load, although 
is considered a minor impact (Tong et al., 2011). 
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depicts the pathways of pharmaceuticals to the environment as well as how they 
may find their way back into the food chain (Benotti et al., 2009; Heberer, 2002). 
 
 
Figure 1 Sources and routes of pharmaceuticals to the environment and the intermediate steps 
encountered between the point source and the receiving environmental compartment or drinking water for 
human consumption (Heberer, 2002). Yellow boxes depict the main sources to the environment; green boxes 
depict the receiving environmental compartments; the red box depicts potable water, a direct source of human 
exposure (Bagnis et al., 2018b). 
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1.1.3. Wastewater and the environment 
1.1.3.1. Wastewater  
The production of waste by human activities is unavoidable, and a proportion ends 
up as wastewater. The management of wastewater by urban administrators has a long 
history. Many relicts of ancient urban wastewater management systems have been found 
in early cities in Eurasia, from sewer and storm water drainage systems dating back to 
the Minoan civilization, around the second millennium BC, to the fundamental basis of 
the modern sewerage systems laid in the Ancient Greece (Angelakis et al., 2005). The 
Greek sewerage systems can be compared only to the modern ones engineered during the 
19th century, which fascinated Victor Hugo to such an extent to write in Les miserables 
that “The history of men is reflected in the history of sewers”  and “it has been a 
sepulcher, it has served as asylum, crime, cleverness, social protest, the liberty of 
conscience, thought, theft, all that the human law persecutes or have persecuted is hidden 
in that hole” (Lofrano and Brown, 2010). Wastewater is, both romantically or 
scientifically, a source for sociological analysis (Lofrano and Brown, 2010), as, for 
instance, when used to determine the use of drugs in a community (legal or otherwise) 
through the measurement of sewage drug biomarkers (Castiglioni et al., 2013). Again 
from an historical perspective, it is interesting to mention the timeline of the sanitation 
evolution drawn by Lofrano and Brown (2010), which highlights five distinct historical 
periods based on the level of sanitation development: early history as the period 
antecedent the Roman period, ending in 465AD with the beginning of the so-called “dark 
age of sanitation”, lasting from the middle ages to the industrial revolution. In the most 
recent days the traditional problems associated with wastewater have been solved by 
developed countries, whilst in those countries characterized by a middle and middle-low 
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income the problem is still concerning because of the lack of access to sanitation of a 
large fraction of the population (Kookana et al., 2014). An instance are the “flying toilets” 
of Kibera, a degraded area in Nairobi, where owing to the lack of sanitation people throw 
excreta in the streets, similar to the middle ages (Lofrano and Brown, 2010). 
The main types of wastewater are domestic wastewater, principally composed of 
black-water (excreta, urine and faecal sludge) and grey-water (bathing and kitchen 
wastewater); industrial wastewater, discharged from manufacturing facilities; 
wastewater from institutions like hospitals; and also infiltration into sewers, storm water, 
leachate, and septic tank wastewater. The composition and quality of the wastewater is 
largely variable between different human societies and industries. Such variability is 
determined by many factors such as lifestyle, behaviour and standard of living of the 
inhabitants, as well as the juridical framework in use in a specific region (Henze and 
Comeau, 2008). For such a reason it is not possible to ‘standardise’ wastewater 
composition, even though it is possible to list the main components and to classify the 
different wastewaters based on the source (Tchobanoglous et al., 2003). 
The wastewater constituents are mainly biodegradable organic materials, 
microorganisms, other organic chemicals (e. g. detergents, pesticides, oil and grease, 
pharmaceuticals, etc.), nutrients, metals, and other inorganic materials. Also some 
physical characteristics are typical of wastewaters such as high temperature waters, 
odour, and radioactivity. Organic matter is the main pollutant carried by wastewaters, 
and it is measured as biochemical oxygen demand (BOD) which if not reduced in 
concentration via treatment, acts as an energy source to surface water microbial 
communities whose growth leads to the stripping the oxygen out of the system ending in 
anoxia and death of invertebrates and fish.. The other components contribute to the 
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toxicity of the wastewater as well, and are of importance during the biological treatment 
in wastewater treatment works (WWTW) and in the receiving surface waters.  
1.1.3.2. Wastewater treatment 
Once generated the wastewater is collected by sewerage systems and conveyed to 
a WWTW where it undergoes various treatment processes aimed at reducing the 
pollutants concentration, namely primary treatment, secondary treatment, and in some 
cases, tertiary and quaternary treatments, the latter two also defined as advanced 
treatments. 
 
Figure 2 Diagram describing the basic primary and secondary treatment processes in a wastewater 
treatment plant. 
The primary treatment mainly consists in the removal of the heavier settleable 
material by gravitation in sedimentation tanks (Figure 2). This is the first kind of 
wastewater treatment in history, some forms were also found in ancient cities, and it is 
the most common form of wastewater treatment (Lofrano and Brown, 2010). More 
recently (since about 1900), biological treatment, described as ‘secondary treatment’, 
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was developed subsequent to primary settlement, which involves the use of micro-
organisms for the conversion of the organic material to carbon dioxide, water and energy 
for growth (Figure 2). The secondary treatment can be of two basic types: attached 
growth and suspended growth. The former consists of a population of microorganisms 
attached to a packing material. The wastewater flows through the space between the 
packing material, i.e. rocks, gravel, sand, redwood or plastic, and other synthetic 
materials, and the pollutants carried by the wastewater are removed by the attached 
growth, or also called biofilm. In the latter secondary treatment method, the microbial 
population is maintained in suspension by mixing the liquid in a properly aerated tank. 
Once the importance of the impact of wastewater on the environment and the return to 
human economics and health was realized some additional advanced treatment became 
more common in developed countries such as membrane systems, adsorption techniques, 
electrodialysis, and disinfection practices (Tchobanoglous et al., 2003). 
1.1.3.3. Wastewater treatment global status 
In many part of the world, and in particular in LLMICs in Asia, Africa and South 
America, wastewater receives only poor or partial treatment and is routinely discharged 
untreated in aqueous environments (Finnegan et al., 2009; Malik et al., 2015).  The reason 
is often found in insufficient infrastructures owing to the rapid development of cities and 
the lack of funds for the necessary upgrade (Malik et al., 2015). This practice leads to an 
immediate serious ecological impairment caused by the main pollutants carried by the 
wastewaters, namely nutrients and other organic pollutants such as, for instance, 
pharmaceuticals (Corcoran et al., 2010). The excessive concentration of nutrients leads 
to algal blooms and eutrophication that itself leads to the consumption of all the oxygen 
available in the water with consequent negative impacts on the local biota, for instance 
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fish kills (Corcoran et al., 2010). The other organic pollutants are present at a lower 
concentration, but might be the cause bioaccumulation in the food chain up to top 
predators including humans. Of particular concern are those organics that can lead to 
endocrine disruption in organisms, which include APIs (Corcoran et al., 2010).  
The wastewater treatment level varies with patterns recognisable at regional level. 
North America, Australia, and Europe show the highest performance in the wastewater 
treatment normalized per connection rate, followed by Middle East and North Africa, 
East Asia and the Pacific, Eastern Europe and Central Asia. The least performant regions 
are Latin America and Caribbean, Sub-Saharan Countries and South Asia (Malik et al., 
2015). The performance is correlated to the income level of each region with a low 
income corresponding to low wastewater treatment and often greatest rate of population 
growth. These data are in accordance with estimates from the United Nations 
Environmental Programme (UNEP) which show that about the 80% of the wastewater 
produced in LLMICs is discharged directly into the environment (Malik et al., 2015).  
A good example of continuous DDUW in fresh surface waters of LLMICs come 
from the Nairobi river basin in Kenya, which has recently shown evidence of consequent 
significant contamination by APIs (K’oreje et al., 2016, 2012; Ngumba et al., 2016). In 
Kenya, the national sewerage coverage is only 17% with variations between cities, for 
instance Nairobi (28%), Mombasa (4%), Kisumu (13%) (K’oreje et al., 2016; Malik et 
al., 2015). Additionally related Nairobi water quality, it should be noted that Nairobi is 
the fastest growing city in Sub-Saharan Africa and it is predicted to have a population 
growth from the actual 3.5 million to 7 million in the coming 20 years as a result of 
migration of people from the rural areas to the city (Mundia and Murayama, 2013); and 
this case is valid for most cities in Africa. 
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1.1.3.4. Impact zone concept 
The DDUW lead to the formation of a severely polluted area downstream of the 
discharge point. Such an area was named “impact zone” for the first time at a workshop 
in 1995 (Limelette III workshop) (A.I.S.E./CESIO, 1995) and the concept has been 
further adopted by several authors (Finnegan et al., 2009; McAvoy et al., 2003; Whelan 
et al., 2007). The impact zone is defined as the area beginning at the discharge point 
source end ending when BOD and ammonia are quantified below their predicted no effect 
concentrations (Figure 3). Such a zone can be thought as a natural treatment system in 
which biodegradation is the main removal process. The factors determining the fate of 
the chemicals present in the impact zone are partitioning processes, which are responsible 
for environmental availability of the pharmaceutical compounds to the bacteria, and other 
toxicants that can be responsible for the decline of one or more bacterium species. 
 
Figure 3 Representation of the impact zone; A: Impact zone, showing dilution and natural attenuation 
directions; B. Complexity of the untreated wastewater matrix (suspended matter, colloids, bacteria, DOM, 
APIs, other contaminants). 
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Little is known about the fate of APIs in this area, but investigations of continuous 
discharge of untreated wastewater in fresh surface waters come from the Nairobi/Athi 
catchment in Kenya, where it has been recently shown evidence of significant 
contamination by pharmaceuticals, detected in concentrations ranging from ng L-1 to 100 
µg L-1 (K’oreje et al., 2016, 2012; Ngumba et al., 2016). Also, in Nigeria were detected 
concentrations of APIs at concentrations above 50 µg L-1 (Olatunde et al., 2014). Several 
studies showed high surface waters concentrations of APIs in South Africa up to 30 µg 
L-1 of atenolol (Agunbiade and Moodley, 2016, 2014), 85 µg L-1 of ibuprofen (Matongo 
et al., 2015), and 430 ng L-1 of several antiretroviral (Wood et al., 2015). Also, the 
wastewater of API factories was deemed as the main source of high concentrations, up 
to mg L-1, in Pakistan (Ashfaq et al., 2017) and India (Larsson, 2014).  
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The background information in the section 1.1.4 is based on the paper published 
in Environmental Chemistry Letters available at https://doi.org/10.1007/s10311-018-
0742-7. 
1.1.4. Environmental natural attenuation processes 
Once wastewater borne APIs enter into the environment they may undergo 
natural attenuation by physical, biological or chemical processes that reduce their 
concentration such as dilution (although sometimes excluded from such processes), 
transformation (photo-degradation; bio-degradation, hydrolysis) and sorption (Figure 4) 
(Gurr and Reinhard, 2006). Volatilization is also a common loss process, though APIs 
are considered negligibly volatile owing to low Henry’s Law constants (Gurr and 
Reinhard, 2006). The importance of natural attenuation lies in the reduction of 
environmental concentration, and therefore potential toxicity of chemicals. The degree 
of such processes determines the fate of contaminants in the environment, namely their 




Figure 4  Fate of active pharmaceutical ingredients (APIs) in the environment and possible routes of 
return of parent compounds or metabolites caused by desorption or transformation processes; The red box 
refers to the APIs and possible chemical features (i.e. Polarity: hydrophobic or hydrophilic; Functionality: 
acidic, neutral, basic, zwitterion); The blue box depicts the environmental receiving compartment; the green 
box depicts the natural attenuation; the yellow boxes serve as subdivision of the three main attenuation 
mechanisms; the pale blue coloured arrows depict the route and causes of return to the aqueous environmental 





1.1.5. TGD approach to producing PECSW for environmental risk assessment 
The European Commission Technical Guidance document on Risk Assessment (TGD) 
includes a detailed section on how to calculate PEC in surface water. The PECs are 
calculated at both regional and local levels, the former used as background, as assumed 
to be constant in the environment, and summed to the latter, which instead describes a 
small standardized environment. The local surface water PECs are the focus of this 
research, which aims at proposing an approach for the particular case of direct discharge 
of untreated wastewater, not discussed in the technical guidance.  
According to the TGD, the local PECs in surface water are calculated with the main 
assumptions that complete mixing of the effluent in surface water is the representative 
exposure situation for the aquatic eco-system; and that for the first approach in the local 
assessments, volatilisation, degradation, and sedimentation are not relevant processes 
because of the short distance between the point of effluent discharge and the exposure 
location, and therefore ignored. 
After going through the wastewater treatment plant processes, and after discharge, the 
dilution is considered the main natural attenuation process and the sorption is also 




The TGD is meant to be a guidance for the calculation of the environmental risk 
assessment of a variety of chemicals and environments, and as such furnishes a widely 
accepted overall approach.  
However, the particular local environment described as the impact zone in this research 
work is peculiar and worth a dedicated approach. In fact, the dilution in this case could 
lead the redistribution process of desorption, which can lead to underestimation of the 
actual PEC in the surface waters at the discharge point. This perspective on the 
calculation of PECs for surface water challenges the TGD assumption that the dilution is 
by default a natural attenuation process and instead raises the question of the role of 
desorption, especially at low levels of dilutions.  
1.1.6. Environmental risk assessment of pharmaceuticals 
The application for marketing of a pharmaceutical for human use needs to be 
accompanied by an environmental risk assessment (ERA) (EMA, 2006). The eventual 
impact caused by the introduction of an API into the environment does not constitute a 
reason for refusal in any case, however precautions to limit such impact need to be 
considered. 
The assessment of the potential risk to the environment caused by a pharmaceutical 
is a step-wise approach consisting of two phases: the first phase (Phase 1) is an estimate 
of the level of exposure to an API in the environment. Depending on whether a potential 
risk is estimated may trigger the next phase, which corresponds of two parts, Tier A and 
B, which are aimed at refining the data about environmental fate and effects. 
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In phase 1, the estimation is based on the API only, irrespective of its route of 
administration, form, metabolism, and excretion. Regardless of the outcome, the 
compounds with a  log Kow above 4.5 are screened for persistence, bioaccumulation, and 
toxicity according to the EU TGD (European Comission Joint Research Centre, 2003). 
In this primarily phase predicted environmental concentrations (PEC) are 
calculated with the following assumptions: a fraction of the overall market penetration, 
the amount used per year is evenly distributed by time and geographic area, the 
wastewater treatment plant (WWTP) is the main source of APIs to the environment, no 
attenuation due to biodegradation or sorption occurs in the WWTP, and metabolic 
transformations are not considered.  







Where PEC is the predicted environmental concentration in surface waters 
(outcome); DOSEai is the maximum daily dose consumed per inhabitant; Fpen is the 
fraction of market penetration with a default value of 0.01; WASTEinhab is the amount of 
wastewater per inhabitant per day with a default value of 200; and DILUTION is the 
dilution factor with a default value of 10.  
If the PEC value is below 0.01 µg L-1 and no other apparent environmental 
concerns are present, the API is considered safe and no further studies are necessary; if 
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the PEC is above such a value, phase 2 – the environmental fate and analyses needs to be 
performed. 
Phase 2 consists of an assessment considering the ratio of the PEC (that consider 
relevant datasets from environmental testing) to ecotoxicological data estimating the 
predicted no effect concentrations (PEC/PNEC) (Tier A). If these data are not considered 
sufficient then further testing is required (Tier B). Greater detail is provided in the 
guideline on the environmental risk assessment of medicines for human consumption 






1.2. Aims of the project 
In the following list are described the main aims of the research: 
1. Assessment of the effect of low levels of dilution (<10) of the sewage effluent 
mixed with receiving water on the partitioning of APIs, namely sorption and 
desorption. 
2. Assessment of the effect of low levels of dilution (<10) of the sewage effluent 
mixed with receiving water on the biodegradation rates of selected APIs. 
3. Development of a model to determine the extent of the impact zone based on 
BOD consumption, predicted from DOC concentrations. 
4. Case study aimed at the characterization of the extent of a real impact zone and 
the occurrence of APIs in a real environment. 
5. Outlining implications for the development of an API ERA approach for the 
impact zone. 
1.3. Scope 
As a preliminary study, a series of laboratory tests were performed to evaluate the 
effects of low levels of dilution on the natural attenuation processes occurring in the 
impact zone. The results were then evaluated against data obtained from field work. The 
scope was a basic provision for data useful in a preliminary assessment of the occurrence 
of APIs within the impact zone and beyond, and for the development of a dedicated ERA 




This thesis begins with an introduction to the APIs as emerging environmental 
contaminants, the source and fate, and brief description of the global wastewater 
treatment status and on the formation of the impact zone as a result of direct discharge 
of untreated wastewater.  
The second chapter is dedicated to a literature review about the sorption of APIs 
in surface fresh water sorbents. Information available in the literature is screened and 
collated, and a critical analysis has been undertaken. 
 Subsequently, in the third chapter, the materials and methods are described. Such 
as the ingredients and methodology used to create the synthetic wastewater, the 
rationale for the selection of the APIs to be investigated, and the analytical 
methodologies.  
In the fourth chapter are the results and discussion about sorption and desorption 
as an effect of dilution of untreated wastewater into freshwater. Some implications of 
these findings for ERA are also provided. 
 The fifth chapter is dedicated to the description of the effects of low levels of 
dilution of untreated wastewater on the biodegradation of APIs. Also, modelling of the 
temporal extent of the impact zone based on the correlation of TOC and BOD is 
attempted and the results discussed together with possible implications for ERA. 
The sixth chapter provides and discusses the data obtained from fieldwork in the 
Nairobi and Athi Rivers Catchment, Kenya. The data about the occurrence of a set of 
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56 APIs along a transect of the catchment are discussed as well as the extent of the 
impact zone. Also in this case are furnished implications for ERA. 
In the conclusions are suggestions for the implementation of an environmental 








2. PROCESSES OF DISTRIBUTION OF ACTIVE 
PHARMACEUTICAL COMPOUNDS IN SURFACE 
FRESHWATER ENVIRONMENTS AND IMPLICATIONS FOR 





This experimental chapter was published as: Bagnis, S., Fitzsimons, M., Snape, 
J., Tappin, A., Comber, S., (2018). Processes of distribution of pharmaceuticals in 
surface freshwaters : implications for risk assessment. Environ. Chem. Lett.; and it is 







Once in the environment, APIs can undergo processes of natural attenuation, i.e. 
dilution, sorption, transformation, depending on the inherent physico-chemical properties 
of the compound, such as water solubility, lipophilicity, vapour pressure, and 
environmental conditions, such as pH, temperature and ionic strength. A key natural 
attenuation process is sorption onto surface water components, namely dissolved organic 
matter (DOM), colloids, suspended solids and sediments, which control APIs 
distribution, residence time and persistence in aquatic systems. Here we review studies 
of sorption capacity of such sorbents to APIs which report on the importance of several 
environmental and sorbent-specific properties, such as the composition, quality, and 
amount of the sorbent, and the environmental pH, which determines the speciation of 
both the sorbent and compound. The major points are the importance of processes of 
distribution on freshwater sorbents for the determination of environmental concentrations 
of pharmaceuticals; the reliability of surrogate standards for DOM distribution; the 
critical evaluation of the significance of the distribution processes on attenuation of APIs; 









2.1. Introduction  
Attenuation of APIs through partitioning onto sorbents in surface waters can be 
significant in controlling distribution, residence time and persistence in aquatic systems 
(Lützhøft et al., 2000); as a result ecotoxicological effects might be either reduced, as the 
pharmaceutical is less bioavailable, or increased through bioconcentration (Ra et al., 
2008). The extent and reversibility of partitioning depends on both the pharmaceutical 
and sorbent surface characteristics (Delle Site, 2001). The degree of partitioning is 
expressed by the partition coefficient (K), which is the particulate:solution concentration 
ratio of the pharmaceutical. The pharmaceutical functionality, basic, acidic, neutral or 
zwitterion, is critical in controlling its fate. For ionisable compounds, where the degree 
of ionization is pH-dependent, expressed by the acid dissociation constant, pKa. Figure 5 
demonstrates the ionisation behaviour of molecules representing basic, acidic and 
zwitterion pharmaceuticals at pH 5 – 9. Basic compounds are fully ionised at the lower 
pH and the neutral fraction abundance increases above pH 7 (Figure 5A), whilst acidic 
pharmaceuticals demonstrate converse behaviour (Figure 5B). The zwitterion, ofloxacin, 
contains at least one charge over the pH range (Figure 5C). These pH-related changes in 




Figure 5 pH-dependent ionization for A. two basic compounds, amitriptyline (AMI) (pKa 9.4) and acetobutol 
(ACB) (pKa 9.2) B. two acidic compounds, diclofenac (DCF) (pKa 4.0) and valsartan (VLS) (pKa 4.7). C. the 
zwitterion ofloxacin (OFX) (pKa basic 8.3, acidic 6.0). All the functionalities show a unionised fraction 
environmental pH range (red lines). 
The main sorbents in aquatic environments are dissolved organic matter (DOM), 
colloids, suspended solids and sediments.  
2.1.1. Dissolved organic matter 
DOM is a biogeochemical product which interacts with organic pollutants in water 
(Leenheer and Croué, 2003). It can be derived from natural or anthropogenic sources and 
is present in natural waters at concentrations ranging from 0.1 mg L-1 in groundwater to 
above 300 mg L-1 in wastewater (Leenheer and Croué, 2003; Tchobanoglous et al., 2003). 
DOM cannot be completely characterized but is regarded as a mixture of aliphatic and 
aromatic compounds with some predominant chemical functionality, including hydroxyl, 
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carboxyl, amido and keto groups (Leenheer and Croué, 2003). For experimental 
purposes, environmental DOM is physically filtrated from water, typically 0.45 or 0.2 
µm membranes, and chemically fractionated (e.g. via sorption and elution from resins) 
in order to obtain operationally-defined DOM fractions, namely hydrophobic or 
hydrophilic, and the acidic, basic or neutral sub-classes (Filella 2009; Maoz and Chefetz 
2010). Further classification is based on fluorescence excitation-emission matrix 
patterns, which show distinct “protein-like” and “humic-like” peaks (Hudson et al., 
2007). DOM in aquatic environments can be derived from in situ autochthonous sources 
by bacterio-plankton activity, or introduced via carbon recycling (Michael-Kordatou et 
al., 2015).  
2.1.2. Colloids 
Colloids are often defined as particles in the size range between 1 nm and 1 µm; 
they include clays such as layered silicates, metal oxides such as Fe- and -Al- hydroxides, 
organic material such as humic acids, proteins, and bio-colloids such as bacteria, viruses, 
and are ubiquitous in the environment (Zhou et al., 2007). Colloids are formed and 
transported to surface waters by weathering and biological processes. Their large specific 
surface area and sorption capacity play a crucial role in the speciation, bioavailability and 
transport of substances in the aquatic environment (Xing et al., 2015; Zhou et al., 2007).  
2.1.3. Suspended solids and sediments 
Suspended solids are a source of material that, in the case of contaminant loads, 
becomes a medium for accumulation in the sediment compartment (Lahti and Oikari 
2011).  Sediments are defined as settled material derived from weathering, erosion of 
minerals, and decay of organic matter, and transported by the action of the wind, water 
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or ice, and the force of gravity acting on the suspended solids. Sediments provide an 
important environmental surface for partitioning processes; and therefore, are of 
importance in determining the fate of chemicals in the environment. 
2.1.4. Importance of sorption in risk assessment 
Sorption processes are important in determining predicted environmental 
concentrations for environmental risk assessments. For example, the OSPAR convention 
states that compounds with distribution coefficient (log Kow) above 4.5 are screened for 
persistence, bioaccumulation and toxicity, following European Technical Guidance on 
Risk Assessment (European Comission Joint Research Centre, 2003).  The European 
Medicines Agency guidelines for the environmental risk assessment of pharmaceutical 
compounds proposes a Phased approach. Phase 1, a pre-screening worst-case scenario, 
considers the parent compound only, irrespective of mode of administration, metabolism 
and excretion (EMA, 2006). If the predicted environmental concentration is above 0.01 
µg L-1, Phase 2 entails analysis of the environmental fate and effects, although a tailored 
environmental risk assessment could be triggered below this threshold if the 
pharmaceutical is shown to affect reproduction. A PBT assessment is required at Phase 
1 for APIs that have a Log Kow >4.5.  Phase 2 is a tiered phase, comprising Tiers A and 
B. Tier A involves the ready biodegradability test (OECD, 1992) followed by a water-
sediment distribution study if the analyte is shown to be persistent (OECD, 2000). 
Toxicity tests are also performed to allow for a Predicted No Effect Concentration to be 
estimated. If the “Predicted Environmental Concentration” : “Predicted No Effect 
Concentration” ratio indicates a risk, a Tier B assessment should be conducted where the 
predicted environmental concentration for surface water is refined to include information 
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from wastewater treatment plant modelling using the SimpleTreat model (EMA, 2006), 
where a factor is applied to allow for the partitioning of the chemical. 
A terrestrial environmental risk assessment is triggered at Tier B if the Koc of the 
active pharmaceutical ingredient is >10,000.  Fish bioconcentration studies at Tier B are 
required if the Log Kow >3 and a sediment toxicity assessment is required for 
pharmaceuticals where 10% of the applied radioactivity adsorbs to sediment in the water-
sediment transformation study conducted at Tier A (EMA, 2006). 
The distribution of a APIs between the particulate and dissolved phases is therefore 
critical in determining its environmental fate, including mobility, persistence, 
bioavailability and subsequent toxicity.  It is also critical for defining whether a terrestrial 
or sediment based environmental risk assessment is required as part of the marketing 
application in Europe. There is currently no study that compiles the available partitioning 
data for APIs, nor identifies the significant data gaps and relates it to pharmaceuticals 
environmental fate. This review evaluates, for the first time, published information 
regarding the partitioning of APIs to DOM, colloids, suspended solids and sediments in 
natural surface aquatic environments and relates this to risk assessment processes.  
2.2. Meta-analyses 
2.2.1. Data collection 
Published studies on the distribution of APIs in freshwater environments were 
screened for the collection of data, documenting the source and concentration of the 
sorbents used in the experiments, pH, and pharmaceutical partition coefficients along 
with physicochemical parameters such as pKa and log Kow. Data sources included the 
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open chemistry database PubChem (https://pubchem.ncbi.nlm.nih.gov/), available 
scientific literature and environmental fate estimation program software (EPI Suite™, 
Table 1, Table 2, Table 3, Table 4). 
Figure 6 shows a graphical comparison of the number of articles, pharmaceuticals, 
metabolites and transformation products, and compounds per functionality investigated 
for each sorbent. Nine articles about sorption processes of pharmaceuticals to DOM, 
mostly reference materials but also some wastewater-derived DOM (Table 1), were 
identified (Bai et al., 2008; Carmosini and Lee, 2009; Ding et al., 2013; Kim et al., 2010; 
Lützhøft et al., 2000; Maoz and Chefetz, 2010; Martínez-Hernández et al., 2014; Peng et 
al., 2014; Yamamoto et al., 2003).  
The total number of pharmaceuticals studied was 20, comprising 1 neutral species, 
3 acidic, 3 basic, 13 zwitterions, and 3 metabolites. The experimental pH ranged from 3 
to 8, which is a critical parameter regarding the charge present on the pharmaceutical 
molecule and its subsequent fate.  
Four articles related to the partitioning of pharmaceuticals to colloids; extracted 
from samples of river water, groundwater, seawater and wastewater (Table 2) (Holbrook 
et al. 2004; Maskaoui et al. 2007; J. L. Zhou et al. 2007; Maskaoui and Zhou 2010). Here, 
10 compounds were studied comprising 2 neutral, 3 acidic, and 5 basic species, with 
experimental pH ranging from 6.4 to 8.5.  
Fourteen articles referring to suspended solids and sediment partitioning were 
identified, with 70 compounds studied (Al-Khazrajy and Boxall, 2016; Githinji et al., 
2011; Lahti and Oikari, 2011; Li et al., 2015; Lin et al., 2010; Löffler et al., 2005; 
Martínez-Hernández et al., 2014; Maskaoui and Zhou, 2010; Paul et al., 2014; Ra et al., 
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2008; Stein et al., 2008; Svahn and Bjorklund, 2015; Yamamoto et al., 2009; Zhou and 
Broodbank, 2014). Of the compounds studied, 4 were metabolites and 8 were 
transformation products; 20 were acidic, 38 basic, 7 neutral, and 3 were zwitterions 
across a pH range of 3.5 to 10 (Table 3, Table 4). 
Suspended solids and sediments dominated the studies on pharmaceuticals (70), 
where a number of metabolites and transformation products were also investigated. Basic 
compounds were most studied in suspended solids and sediments (38), followed by the 
acidic (20), neutral compounds (7), and zwitterions (3). The distribution to colloids was 
investigated for 5 basic, 3 acidic and 2 neutral compounds. The DOM distribution studies 
included the largest amount of zwitterion compounds (13), followed by acidic (3), basic 
(3) and neutral (2).   
 
Figure 6 A comparison of published articles on pharmaceuticals partitioning to DOM (green), colloids (red), 
































pharmaceutical ingredients (APIs), metabolites, transformation products, and divided per pharmaceuticals 
functionality: acidic, basic, neutral and zwitterion. 
The measured organic carbon-water distribution values (Koc) of each compound 
were plotted against the corresponding octanol-water distribution coefficient values 
(Kow) for the three sorbents; i.e. DOM, colloids, and suspended solids and sediments. No 
relationship was apparent which deviates from correlations for non-polar organics. 
However, selecting only the neutral pharmaceuticals and plotting organic carbon 
normalised log Koc against corresponding log Kow for each sorbent did show a linear 
relationship for DOM (R2=0.846), albeit for a limited number of data (n=5). No 
significant relationship was observed for other sorbents (Figure 7). 
 
Figure 7 Organic carbon-water (Koc) distribution values of the neutral compounds plotted against the 
correspondent octanol-water (Kow) distribution coefficient value for each sorbent, namely dissolved organic 
matter (DOM) (black dots) R2=0.846, colloids (red dots) R2=0.055, suspended solids and sediments (green 
triangles) R2=0.450; Showing a relationship only for DOM, though for a very limited number of data (5).  
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2.2.2. Partitioning to dissolved organic matter 
Yang et al., (2011) reported a weak positive linear relationship (R2= 0.509) 
between the freshwater total concentration of five groups of antibiotics and DOM. 
Furthermore, Lützhøft et al. (2000) demonstrated an inverse relationship between the 
concentration of “free” pharmaceuticals in solution and DOM concentration, limiting 
bioavailability and possibly toxicity (Rowett et al., 2016; Urrestarazu Ramos et al., 
1998), but increasing environmental persistence. These two studies highlight both the 
lack of available data as well as a potentially significant role for DOM in determining 
environmental exposure to pharmaceuticals. 
2.2.2.1. Dissolved organic matter composition 
The composition of DOM is source-dependent. For example, anthropogenic 
wastewater is mainly composed of proteinaceous matter, whilst freshwater DOM is 
dominated by humic substances (Hudson et al. 2007; Hernandez-Ruiz et al. 2012). The 
partitioning of the β-blocker, propranolol, on DOM derived from river and lake surface 
water generated log Kdom values ranging from 3.9 - 5.2 L kg
-1 (Table 1), with protein-like 
DOM associated with lower values and humic-like substances exhibiting highest log 
Kdom (Peng et al., 2014). Similar results were obtained for the anti-epileptic drug, 
carbamazepine, which showed most extensive partitioning to humic substances, 
including fulvic acids from landfill leachate, river water and Amherst humic acid, with 
log Kdom between 3.41 and 5.04 L kg
-1 (Table 1) (Hernandez-Ruiz et al., 2012a). 
However, complexation of carbamazepine with tryptophan-like DOM was also 
significant, suggesting an important role for anthropogenic organic matter in the transport 
and transformation of such pharmaceuticals (Wang et al., 2016). Since carbamazepine is 
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a neutral compound, hydrophobic sorption mechanisms to humic acid were proposed 
(Bai et al. 2008).  
2.2.2.2. Organic matter reference standards as a proxy for partitioning of 
pharmaceuticals 
The use of reference standards of humic DOM as a proxy for measuring 
partitioning of pharmaceuticals to DOM may result in an overestimation of the binding 
capacity. Carmosini and Lee, (2009) and Peng et al., (2014) investigated the partitioning 
of the zwitterion, ciprofloxacin, to contrasting DOM types at different pH and ionic 
strengths. The DOM included Leonardite standard humic acid, Pahokee Peat humic acid, 
Pahokee Peat II standard fulvic acid and Elliott Soil II standard fulvic acid. Other DOM 
types were obtained from digested and undigested municipal biosolids, municipal 
wastewater effluent, and beef industry lagoon wastewater. The wastewater-derived DOM 
showed much less affinity for ciprofloxacin than the reference humic standards. 
Furthermore, the former did not show a pH-sorption correlation as in the latter DOM 
type, which suggests that a mechanism other than ion exchange was controlling the 
sorption process. These interactions are likely driven by the more aliphatic protein 
composition of the wastewater-derived DOM than the aromatic humic DOM of the 
reference standards, exhibiting a different sorption characteristic and cation exchange 
capacity. Such variation in partitioning has also been observed for pharmaceuticals, 
carbadox, tetracycline, and lincomycin, tested using reference standards such as 
Leonardite humic acid and Aldrich humic acid, where the former showed greatest 
sorption capacity, probably as a result of more interaction sites being available (Table 1) 
(Ding et al., 2013). 
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Table 1 Dissolved organic matter (DOM) partition coefficient (Log KDOM) for 
pharmaceuticals, sources and type of organic matter, experimental concentration and pH. 
Legend: * metabolites; N.A. not available. 
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Humic acids 79.4 8 3.26 Ding et al. 2013 
Carbamazepine Neutral 13.9 
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1, 5, 12.5, 
25, 50 
3 3.44 Lützhøft et 
al. 
2000 
  1, 5, 12.5, 
25, 50 
4 3.65 Lützhøft et 
al. 
2000 
1, 5, 12.5, 
25, 50 
5 4.23 Lützhøft et 
al. 
2000 
1, 5, 12.5, 
25, 50 
6 4.39 Lützhøft et 
al. 
2000 
1, 5, 12.5, 
25, 60 
7 4.23 Lützhøft et 
al. 
2000 
1, 5, 12.5, 
25, 50 
8 4.36 Lützhøft et 
al.  
2000 
Ibuprofen Acidic 4.41   3.5 Wastewater and 
Suwannee river. 
n. a. 8  n. a. n. a. Hernandez
-Ruiz et al. 
2012 
Lincomycin Basic 7.6 
 
0.2 Reference standard Leonardite 
humic acid 
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7 n. a. Kim et al. 2010 
Oxolinic acid Zwitterio
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6.9   0.68 Aldrich humic 
acids; 
Humic acids;  1, 5, 12.5, 
25, 50 
3 3.87 Lützhøft et 
al. 
2000 
  1, 5, 12.5, 
25, 50 
4 4.00 Lützhøft et 
al. 
2000 
1, 5, 12.5, 
25, 50 
5 4.37 Lützhøft et 
al. 
2000 
1, 5, 12.5, 
25, 50 
6 4.50 Lützhøft et 
al. 
2000 
1, 5, 12.5, 
25, 50 
7 4.48 Lützhøft et 
al. 
2000 
1, 5, 12.5, 
25, 50 
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7 2.01 Kim et al. 2010 
2.2.2.3. Hydrophobicity of dissolved organic matter and its impact on 
partitioning 
The role of the different DOM fractions, namely hydrophobic or hydrophilic, and 
the sub-classes acidic, basic or neutral, on partitioning of pharmaceuticals depends on 
their chemical functionalities and degree of ionisation (Lützhøft et al., 2000; Michael-
Kordatou et al., 2015). For example, hydrophobic DOM fractions dominate the 
distribution of the acidic naproxen and the neutral carbamazepine at low pH (4), whilst 
at more environmentally relevant pH (6.5 - 8), the hydrophilic DOM fractions were more 
influential (Maoz and Chefetz 2010). In fact, despite the predominance of the acidic 
fraction of the hydrophilic DOM, which is expected to show little affinity for the 
negatively-charged naproxen, there is evidence that the neutral and basic moieties play 
an important role in the binding of the neutral carbamazepine and the acidic ibuprofen 
(Hernandez-Ruiz et al., 2013). Notwithstanding, the contribution to binding of each 
fraction is determined by its relative abundance in DOM mixtures (Maoz and Chefetz 
2010). The calculated values regarding sorption of pharmaceuticals to bulk DOM are 
based on experimentally discrete fractional sorption values, and differ from bulk 
experimental measurements (Maoz and Chefetz 2010). On this basis, it is hypothesised 
that DOM fractions interact with each other at the molecular level and do not behave as 
independent entities in the binding processes. Thus, studying DOM fractions as discrete 
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entities may lead to incorrect estimates of pharmaceuticals partitioning to the bulk DOM 
(Maoz and Chefetz 2010). 
2.2.3. Partitioning to colloids 
The partitioning of pharmaceuticals to colloids is poorly understood, with little 
supporting research available. The available data show that pharmaceuticals partition to 
colloids to a greater degree than other sorbents (Figure 8) (Table 2). The sorption capacity 
of colloids is determined by the type, influenced by its source and environmental 
compartment, such as freshwater, wastewater, or seawater. Such a variation can lead to 
large differences in partition coefficient values for the same pharmaceutical (Zhou et al., 
2007). Examples include data for colloids from river water, treated effluent, and seawater 
showing a distribution coefficient variation of a factor of 6 - 12 for the synthetic 
oestrogen 17-α ethynylestradiol. In addition, despite a higher amount of colloidal fraction 
in the wastewater effluent, no major partitioning variation was observed between 
wastewater effluents and freshwater colloids, whilst higher Kcoc values were observed for 
the lower concentrations of seawater colloids. This data confirms that the physical-
chemical properties of the colloids have much more influence than their actual 





























































Figure 8 Comparison of pharmaceuticals partition coefficients for different sorbents, namely dissolved organic 
matter (log Kdom), colloids (log Kcoc), suspended solids (log Kss), and sediments -bulk (log Kd sed)) and -




Table 2 Colloids partition coefficients (Log Kcoc) for pharmaceuticals, source and size fraction, experimental concentration and 
pH. Legend: * metabolites; N.A. not available. 
Compound Type pKa 
 
Log Kow Source Size fraction Concentration 
(mg L-1) 
pH Log Kcoc  
(L kg-1) 
Reference Year 
17α-Ethynilestradiol neutral 10.2 
 
3.67 Biological wastewater 
treatment system  
<30kD 6.0 7.1 5.2 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<30kD 5.3 7.1 3.0 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<30kD 4.9 7.1 5.2 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<30kD 5.1 7.1 4.5 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<100kD 5.9 7.1 4.7 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<100kD 5.4 7.1 4.5 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<0.22 µm 7.7 7.1 5.4 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<0.22 µm 7.5 7.1 4.9 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<0.22 µm 5.5 7.1 5.0 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<0.22 µm 7.1 7.1 5.3 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<1.5µm 8.9 7.1 4.8 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<1.5µm 7.7 7.1 5.0 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<1.5µm 6.2 7.1 4.9 Holbrook et 
al.   
2004 
     Biological wastewater 
treatment system  
<1.5µm 7.8 7.1 5.2 Holbrook et 
al.   
2004 
 
River water between >1 kDa 
and <0.7 μm; 
2.3 6.4 4.57 Zhou et al. 2007 
 River water between >1 kDa 
and <0.7 μm; 
3 7.3 3.8 Zhou et al. 2007 
 STWs effluents between >1 kDa 
and <0.7 μm; 
9.2 7.1 3.73 Zhou et al. 2007 
 River water between >1 kDa 
and <0.7 μm; 
2.9 8.5 3.84 Zhou et al. 2007 
 Sea water between >1 kDa 
and <0.7 μm; 
0.4 8 4.47 Zhou et al. 2007 
 STWs effluents between >1 kDa 
and <0.7 μm; 
7.5 6.8 4.63 Zhou et al. 2007 
Carbamazepine neutral 13.94 
 









River water between >1 kDa 





Diclofenac acidic 4 
 











River water between >1 kDa 





Indomethacin acidic 3.96 
 









River water between >1 kDa 





Mebeverine basic 8.2 
 









River water between >1 kDa 





Meclofenamic acid acidic 3.73 
 









River water between >1 kDa 





Propranolol basic 9.7 
 









River water between >1 kDa 





Sulfamethoxazole basic 6.2 
 









River water between >1 kDa 





Tamoxifen basic 8.87 
 
6.3 River water; STWs 
effluents; groundwater; 
n. a. 




Thioridazine basic 9.5 
 











Published data show no relationship between Koc and Kow for a series of APIs 
(Holbrook et al., 2004; Liu et al., 2005; Maskaoui et al., 2007; Yamamoto et al., 2003), 
which has been related to mechanisms of sorption dictated chiefly by the charge on the 
pharmaceuticals rather than hydrophobicity (Holbrook et al., 2004; Yamamoto et al., 
2003). Nevertheless, it should be noted that Maskaoui et al. (2007) showed a positive 
relationship between Kcoc and Kow, and postulated a role for hydrophobicity in controlling 
the partitioning processes of APIs on colloids. However, the study did not present the 
experimental pH and the variability of the charge of the compounds studied. The pKas 
suggest that most of the acidic and basic compounds would have been dissociated at 
environmental pH, which would strongly influence the relationship between Kow and 
Kcoc. 
2.2.4. Partitioning to suspended solids & sediments 
Preferential partitioning of some pharmaceuticals to suspended solids, and their 
absence in surface water solution in river catchments, highlights the significance of 
sorbents (Ferreira Da Silva et al., 2011). Both the characteristics of the pharmaceutical 
and the suspended solids are important in determining observed behaviour; in this case, 
sorption was driven by the positively-charged functionality of the pharmaceutical 







Table 3 Suspended solids partition coefficients (Log Kd) and normalized to organic matter content (log Koc) for pharmaceuticals, 
source, sorbent, experimental concentration and pH. Legend: * metabolites; N.A. not available. 



















3.67 Synthetic Artificial alumina suspended 
particles coated with humic 
acid; 




















































Diclofenac acidic 4 
 
4.51 River water; STWs 
effluents;  






Synthetic Artificial alumina suspended 
particles coated with humic 
acid; 
1 7.8 2.13 4.29 Ra et al. 200
8 
Gemfibrozil acidic 4.5 
 
4.7 Synthetic Artificial alumina suspended 
particles coated with humic 
acid; 
1 7.8 2.39 4.55 Ra et al. 200
8 
Ibuprofen acidic 4.41 
 








Synthetic  Alumina suspended particles 
coated with humic acid 
1 7.8 1.59 3.76 Ra et al. 200
8 
Indomethacine acidic 3.96 
 
15 River water; STWs 
effluents;  





Mebeverine neutral 8.2 
 
5.12 River water; STWs 
effluents;  









5 River water; STWs 
effluents;  





Naproxen acidic 4.2 
 










Propranolol basic 9.7 
 
1.2 River water; STWs 
effluents;  












0.48 River water; STWs 
effluents;  





Tamoxifen basic 8.87 
 
6.3 River water; STWs 
effluents;  





Thioridazine basic 9.5 
 
5.9 River water; STWs 
effluents; 





Tolfenamic acid acidic 4.3 
 
5.17 Synthetic Artificial alumina suspended 
particles coated with humic 
acid; 
1 7.8 2.79 4.95 Ra et al. 200
8 
There are limited data on pharmaceutical sediment sorption, accumulation, and 
formation of transformation products (Bu et al., 2013; Savci, 2013) (Table 4). One study 
reported concentrations 10 – 32 times higher in sediments than in water (Agunbiade and 
Moodley, 2016) with other studies confirming the importance of sediments as sorbents 
(Stein et al. 2008; Yamamoto et al. 2009; Varga et al. 2010; Martínez-Hernández et al. 
2014; Svahn and Bjorklund 2015; Li et al. 2015). For acidic pharmaceuticals, however, 
the charge repulsion limits pharmaceutical - sediment interactions (Koumaki et al., 2016). 
 
Table 4 Sediments partition coefficients (Log Kd) and normalized to organic matter content (log Koc) for pharmaceuticals, source, 
and pH. Legend: * metabolites; N.A. not available. 
Compound Type pKa 
 
Log Kow  Source pH Log Kd 






n. a. n. a. 
 




-0.8-0.25 1.3-1.6 Stein et al. 2008 
10,11-dihydrocarbamazepine* n. a. n. a. 
 
n. a. Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 




0.08-0.94 2.2-2.3 Stein et al. 2008 




n. a. n. a. Li et al. 2015 
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n. a. n. a. Li et al. 2015 
 







n. a. n. a. Li et al. 2015 




n. a. n. a. Li et al. 2015 




n. a. n. a. Li et al. 2015 
Acebutolol basic 9.2 
 
1.71 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 
0.5-1.0 2.35-2.47 Lahti and Oikari 2011 
     River  3.28 5.05 Lin et al. 2010 









Hernández et al. 
2014 






Yamamoto et al. 2009 
River 
 
0.7 2.47 Lin et al. 2010 
Alprenolol basic n. a. 
 
n. a. Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 
n. a. n. a. Lahti and Oikari 2011 
Amitryptyline basic 9.4  4.92 River 7 0.94-2.39 2.95-4.10 Al-Khazrajy and 
Boxall 
2016 
Atenolol basic 9.6 
 
0.16 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 





Hernández et al. 
2014 
River, lake n. 
a. 









Yamamoto et al. 2009 
River 7 
0.34-1.31 
1.93-2.7 Al-Khazrajy and 
Boxall 
2016 
Bendroflumethiazide basic n. a. 
 
n. a. River, lake 
 
n. a. n. a. Svahn and 
Bjorklund 
2015 
Bezafibrate acidic 3.6 
 
4.25 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 




n. a. n. a. Li et al. 2015 




n. a. n. a. Li et al. 2015 
Bisoprolol hemifumarate basic 9.5 
 
1.87 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 
0.3-0.8 2.17-2.3 Lahti and Oikari 2011 










2.4 4.16 Lin et al. 2010 
Carbamazepine neutral 13.9 
 
2.45 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 




n. a. n. a. Li et al. 2015 










0.23-1.09 2.4-2.5 Stein et al. 2008 
River, lake 
 









Yamamoto et al. 2009 
River 
 









n. a. n. a. Li et al. 2015 




n. a. n. a. Li et al. 2015 




n. a. n. a. Li et al. 2015 




n. a. n. a. Li et al. 2015 






0.4 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 
2.6 4.79 Lahti and Oikari 2011 
Citalopram basic 9.6 
 
1.39 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 
3.9-4.6 5.32-6.02 Lahti and Oikari 2011 




n. a. n. a. Li et al. 2015 
 
River 7.7 -0.52 1.41 Loffler et al. 2005 




0.32-1.15 2.4-2.5 Stein et al. 2008 
D3-ibuprofen acidic n. a. 
 
n. a. Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 
n. a. n. a. Lahti and Oikari 2011 
D5-fluoxetine basic n. a. 
 
n. a. Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a.  
n. a. n. a. Lahti and Oikari 2011 
Demeclocycline basic n. a. 
 
n. a. Setteable particulate matter from wastewater 
treatment works effluents 
n. 
a. 
n. a. n. a. Lahti and Oikari 2011 
Diazepam  basic 3.4 
 
2.85 River 7.7 0.48 2.28 Loffler et al. 2005  
River n. 
a. 
0.28-1.4 2.4-2.8 Stein et al. 2008 
Diclofenac acidic 4.2 
 
4.51 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 




n. a. n. a. Li et al. 2015 
River, lake 
 







n. a. Zhou and 
Broodbank 
2014 




0.15-0.81 2.3-2.2 Stein et al. 2008 
Diltiazem basic 8.06  2.8 River 7 1.34-3.00 2.90-4.12 Al-Khazrajy and 
Boxall 
2016 
Enrofloxacin acidic n. a. 
 
n. a. Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 
n. a. n. a. Lahti and Oikari 2011 




n. a. n. a. Li et al. 2015 
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Fluoxetine basic 10.1 
 
1.22 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 








Yamamoto et al. 2009 








n. a. n. a. Svahn and 
Bjorklund 
2015 




n. a. n. a. Li et al. 2015 




n. a. n. a. Li et al. 2015 
Ibuprofen acidic 4.9 
 
3.97 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 




n. a. n. a. Li et al. 2015 
River 
 







Yamamoto et al. 2009 
Ifenprodil basic 9.34, 
9.99 
 
n. a. River  
 
1.5 - 2.66 - 
3.14 
4.61 - 4.67 
- 4.91 
Yamamoto et al. 2009 
Indomethacin acidic 3.96 
 
n. a. River  
 
-0.92 - 
0.17 - 0.83 
2.20 - 2.20 
- 2.60 
Yamamoto et al. 2009 




7.7 n. a. Loffler et al. 2005 




7.7 3.07 Loffler et al. 2005 
Ketoprofen acidic 4.5 
 
3.12 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 




n. a. n. a. Li et al. 2015 
Mefenamic acid acidic 3.73 
 






Yamamoto et al. 2009 
     River 7 0.26-1.27 1.88-2.52 Al-Khazrajy and 
Boxall 
2016 
Metoprolol basic 9.7 
 
1.69 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 




n. a. n. a. Li et al. 2015 




n. a. n. a. Li et al. 2015 




0.5-1.33 12.6-2.7 Stein et al. 2008 
N4-acetyl-sulfamethoxazole* basic n. a. 
 




0.24-1.2 Stein et al. 2008 
Naproxen acidic 4.2 
 
3.18 Settleable particulate matter from wastewater 
treatment works effluents 
n. 
a. 








Hernández et al. 
2014 
Ofloxacin zwitterion 6.0, 
8.3 
 
0.35 Suspended particulate matter from wastewater 
treatment works effluents 
n. 
a. 
2.5 4.64 Lahti and Oikari 2011 
Oxazepam basic 1.7 
 
2.4 Suspended particulate matter from wastewater 
treatment works effluents 






0.30-1.37 2.4-2.7 Stein et al. 2008 
River, lake 
 
n. a. n. a. Svahn and 
Bjorklund 
2015 




-1.22 Suspended particulate matter from wastewater 
treatment works effluents 
n. 
a. 
2.5 4.64 Lahti and Oikari 2011 
Paracetamol basic 9.4 
 
0.46 Suspended particulate matter from wastewater 
treatment works effluents 
n. 
a. 
n. a. n. a. Lahti and Oikari 2011 
 
Suspended particulate matter from wastewater 
treatment works effluents 
7.7 n. a. n. a. Loffler et al. 2005 












Yamamoto et al. 2009 
River 
 





1.89 to 2.9 3.11-3.95 Zhou and 
Broodbank 
2014 




n. a. n. a. Li et al. 2015 
Sotalol basic 9.6 
 
0.24 Suspended particulate matter from wastewater 
treatment works effluents 
n. 
a. 




n. a. n. a. Li et al. 2015 























0.75-1.44 2.19-2.8 Stein et al. 2008 








0.38-0.89 3.01-2.5 Stein et al. 2008 




n. a. n. a. Li et al. 2015 
2.2.4.1. Influence of compound speciation  
The degree of ionisation influences partitioning on suspended solids (Table 3), with 
strong pH dependence for zwitterions, such as ciprofloxacin and amoxicillin, controlling 
partitioning to suspended solids in wastewater (Githinji et al., 2011). Acidic ibuprofen 
and naproxen were adsorbed in larger amounts at pH lower than their pKa (4.4 and 4.2, 
respectively), where they were mainly in unionized form (Paul et al., 2014). 
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In contrast, for zwitterions, an increase in Kd was observed at lower pH due to 
protonation of the amine group. As might be expected, higher Kd values were observed 
for amine-containing pharmaceuticals than for neutral or carboxylic compounds 
(Martínez-Hernández et al., 2014; Stein et al., 2008; Svahn and Bjorklund, 2015; 
Yamamoto et al., 2009) (Table 4). For example, ibuprofen showed a significant increase 
in Kd as pH decreased from 7 to 4, the latter pH value being below the pKa of the acidic 
compound (4.5), meaning that the neutral species dominated (Oh et al., 2016). Stein et 
al. (2008) showed that compounds with structures similar to carbamazepine and its 
metabolites, and some opiates and tranquilizers, had a similar distribution trend. 
Furthermore, the dominance of ionization over hydrophobicity as a sorption mechanism 
to suspended solids and sediments was confirmed by poor correlation of Kd and Kow 
(Stein et al., 2008; Yamamoto et al., 2009). 
2.2.4.2. Sediment composition  
The importance of the sediment composition to sorption was demonstrated by a 
large variation in Kd using field data from varying sampling locations (Zhou and 
Broodbank, 2014). The organic carbon content of the sediment correlated with the degree 
of pharmaceutical sorption (Martínez-Hernández et al., 2014; Stein et al., 2008; Svahn 
and Bjorklund, 2015; Varga et al., 2010), which is consistent with the large Koc values 
reported (Table 4). Despite the important role played by the organic carbon fraction, 
variability in cation exchange capacity and sediment texture can also influence sorption 
of APIs (Al-Khazrajy and Boxall, 2016; Le Guet et al., 2018). Furthermore, the molecular 
weight of pharmaceuticals was found to be positively correlated with Koc, showing that 
the partitioning processes tended to favour relatively large molecules, similar to 
hydrophobic contaminants (Zhou and Broodbank, 2014). Resuspension of sediment leads 
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to a decrease in Kd (Aminot et al., 2015; Zhou and Broodbank, 2014). This is likely due 
the larger specific surface area of suspended solids compared with sediments, leading to 
a shift in equilibrium towards the more readily available exchange sites of the suspended 
solids. 
2.2.4.3. Accumulation in sediments 
The sorption of APIs onto sediments and resuspendable suspended solids may lead 
to accumulation. APIs contamination of the benthic environment in areas close to urban 
wastewater treatment works, with concentrations up to 200 ng g-1 dry weight, has been 
reported (Lahti and Oikari 2011). Once in the sediment, APIs may undergo 
transformation processes and release lower molecular weight, more soluble 
transformation products into the dissolved phase which, in turn, partition according to 
the physico-chemical properties of the newly-formed moieties. Thus, sediments have 
been considered a potential secondary source of pharmaceutical contamination, likely to 
occur over a wide area downstream of discharges and therefore should be recognized as 
part of the environmental risk caused by pharmaceuticals in the environment (Li et al. 
2015). 
2.2.4.4. Metabolite sorption 
In addition to the parent compounds, sorption of metabolites is little understood, 
with only three studies having included metabolic products (Lahti and Oikari, 2011; 
Löffler et al., 2005; Stein et al., 2008). Löffler et al. (2005) compared the sorption to 
sediments of 10 pharmaceuticals and metabolites, including diazepam and its metabolite 
oxazepam; ibuprofen and its metabolite 2-hydroxyibuprofen; carbamazepine and its 
metabolite 10,11-dihydro-10,11-dihydroxycarbamazepine, metabolite and the active 
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form of clofibrate of clofibric acid, iopromide, paracetamol, and ivermectin. Binding to 
sediments was ascribed by the authors as the main reason for rapid elimination of 
paracetamol from solution. Carbamazepine showed a moderate affinity for sediments, 
whilst the accumulation of 10,11-dihydro-10,11-dihydroxycarbamazepine was 
insignificant, most likely because of its high solubility and hydrophilicity (log Kow = 
0.13) (Miao et al., 2005). The lipid regulator, clofibric acid, showed a very low affinity 
for sediments at pH close to its pKa of 7.7, suggesting low sorption under most 
environmental conditions. Due to its moderate hydrophobicity, oxazepam was rapidly 
and extensively partitioned to sediments (Löffler et al., 2005). The high hydrophobicity 
of ivermectin was reported as the main cause of rapid and extensive sorption to 
sediments. Ibuprofen partitioned to sediments only moderately, as did its metabolite 2-
hydroxyibuprofen. In summary, sorption to sediments was elevated for ivermectin, 
diazepam, oxazepam, and carbamazepine with Koc ranging from 1172 L kg
-1 for 
ivermectin to 83 L kg-1 for carbamazepine (Löffler et al., 2005), consistent with their 
respective physico-chemical properties (Table 4). 
2.2.5. Implication for environmental risk assessments 
In the environmental risk assessment for `down-the-drain chemicals’, such as 
pharmaceuticals, water is the main environmental compartment of concern (EMA, 2006). 
As such, the distribution to DOM, colloids, suspended solids and sediments in surface 
fresh water are of importance in determining the environmental exposure of these 
contaminants. The sorption to freshwater sorbents is accounted for in the predicted 
environmental concentration refinement of Tier B of the environmental risk assessment 
for pharmaceuticals by the calculation of a factor, as shown in Equation 2 (EMA, 2006; 




𝐹𝐴𝐶𝑇𝑂𝑅 = (1 + 𝐾𝑝𝑠𝑢𝑠𝑝 ∗ 𝑆𝑈𝑆𝑃𝑤𝑎𝑡𝑒𝑟 ∗ 10
−6) 2 
Where Kpsusp is the distribution coefficient to suspended solids; and SUSPwater the 
concentration of suspended solids. 
However, this calculation considers sorption on suspended solids but not 
specifically on DOM and/or colloidal fractions. As DOM and colloidal matter are 
responsible for most sorption (Figure 8), their omission could lead to overestimation of 
exposure. Additionally, as evidenced from this study, the source and quality of the 
sorbent is a key factor in determining the partitioning extent of pharmaceuticals. This is 
particularly apparent when reference standards are used to assess the degree of sorption 
to DOM, and results in a high degree of uncertainty of the distribution capacity. These 
aspects should be addressed in site-specific risk assessment as they could profoundly 
affect the exposure estimate. The importance of the pH dissociation of the 
pharmaceuticals is also clearly demonstrable, which impacts significantly on the extent 
of sorption to freshwater sorbents.  
2.3. Conclusions  
As a general conclusion, there is a paucity of information on processes by which 
APIs sorb to surfaces in aquatic environments. Nevertheless, reports show that the 
sorption of pharmaceuticals in the aquatic environment strongly depends on their 
chemical functionality and the sorbent properties, with basic compounds more readily 
adsorbed than neutral or acidic ones. Therefore, sorption increases at pH below pKa for 
all functionalities. The comparison of the partition coefficients of the different sorbents 
59 
 
(Figure 8) shows a net predominance of sorption onto colloids, and the following general 
trend of sorption: colloids > DOM > sediments > suspended solids. The Kow does not 
demonstrate a relationship with the distribution coefficients (K) of the polar and ionizable 
pharmaceuticals and the analyzed sorbents, which is most likely due to additional polar 
interactions between ionized pharmaceutical functional groups and the sorbent. Also, the 
adjustment of K to pH has not established a relationship between the adjusted partition 
coefficient (D) and Kow. 
With regard to DOM composition, humic substances generally show more 
affinity for APIs than protein-like DOM, while a poor correlation was found between 
sorption of pharmaceuticals reference and to environmental DOM. Furthermore, it is 
important to note that the investigation of the role of different fractions of DOM in 
isolation does not represent an environmentally-realistic estimate of pharmaceutical 
sorption. Partitioning to colloids is significantly under-researched, with the limited 
available information suggesting they are a major physico-chemical variable controlling 
pharmaceutical partitioning in water. Concerning other identified sorbents, suspended 
solids interactions with pharmaceuticals show dependence on the degree of 
pharmaceutical ionization. Again, no relationship between Kow and Kdss was 
demonstrated. Sediments can be considered both as a sink for pharmaceuticals and as a 
secondary source of pharmaceutical contamination in the form of transformation 
products. Differences in sediment Kd from separate studies are most likely influenced by 
differences in sediment composition, e.g. organic carbon content, grain size, clay 
fraction, cation exchange capacity, experimental conditions, and the concentration of 
















The aim and objectives of this research were addressed through a series of 
laboratory experiments and a final field study. In this chapter are described the materials, 
such as the active pharmaceuticals ingredients (APIs) and the synthetic wastewater (SW). 
A description of the sample preparation (i.e. filtering and solid phase extraction (SPE)) 
and the development of the High Pressure Liquid Chromatography (HPLC) coupled with 
Mass Spectrometry (MS) methodology is also described, as well as the fluorescence 
spectrophotometry and total organic carbon (TOC) analysis techniques.  
All the laboratory scale experiments were conducted at the University of Plymouth. 
The fieldwork consisted of a sampling campaign carried out in the Nairobi/Athi River 
Catchment, Kenya, and in such case the samples preparation was conducted in the 
laboratory of Jomo Kenyatta University, Nairobi, whilst the analyses were partly 
performed at the University of Plymouth and partly at the University of York. All the 
study specific materials and methods are outlined in the respective relevant chapters. 
3.2. APIs selection 
The APIs for the research needed to be representative for LLMICs where DDUW 
is occurring with greatest impact. Also the API functionality was considered as a 
selection criterion owing to its importance in distribution processes. Accounting for these 
two criteria substances were selected on the basis of the abundance of information in the 
literature, and the evidence of occurrence in LLMICs. The first parameter was considered 
necessary because of the novelty of the research. The latter parameter was deemed 
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necessary for extending the research to compounds typically found in impact zones of 
LLMICs.  
Table 5 provides a list of the selected APIs, namely the neutral carbamazepine 
(CBZ), acetaminophen (ACE), and nevirapine (NVR), the acidic diclofenac (DCF) and 
valsartan (VLS), the basic acetobutol (ACE) and amitriptyline (AMI); and their structure, 
functionality, pKa, log Kow, molecular formula, monoisotopic mass, and charged mass - 
positive and negative. 
All the compounds were purchased at the highest purity available either from 
Sigma-Aldrich (Acetobutol hydrochloride, amitriptyline hydrochloride, nevirapine, 
valsartan, acetaminophen) or Fisher Scientific (carbamazepine, diclofenac sodium). 
3.1.1. Acebutolol 
ACE is a cardio-selective beta blocker for the treatment of hypertension and 
arrhythmias. It reduces the work of the heart and allows it to beat more regularly, which 
is valid for other beta blockers as well (Drugbank, 2018a). 
The DDD1 for ACE is of 0.4 g via oral or parental administration e.g. by injection 
or intravenously, according to the World Health Organization (WHO, 2018a). The 
elimination of ACE is approximately of the 30-40% via renal excretion and the 50-60% 
via non-renal mechanisms, including excretion through the bile and direct passage 
through the intestinal wall (Drugbank, 2018a).  
                                                     
1 “The basic definition of the defined daily dose (DDD) is the assumed average maintenance dose 
per day for a drug used for its main indication in adult. Drug utilization data presented in DDDs 




Table 5, list of the selected active pharmaceutical ingredients (APIs), namely acebutolol (ACE), acetaminophen (ACT), 
amitriptyline (AMI), carbamazepine (CBZ), diclofenac (DCF), nevirapine (NVR) and valsartan (VLS), and their structure, 
functionality, pKa, log Kow, molecular formula, monoisotopic mass and charged mass: positive and negative. 







































































ACT, also known as paracetamol, is a pharmaceutical widely used as analgesic and 
antipyretic. The therapeutic effects of ACT are close to the salicylates but lacking of 
anti—inflammatory, antiplatelet and gastric ulcerative effects (Drugbank, 2018b). 
The DDD for ACT is of 3 g via the oral, parental administration e.g. by injection 
or intravenously, or rectal according to the World Health Organization (WHO, 2018b). 
ACT undergoes mainly glucoronidation (45-55% of the dose) and sulfation (30-35% of 
the dose). About 80% of ACT is excreted in urine after transformation and the 3% only 
unchanged (Drugbank, 2018b). 
This API was chosen for his widespread use and as a relatively well studied 
compound, which therefore allows its use as a reference compound. The physico-
chemical properties of ACT are listed in Table 5. 
3.1.3. Amitriptyline 
AMI is used in the treatment of depression and as an analgesic. This compound has 
a strong effect on the mood of depressed individuals through the inhibition of serotonin 
and norepinephrine reuptake (Drugbank, 2018c). 
The DDD of AMI is of 75 mg via the oral, parental administration e.g. by injection 
or intravenously (WHO, 2018c). AMI is mainly metabolized as the active nortriptyline 
in the liver, which can undergo further hydroxylation followed by conjugation with 
glucoronic acid. Other metabolites are formed but with much weaker activity (Drugbank, 
2018c). AMI is mostly excreted through urine as glucuronide or sulphate conjugate of 
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metabolites, and only 2% the total amount in urine is its parental form; a small amount 
is also detectable in faeces (Drugbank, 2018c). 
AMI was chosen because of its high prescription rate and its detection in the 
environment (Li et al., 2013), and it was considered of interest in a mechanistic study of 
sorption processes for its relatively high distribution coefficient (log Kow 4.92) and its 
basic functionality (Table 5). 
3.1.4. Carbamazepine 
CBZ is an anticonvulsant used to control epileptic seizure. The mechanisms of 
action are not fully understood yet (Drugbank, 2018d). 
The DDD of CBZ is of 1 g via the oral, parental administration e.g. by injection or 
intravenously (Drugbank, 2018d). CBZ is excreted mainly in urine (72%) and the rest is 
found in faeces (28%). The parental compound constitutes only the 3% of the total 
(Drugbank, 2018d). 
This API was chosen because of it has been relatively well studied and therefore 
well-known environmental behaviour, which made it the ideal candidate as control 
compound. The physico-chemical properties of CBZ are furnished in Table 5. 
3.1.5. Diclofenac 
DCF is a non-steroidal anti-inflammatory drug used for its antipyretic and 
analgesic action in the treatment of acute and chronic signs and symptoms of 
osteoarthritis and rheumatoid arthritis and pain more in general (Drugbank, 2018e). 
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The DDD for DCF is of 0.3 g via the oral, parental administration e.g. by injection 
or intravenously, or rectal according to the World Health Organization (WHO, 2018d). 
DCF is excreted totally in its glucuronide and sulphate conjugates of the metabolites in 
urine (65%) and only a little fraction of the total as conjugate of the parent compound 
and metabolites through biliary excretion (35%) (Drugbank, 2018e). 
DCF was chosen as relatively well studied compound and global wide use, in 
addition to its proved ecotoxicological effects (Swan et al., 2006). Also, the negatively 
charged functional group at environmental relevant pH was considered of interest for 
mechanistic studies of distribution conducted in this research. 
3.1.6. Nevirapine 
NVR is a widely used antiretroviral with activity against human immunodeficiency 
virus type 1 (HIV-1). NVR is prescribed when the symptoms of the decline of the 
immune system have become evident and infections are spreading. The virus can become 
resistant to NVR if used without other HIV medications, and it is effective only for a 
limited time (Drugbank, 2018f).  
The DDD for NVR is of 0.4 g via the oral administration only according to the 
World Health Organization (WHO, 2018e). This API is extensively metabolised via the 
cytochrome P450 metabolism in the liver. Only a small fraction of the parent compound 
is excreted through urine (<3%), indicating a minor role of such excretion route 
(Drugbank, 2018f). 
This compound was chosen as widely prescribed and detected in LLMICs in Africa 
(K’oreje et al., 2012; Madikizela et al., 2017; Ngumba et al., 2016) and for its 
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resemblance of physico-chemical properties to the highly persistent CBZ, which 
suggested a similar behaviour in the environment (Table 5). 
3.1.7. Valsartan 
VLS is an angiotensin-receptor blocker used to treat a variety of cardiac conditions 
such as hypertension, diabetic nephropathy and heart failure. VLS belongs to a class of 
antihypertensive agents called angiotensin II receptor blockers (ARBs) (Drugbank, 
2018g). 
The DDD for VLR is of 80 mg via the oral administration only according to the 
World Health Organization (WHO, 2018f). This compound is excreted 80% as 
unchanged drug and is not metabolised significantly in humans. The main excretion route 
is through faeces (83%) and the 13% is through urine, mainly as the parent compound 
(Drugbank, 2018g). 
VLS was chosen as a widely used API in high and LLMICs (Siddiqui et al., 2011). 
Additionally, it was chosen as representative for negatively charged compounds (Table 
5). 
3.1.8. Others 
In addition to these compounds a list of 55 APIs was screened for in the samples 
from a field work conducted in the Nairobi/Athi River catchment in Kenya. These 
compounds are listed in the relevant chapter as it is out of the scope of this section to 




3.3. Synthetic wastewater and characterization 
This section is based on the supporting information of the paper published as: 
Bagnis, S., Fitzsimons, M., Snape, J., Tappin, A., & Comber, S. (2018). Sorption of 
active pharmaceutical ingredients in untreated wastewater effluent and effect of 
dilution in freshwater: Implications for an “impact zone” environmental risk 
assessment approach. Science of the Total Environment, 624, 333–341. 
https://doi.org/10.1016/j.scitotenv.2017.12.092. 
The use of synthetic wastewaters (SW) is widely adopted for research purposes 
and in operational management. For instance in laboratory or pilot-scale WWTW 
where the use of an artificial wastewater is aimed at the control of loading conditions 
(O’Flaherty and Gray, 2013). SW are typically used for testing the fate of chemical, 
for studies of compounds toxicity, for the design, evaluation and optimisation of 
treatment technologies, and for the investigation of biological treatment processes 
(Githinji et al., 2011; Paul et al., 2014). There are several reasons for adopting a SW 
instead than real wastewater. The first reason is that SW can provide reproducibility 
because of the constant composition in terms of carbon and nutrients, in contrast to 
real wastewater; secondly, the use of ‘real’ wastewater may not be feasible or 
practical (i.e. there may be no WWTW near the laboratory); thirdly, the use of real 
wastewater can lead to an occupational risk caused by the pathogenic bacterial 
population likely to be present in the wastewater; In addition, the synthetic 
formulation is not as malodorous as real wastewater (O’Flaherty and Gray, 2013).  
There are many SW formulations described in the literature. The Organization 
for Economic Co-operation and Development (OECD) series of guidelines for testing 
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of chemicals proposes a SW that has been widely used for regulatory purposes. Due 
to the statutory nature of the OECD, the relative guidelines for biodegradation tests 
are often considered as the “confirmatory test” when the use of different guidelines 
can lead to variation in the results (O’Flaherty and Gray, 2013). In these guidelines 
the use of a SW has been commonly referred as the ‘standard SW’ since it is routinely 
used in such tests (O’Flaherty and Gray, 2013; OECD, 2001). Because of the 
importance given to this formulation, and the wide acceptance as reference standard 
SW, there has been a reluctance to use any other. However, this formulation has not 
been exempt from criticisms. Boeije et al. (1999) criticise that the use of peptone and 
meat extract in the OECD method can lead to operational problems such as sludge 
bulking, and blame the unbalanced composition as a possible cause of decline of 
microbial activity, in comparison with real domestic sewage.  Another criticism 
regards the biological nutrient removal and the unsuitability of the medium owing to 
an unbalanced ratio between C/N/P, respectively 100:18:2 (Dubber and Gray, 2011). 
Regardless of the OECD formulation, more general criticisms consider SWs as not 
representative of real wastewaters because of incomparability of COD and C/N/P 
ratios to real wastewaters, which can lead to bacterial growth selectivity and therefore 
different microbial population composition than the one present in WWTWs (Boeije 
et al., 1999). Despite all the criticisms, it must be emphasized that there is not a 
standard real wastewater; Metcalf and Eddy (2003) provide a table with a range of 
data for a typical untreated domestic wastewater composition, which may be adopted 
as a guideline (Table 6) (Tchobanoglous et al., 2003). 
A review of SW recipes available in literature was conducted by O’Flaherty 
and Gray (2013). The review aims at the identification of the most realistic 
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composition by means of comparison with real wastewaters samples. As already 
mentioned, the synthetic SW formulation mostly used refers to the OECD guidelines 
(OECD 303A). The OECD recipe is a suggestion, and can be modified depending on 
the experimental conditions the user is seeking to simulate. The original recipe was 
augmented with 200 mg/L of glucose by Prochaska and Zouboulis (2009); and it was 
used in a TOC concentration of 10 to 50 mg L-1 by Zwiener et al., (2000). The other 
SW analysed were Bracklow et al., (2007), Chuang et al., (1998), Kiso et al., (2000),  
La Para et al., (2006), Nopens et al., (2001),  Stasinakis et al., (2003), Synthetic 
sewage 2 (BSI, 2007), Tsang et al., (2008), Syntho (Boeije et al., 1999), and Synthes 
(Aiyuk and Verstraete, 2004).  
No one recipe is completely representative for wastewater, but each could be 
suitable for a different experimental application. In particular, Syntho and Sinthes 
have formulations that achieve the closest resemblance to real wastewater 
(O’Flaherty and Grey, 2013). A SW formulation involving the use of pet rabbit feed 
as insoluble organic suspended solids source was developed (Esperanza et al., 2004) 
and used as wastewater feed in a laboratory scale wastewater treatment plant. The 
same formulation was adopted afterwards by other authors for sorption studies 
(Githinji et al., 2011; Paul et al., 2014). This case is mentioned to report the variability 
in SW formulations. 
According to the authors, there is no such a thing as an ideal synthetic 
wastewater which is appropriate all situations and the criteria for the selection is 
dependent on the intended application. Regardless, the use of synthetic wastewater 
provides distinct advantages over the use of real wastewater, especially its 
reproducibility (O’Flaherty and Gray, 2013). 
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Table 6 Typical compositions of untreated domestic wastewater (Tchobanoglous et al., 
2003). 
Constituent Unit Concentration 
Low strength Medium strength High strength 
Solids, total (TS) mg L-1 537 806 1612 
Dissolved, total (TDS) mg L-1 374 560 1121 
Fixed mg L-1 224 336 672 
Volatile mg L-1 150 225 449 
Suspended solids, total (TSS) mg L-1 130 195 389 
Fixed mg L-1 29 43 86 
Volatile mg L-1 101 152 304 
Settleable solids mL L-1 8 12 23 
Biochemical oxygen demand 5d, 20 ˚C (BOD) mg L-1 133 200 400 
Total organic carbon (TOC) mg L-1 109 164 328 
Chemical oxygen demand (COD) mg L-1 339 508 1016 
Nitrogen (total as N) mg L-1 23 35 69 
Organic mg L-1 10 14 29 
Free ammonia mg L-1 14 20 41 
Nitrites mg L-1 0 0 0 
Nitrates mg L-1 0 0 0 
Phosphorus (total as P) mg L-1 3.7 5.6 11 
Organic mg L-1 2.1 3.2 6.3 
Inorganic mg L-1 1.6 2.4 4.7 
Potassium mg L-1 11 16 32 
Chlorides mg L-1 39 59 118 
Sulfate mg L-1 24 36 72 
Oil and Grease mg L-1 51 76 153 
Volatile organic compounds (VOCs) µg L-1 <100 100-400 >400 
Total coliform No./100ml 106-108 106-109 107-1010 
Fecal coliform No./100ml 103-105 104-106 105-108 
Cryptosporidium oocysts No./100ml 10-1-101 10-1-102 10-1-103 
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Giardia lamblia cysts No./100ml 10-1-102 10-1-103 10-1-104 
 
Syntho, one of the synthetic wastewater (SW) recipe available in literature was selected 
to be used in this study (Boeije et al., 1999). The original recipe was augmented three 
times in order to obtain a concentration typical for high strength wastewater 
(Tchobanoglous et al., 2003).  
The chemicals used  for the synthesis of the SW (Table 7) were: Genapol C100, 
Potassium molybdate, Genapol X-080 (Sigma Aldrich); Starch, for biochemistry, potato, 
hydrolysed for electrophoresis, Acros Organics; Glycerol, 99+%, extra pure, Acros 
Organics; Ammonium chloride; Uric acid, 99+%, Acros Organics; Kieselguhr, pure, 
white; Sodium bicarbonate, 99.7+%, ACS reagent, Acros Organics; Iron(III) sulphate, 
technical; Cobalt(II) chloride hexahydrate, for analysis, Acros Organics; Chromium(III) 
nitrate monohydrate, 99%, Acros Organics; Copper(II) chloride dihydrate, extra pure, 
SLR; Ethylenediaminetetraacetic acid, extra pure, SLR; manganese(II) sulfate 
monohydrate, 99+%, extra pure, Acros Organics; nickel(II) sulphate hexahydrate, 99%, 
for analysis, Acros Organics; zinc chloride, 99.99%, (trace metal basis), anhydrous, 
Acros Organics; sodium acetate anhydrous, extra pure, SLR; Dextrin, Acros Organics; 
Lactose monohydrate, Certified AR for analysis, fine powder; Meat Extract (Sigma-
Aldrich); Peptone special, for microbiology (Sigma-Aldrich); Urea, analytical regent 
grade (Fisher); potassium phosphate monobasic (Fisher); magnesium phosphate 
monobasic (Fisher); calcium chloride dehydrate (Fisher). 
Table 7 List of ingredients of Syntho and augmented concentration values (Boeije et al. 1999). 
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Compound Unit Amount Compound Unit Amount 
Na acetate* mg L-1 100 Genapol C100*** mg L-1 10 
Dried meat extract*** mg L-1 45 Lyophilized sludge+ mg L-1 600 
Low-fat milk 
powder*** 
mg L-1 100 CaCl2** mg L-1 15 
Potato starch* mg L-1 100 NaHCO3* mg L-1 75 
Glycerol* mg L-1 60 FeSO4 3H2O* mg L-1 30 
Peptone*** mg L-1 85 CoCl2 6H2O* µg L-1 150 
NH4CL* mg L-1 33 Cr(NO3)9H2O* µg L-1 2040 
Urea** mg L-1 225 CuCl2 2H2O* µg L-1 1440 
Uric acid* mg L-1 27 EDTA* µg L-1 0.66 
K3PO4H2O** mg L-1 60 K2MoO4*** µg L-1 60 
MgHPO4 3H2O** mg L-1 75 MnSO4 H2O* µg L-1 300 
Genapol X-080*** mg L-1 10 NiSO4 6H2O* µg L-1 900 
Diatomaceous earth* mg L-1 30 ZnCl2* µg L-1 540 
Diet fibres* mg L-1 100    
*, obtained from Acros organic, UK; ***, obtained from Sigma-Aldrich, UK; **, obtained from Fisher, UK; 
+, Central Wastewater Treatment Works at Plymouth, Devon, UK. 
 
The excitation-emission fluorescence matrix (EEM) of the SW showed the typical 
protein-like composition of crude wastewater, namely tryptophan-like (T1) and tyrosine-
like (T2) peaks, and a minor peak of humic acids (HA) (Figure 9) (Hernandez-Ruiz et 
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al., 2012b). Figure 10 shows the evolution of the peaks of the three components of 
Syntho, namely tyrosine-like, tryptophan-like and humic acids, during the 24 hours. The 
stability of all the three peaks is achieved after 12 hours. The results from FTIR analysis 
(Figure 11) showed a chemical “fingerprint” which remained constant, meaning that the 
medium was stable over the duration of the experiment. The respective curves in the 
graph were all consistent over time and the precision demonstrates the reproducibility of 
the SW.  
 
Figure 9 the excitation-emission fluorescence matrix of the synthetic wastewater (Syntho). T1 is the tryptophan-





Figure 10 the evolution of the peaks of the three components of Syntho, namely Tyrosine-like, Tryptophan-
like and humic acids, during the duration of 24 hours. The stability of all the three peaks is achieved after 12 
hours.  
In addition the peaks observed for the SW using FTIR showed strong similarities 
to real wastewater (Chefetz et al., 2006).
 
Figure 11 Fourier Transmission InfraRed (FTIR) spectra depicting the reproducibility and stability of the 



























3.4. Analytical methodology development 
3.4.1. Solid phase extraction 
A solid phase extraction protocol was developed and tested as appropriate sample 
preparation, aimed at improving the chromatography and mass spectrometry detection 
and quantification and to preserve the performance of the instrument. The protocol 
followed a previous method for the multi-residue analysis of pharmaceuticals in 
wastewater (Vergeynst et al., 2015).  
3.1.1. The samples were filtered through a 0.7 µm GF/F filter (Whatman), the 
first 2 ml of sample were discarded to prevent sorption losses (Kiehm and 
Dressman, 2008). Several cartridges were tested for recovery: OASIS HLB 
(Waters), StrataX (Phenomenex), and Telos (Kinesis). The following 
features were common to the three tested cartridges: 200 mg polymeric 
sorbent and 6 cc (mL) barrel volume.  
The recovery of all the compounds was tested as well with several eluents, namely 
methanol only, methanol with 2% formic acid, and methanol with 5% ammonia. After 
elution the samples were blown down under nitrogen at 40 ˚C and reconstituted in 1:10 
proportions of methanol and water.  
The OASIS HLB cartridges with methanol plus 2% formic acid as eluent 
performed the best, and therefore were adopted in the methodology. The results of the 
SPE recovery and matrix effect tests for the seven selected APIs and the chosen cartridge 




Figure 12 shows the solid phase extraction (SPE) recovery (%) of APIs in ultra-high purity water (UHP) and 
the matrix effects in filtered synthetic wastewater and reconstituted sample. It is also shown the analysis of 
UHP with APIs and no SPE. Acetaminophen (ACT); acebutolol (ACE); nevirapine (NVR); carbamazepine 
(CBZ); amitriptyline (AMI); valsartan (VLS); diclofenac (DCF). 
The recovery of all the APIs in UHP was optimal and no significant differences 
were detected between the analyses of the solid phase extracted APIs and the APIs 
standards in UHP (Figure 12). The observable matrix effects caused by the filtered 
synthetic wastewater are likely to result from sorption to the organic matter dissolved in 
UHP. 
3.4.2. Liquid chromatography and mass spectrometry 
3.4.2.1. HPLC-MS methodology 
The HPLC-MS method development for the analysis of the seven selected APIs 
was conducted over a period of several months to achieve the best sensitivity and 
resolution in a single methodology, to be applied throughout the laboratory scale tests. 









ACT ACE NVR CBZ AMI VLS DCF
%
APIs
H2OSpikedNOSPE H2OSpikedSPE FLTRDWWSpikedSPE Postspike
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modes, resolution, scan range, etc. and the chromatographic conditions, e.g. column, 
injection volume, eluents, etc. 
Chromatographic separation for the seven APIs was obtained using a Thermo 
Scientific Dionex U3000 UHPLC system. The chromatography column was an ACE 
UltraCore 2.5 SuperC18 (100 x 2.1 mm, 2.5 µm) (Serial number A156729; Batch: V14-
8055; Catalogue number: CORE-25A-1002U) operating at a temperature of 50°C. 
During the preliminary screening phase of the methodology development injection 
volumes between 5 - 20 µL were tested. The injector wash was a solution of 
water/methanol 1:1% v/v. The tested aqueous eluents were 0.1% formic acid in water 
(Fluka, LC/MS Chromasolv) and 0.1% ammonia in water, whilst the organic eluents 
were methanol (Thermo Fisher Scientific, Optima LC/MS) and acetonitrile. The eluent 
flow rate was set at 500 µL min-1.  
After a few tests, the best chromatographic conditions were obtained with a sample 
injection of 5 µL, and water (0.1% v/v formic acid) and methanol as the mobile phase 
solvents. The gradient program ran from 95:5 proportion of D:A to 0:100 for a duration 
of 5.5 minutes. A constant elution of 0:100 was kept for the duration of 2 minutes. The 
equilibration time was run at the initial conditions (95:5) for 2.5 minutes (Figure 13). 
High Resolution Accurate Mass - Mass Spectrometry (HRAM-MS) was performed 
by means of a Thermo Scientific - Q Exactive Focus - Quadrupole-Orbitrap.  
The ionisation source was Heated Electro-Spray Ionisation (HESI), and set as 
follow: Sheath gas 53 Arb (nitrogen); Auxiliary gas 14 Arb (nitrogen); Sweep gas 3 Arb 
(nitrogen); Vaporiser temperature 300 °C; Polarity Positive and/or negative ion; Spray 




Figure 13 shows the high pressure liquid chromatography (HPLC) gradients conditions from the 
system software interface (Dionex Chromeleon). %D, ultra-high purity water amended with 0.1% formic 
acid; %A, methanol. 
The mass spectrometer detector settings were as follow: Resolution 17,500 and 
35,000 @ m/z 200; Polarity positive or negative ions; Scan range full scan m/z 100 -
1000; AGC target 1.0E6 (automatic gain control); Micro scans 1; Maximum ion time 
was set as automatic. The mass calibration was performed by external injection of the 
following mass calibration solutions: auto-calibration using Pierce LTQ Velos ESI 
positive ion calibration solution (n-butylamine, caffeine, MRFA, and Ultramark 1621, 
Thermo Fisher Scientific, UK) and Pierce LTQ Velos ESI negative ion calibration 
solution (sodium dodecyl sulphate, sodium taurocholate and ultramark 1621, Thermo 
Fisher Scientific, UK). 
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3.4.2.2. Data analysis 
 The data analysis was performed by means of the Thermo Excalibur software 
by Thermo, UK. The qualitative and quantitative browsers were respectively used for 
the chromatogram qualitative analysis and the quantification of analytes in the 
samples. 
The samples were analysed in triplicates and the quality along the run time was 
checked by quality control (QC) standards and blanks set at regular intervals 
throughout the run. 
A chromatogram is provided in Figure 14 (A and B) to show the peak quality 
and the retention times of the seven APIs under the methodology chromatographic 
conditions (acetaminophen (ACT); valsartan (VLS); diclofenac (DCF); nevirapine 
(NVR); carbamazepine (CBZ); acebutolol (ACE); amitriptyline (AMI)). 
The detection and integration of the analyte peak were achieved using the ICIS 
algorithm set as in Figure 15. The quantification was obtained through calibration 
curved obtained from external calibration standards spanning eight concentrations, 
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Figure 14 A and B show the peak quality and retention times of the seven APIs selected for this study (Acetaminophen (ACT); valsartan (VLS); diclofenac (DCF); nevirapine 
(NVR); carbamazepine (CBZ); acebutolol (ACE); amitriptyline (AMI)) under the methodology chromatographic conditions. 
RT: 0.00 - 10.00
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Figure 16 shows the external calibration curves used for the quantification of the APIs.
Acetaminophen
Y = 151317+1.53664e+006*X-2647.38*X^2   R^2 = 0.9992   W: Equal













Y = 6.1759e+006+4.79061e+006*X   R^2 = 0.9984   W: Equal

















Y = 6.09881e+006+5.37737e+006*X   R^2 = 0.9986   W: Equal


















Y = 8.02341e+006+3.56839e+006*X+43223.3*X^2   R^2 = 0.9987   W: Equal
















Y = 1.6801e+006+6.05973e+006*X-13948.7*X^2   R^2 = 0.9998   W: Equal
















Y = -301508+1.2589e+006*X   R^2 = 0.9996   W: Equal













Y = 7548.1+995539*X   R^2 = 0.9996   W: Equal


















3.4.2.3. HPLC-MS direct injection methodology 
The subset of 55 target APIs (A1) were selected from the list of APIs validated in 
the methodology of Furlong et al., (2014) and analysed at the Department of 
Environmental Sciences, University of York, York, United Kingdom. 
The determination of APIs in filtered water was achieved by a “direct aqueous 
injection - high performance liquid chromatography (HPLC) tandem mass spectrometry 
(MS/MS) system methodology”, developed and validated by the United States 
Geological Survey (USGS) agency (Furlong et al., 2014).  
Briefly, the method is validated for the determination of the 55 human-use APIs 
analysed in this work using “a direct-injection” of 100 µL volume of the pre-filtered (0.7 
µm mesh glass filter) sample in an HPLC-MS/MS using an electrospray ionization source 
set in the positive mode. An inline stain-less filter was applied before the column (4.6 
mm, 0.2 µm). The APIs were separated using a reversed phase column (Zorbax Eclipse 
plus-C18 HPLC column, 1.8 µm particle size, 3.0 inner diameter and 100 mm of length) 
with a gradient of water modified with formic acid/ammonium formate and methanol.  
The use of multiple reaction monitoring (MRM) was adopted to enhance the 
sensitivity and specificity of electrospray HPLC/MS/MS for the qualitative 
determination of the compounds in the matrix. An internal standard method using stable 
isotope dilution standards (IDS) of target pharmaceuticals and the pesticide atrazine was 
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used for quantification (Furlong et al., 2014). The goal of the methodology development 
was to provide a routine method for the determination of APIs at limit of detection (LOD) 
and quantification (LOQ) below 50 ng L-1 (A2). 
3.4.3. Fluorescence spectrophotometry 
A fluorescence spectrophotometry methodology was used for the characterization 
of the synthetic wastewater and for the qualitative evaluation and quantification of 
protein-like DOM as a wastewater marker in the samples from the Nairobi/Athi river 
catchment sampling campaign. 
The methodology consisted of placing an aliquot of the pre-filtered sample (0.7 
µm) in a quartz glass cuvette (Hellma fluorescence cuvette 200-2500 nm spectral range) 
which was analysed using 3D-fluorescence scan mode on an Hitachi F-4500 fluorescence 
spectrophotometer. The emission range was comprised between 300 and 500 nm, whilst 
the excitation range was between 200 and 400 nm. The other parameters are shown in 
Table 8. 
Table 8 Instrument parameters for the 3D-fluorescence scan mode (EX: excitation; EM: emission; WL: 
wavelength). 
Instrument Parameters 
Measurement type: 3-D Scan 
Data mode: Fluorescence 
EX  Start WL: 200.0 nm 
EX  End WL: 400.0 nm 
EX Sampling Interval: 10.0 nm 
EM  Start WL: 200.0 nm 
EM  End WL: 500.0 nm 
EM Sampling Interval: 10.0 nm 
Scan speed: 2400 nm/min 
EX Slit: 5.0 nm 
EM Slit: 5.0 nm 
PMT Voltage: 950 V 
Response: 0.004 s 
Corrected spectra: Off 




 The methodology was based on the most commonly studied DOM 
fractions detected in natural waters, namely humic substances, humic and fulvic 
acids, and amino-acids of proteins and peptides, and their specific EX/EM peak 
positions (Hudson et al., 2007)(Figure 17). 
 
Figure 17 Excitation/Emission Matrix (EEM) showing the common peak positions for humic and fulvic acids 
(A and C) and protein-like compounds (T). Also, some common features of EEMs are indicated (Hudson et 
al., 2007). 
The protein-like DOM, namely tyrosine and tryptophan-like were quantified by 




Figure 18 external calibration curve for the quantification of tyrosine-like compounds (EX/EM 230/290). 
 
 
Figure 19 external calibration curve for the quantification of tryptophan-like compounds (EX/EM 230/350). 
  
























































The peaks of fluorescence in the excitation/emission matrix (EEM) which 
correspond to tryptophan (230/350) and tyrosine (230/290) were used as a proxy of 
sewage contamination according to the method proposed by Bagnis et al., (2019), 
fluorescence spectrometry of the dissolved organic matter (DOM) can be used to 
characterize the extent of the impact zone. The samples were diluted to a TOC level of 5 
mg L-1 or less to allow quantification and to minimize the filter effects. The analyses 
were performed in triplicates using 1 ml of pre-filtered sample in a fluorescence 
spectrophotometer, Hitachi F-4500. A 3-D scan was performed at a range from 200 to 
500 nm for both excitation and emission at a sampling interval of 10 nm and 2400 nm/min 
of scan speed. A blank of ultra-high purity water (UHP) was subtracted from the samples 
to eliminate the signal noise from the actual sample. An external calibration curve from 
tryptophan (Acros Organic) and tyrosine (Sigma) standards was used to quantify the 
amount of both the tryptophan and tyrosine-like DOM. 
3.4.4. Total dissolved organic carbon 
The analyses of the total dissolved organic carbon (TDOC) were performed by 
means of a high-temperature catalytic oxidation (HTCO) coupled to chemilumiscence 
detection (Badr et al., 2003). The measurements were performed using a Shimadzu TOC-
V analyser fitted with an ASI auto-analyser according to the method of Badr et al., 
(2003). The samples were previously filtered through a 0.7 µm glass filters, diluted 20 
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times, and acidified to avoid any bacteriological growth and therefore to preserve the 
samples (10 µL 6 M HCl per 10 ml sample). Subsequently the samples were frozen at - 
20 °C until the time of analyses. 
The samples were defrosted and loaded on the instrument in acid washed and 
combusted auto-sampler vials. In order to remove dissolved inorganic carbon the samples 
were sparged using high purity oxygen (8 min at 75 mL min-1). Subsequently, the samples 
were injected into a combustion column pre-heated at 650 °C and the DOC oxidised to 
CO2 in the presence of a platinum coated aluminium oxide catalyst. The CO2
 was detected 
by means of a non-dispersive infrared detector (NDIRD). The recorded voltage peak 
measurement was used for quantification of DOC through a series of external calibration 







4. SORPTION OF ACTIVE PHARMACEUTICAL INGREDIENTS 
IN UNTREATED WASTEWATER EFFLUENT AND EFFECT 
OF DILUTION IN FRESHWATER: IMPLICATIONS FOR AN 






This experimental chapter was published as: Bagnis, S., Fitzsimons, M., Snape, 
J., Tappin, A., & Comber, S. (2018). Sorption of active pharmaceutical ingredients in 
untreated wastewater effluent and effect of dilution in freshwater: Implications for an 
“impact zone” environmental risk assessment approach. Science of the Total 








Evidence of ecotoxicological effects of active pharmaceuticals ingredients (APIs) 
has increased research into their environmental fate. In low and low-middle income 
countries (LLMICs) the main source of APIs to surface waters is from discharge of 
untreated wastewater. Consequently, concentrations of APIs can be relatively high in the 
“impact zone” downstream of a discharge point. Little is known about the fate of APIs in 
these impact zones. In this laboratory scale investigation, the effect of successive dilution 
of synthetic untreated wastewater (dilution factor 1 to 10) on the distribution of APIs was 
studied. The sorption was consistent with the chemical properties of each compound: 
charge, lipophilicity, and structure. Dilution increased desorption of the basic and neutral 
APIs (up to 27.7%) and correlated with their lipophilicity (R2>0.980); the positive charge 
was of secondary importance. Anions did not significantly desorb (< 10% loss). 
Increased concentrations of dissolved organic matter at dilutions of 8 and 10 times that 
of untreated wastewater coincided with lower dissolved API concentrations. The data 
showed a clear trend in the desorption process of APIs that may lead to higher exposure 
risk than anticipated. Therefore, it is suggested that these aspects should be accounted for 
in the development of dedicated environmental risk assessment approach for APIs in 










The increasing consumption and production of active pharmaceutical ingredients 
(APIs) in low and low-middle income countries (LLMICs) is growing environmental 
concern owing to the awareness of possible ecotoxicological effects (Kookana et al., 
2014).  This is related to the diffused practice of direct discharge of untreated wastewater 
(DUW), the main source of APIs to the environment, which creates a heavily polluted 
area downstream from the discharge point, named the “impact zone” (A.I.S.E./CESIO, 
1995; Finnegan et al., 2009; Kookana et al., 2014; Malik et al., 2015; Nansubuga et al., 
2016; Thebo et al., 2017).  
Little is known about the environmental fate of APIs in the “impact zone” created 
by the DUW. Nevertheless, a few available measured environmental concentrations 
(MECs) of APIs in impact zones of LLMICs show higher concentrations than for high-
income countries with developed wastewater treatment infrastructure (Madikizela et al., 
2017). For instance, in the Nairobi River basin, Kenya, APIs were detected at 
concentrations ranging from ng L-1 to 160 µg L-1 (K’oreje et al., 2016, 2012; Ngumba et 
al., 2016), in Nigeria were reported individual concentrations above 50 µg L-1 (Olatunde 
et al., 2014), and again, in South Africa were detected concentrations of atenolol and 
ibuprofen up to 30 and 85 µg L-1 respectively (Agunbiade and Moodley, 2016, 2014; 
Matongo et al., 2015), and antiretroviral were quantified at concentrations up to hundreds 
of ng L-1 (Wood et al., 2015). Pharmaceutical factories wastewater was thought to be the 
source of APIs concentrations up to mg L-1 in Pakistan (Ashfaq et al., 2017) and India 
(Larsson, 2014); and in tropical Asia, sulphonamides antibiotics in surface waters were 
found to be at higher concentrations than in high-income countries (Shimizu et al., 2013). 
In one reported case, the environmental risk assessment showed a potential for risk, and 
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pharmaceutical manufactory wastewater contribution was deemed as important, as also 
evidenced by other investigations (Ashfaq et al., 2017; Larsson, 2014; Ngumba et al., 
2016). Although API manufacturing sites would be expected to be identified as high risk, 
it should also be noted that in high income countries direct discharge of untreated 
wastewater from such factories is illegal. The reported data for LLMIC countries 
therefore highlights the environmental concerns and need for carefully considered risk 
assessment.  
As demonstrated above, globally there are common occurrences of API 
concentrations in “impact zones” which exceed 0.01 µg L-1 for any individual compound.  
Under the existing risk assessment process, if predicted, such a PEC would trigger Phase 
II of the environmental risk assessment (ERA) (EMA, 2006), which consists of a two-
step tiered protocol to evaluation of the risk. Tier A is an initial environmental fate and 
effects analysis that, if resulting in a risk, should be followed by Tier B, an extended 
environmental fate and effects analysis (EMA, 2006). The latter is a refinement of the 
predicted environmental concentration (PEC) in the surface water using a distribution 
coefficient, which considers the moiety adsorbed to sewage sorbents as being retained in 
the wastewater treatment sludge (OECD, 2000). Equation 3 is used for PEC refinement in 




𝐸𝑙𝑜𝑐𝑎𝑙𝑤𝑎𝑡𝑒𝑟 ∗ 𝐹𝑠𝑡𝑝 𝑤𝑎𝑡𝑒𝑟




Where PECsurface water is the output of the local surface water concentration (µg l
-1); 
Elocalwater is the local emission to wastewater of the relevant residue (µg L
-1); Fstp water is 
the fraction of emission directed to wastewater (µg L-1); WASTEWinhab is the amount of 
wastewater per inhabitant per day (L d-1); CAPACITYstp is the capacity of the local 
wastewater treatment plant (l); FACTOR accounts for adsorption to suspended matter; 
and DILUTION is the DF, with a default value of 10 (EMA, 2006).  
 Where untreated wastewater is discharged there is little or no retention of sludge, 
the entire crude sewage is input to the “impact zone” scenario. Consequently, the sorbents 
loaded with APIs are discharged and diluted with the receiving freshwater, and possible 
redistribution processes might cause imprecise calculation of PECs and the associated 
risk quotient.  
Engineering protocols recommended a ratio of river flow to untreated wastewater 
flow of 40 (DF) (Keller et al., 2014) to allow dilution and dispersion of pollution. A DF 
of 10, assuming previous wastewater treatment, is used as the default value for 
environmental risk assessment (EMA, 2006; European Comission Joint Research Centre, 
2003). 
Although risk assessments are inherently designed to be conservative, reported data 
suggests that this level of dilution may not always occur. In at least 14 countries 
worldwide, the local predicted DF median observations show a value below 10, the 
majority being in North Africa and the Middle East, with Belgium as the only European 
country (Keller et al., 2014). The number increases to 53 countries worldwide if data of 
observations falling in the 5 and 25 percentiles are considered (Keller et al., 2014) . The 
APIs sorption processes to wastewater sorbents control the exposure to biota (Agunbiade 
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and Moodley, 2016; Carmosini and Lee, 2009; Hernandez-Ruiz et al., 2012b; Hudson et 
al., 2007; Lahti and Oikari, 2011; OECD, 2000; Peng et al., 2014; Svahn and Bjorklund, 
2015; Wang et al., 2016; Zhou et al., 2007), and since DUW occurs at dilutions that can 
cause significant desorption of APIs (Hajj-Mohamad et al., 2017; S. F. Yang et al., 2011) 
such exposure might be underestimated with simple dilution calculations.  
The aim of this study was to assess the partitioning of APIs to wastewater sorbents, 
and to quantify the potential dilution-induced desorption in receiving freshwaters using 
a standardised synthetic untreated wastewater diluted across a range of DFs. This 
approach was designed to assess the effect of the major constituents present in untreated 
wastewater (particularly the presence of high concentrations of organic carbon, 
potentially capable of ‘stabilising’ APIs in the dissolved phase) on the environmental fate 
of APIs. Outcomes of the study could then be used to inform the development of an 
improved exposure assessment approach for a range of contaminants in the impact zone 
generated by the DUW in freshwaters.  
4.2. Experimental approach 
Triplicate SW incubations (500 mL) were spiked with APIs each at a concentration 
of 100 µg L-1. This concentration was chosen for the following reasons: (i) it represented 
levels that have been observed in impact zones (Azuma et al., 2017; Kookana et al., 2014; 
Madikizela et al., 2017); (ii) levels were not high enough to bias any physico-chemical 
effects which might occur in the impact zone; (iii) concentrations were high enough to 
allow accurate and precise determination using the applied analytical technique in the 
dissolved phase after equilibration (particularly for the strongly adsorbing APIs). 
Samples were continually stirred and progressively diluted using UHP (MilliQ, deionised 
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water resistivity of at least 18.2 MΩ•cm at 25 oC). A pH of 7.5 was chosen as 
representative of the environmental and wastewater matrix. Sample blanks and controls 
were included (Figure 20). The flasks were wrapped in aluminium foil to avoid exposure 
to light. The dilution distribution dynamics were tested over a range of ten dilution factors 
(DF): 1, 1.2, 1.4, 1.6, 1.8, 2, 2.2, 4, 8, 10. The DFs were based on the progressive 
achievement of DF 10, which is the environmental risk assessment default assumption 
(EMA, 2006; Keller et al., 2014). After each dilution, the sample was left for 24 hours to 
reach equilibrium before sampling, which was a conservative time estimate (Conrad et 
al., 2006; S. F. Yang et al., 2011).  
 
Figure 20 Experimental design of the dilution experiment. A-B-C were sample replicates; D was the blank 
and E was the control where APIs were added to buffered and sterilized (NaN3) ultra-high pure water (UHP). 
Each batch was progressively diluted with UHP from the dilution factor (DF) 1 to 10 (1, 1.2, 1.4, 1.6, 1.8, 2, 4, 
6, 8, 10) along a period of 10 days. 
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4.3. Experimental approach 
4.3.1. Calculations 
4.3.1.1. Determination of Kd values 
The environmental fate of a contaminant is largely determined by its sorption 
behaviour. The extent of sorption is expressed as the distribution coefficient, Kd, 
normally determined by the particulate : dissolved ratio at equilibrium (Franco and 
Trapp, 2008). In this study the concentration in solids refers to sorption to the bulk 
sorbents of untreated wastewater, including colloids and DOM, and therefore hereafter 
named as concentration in sorbents (Cs) whilst the concentration in water (Cw) to the 
freely available fraction.  
Therefore, the Kd exp. is obtained from the ratio of the compound concentration in 






The distribution coefficient was calculated at each DF. The modelled distribution 
coefficient values (Kd Mod.) were also calculated for comparison to the experimental ones. 
The pH dependent octanol-water distribution coefficient (Dow), which accounts for 
compound dissociation, dependent on the pKa, was calculated for each compound 





𝐥𝐨𝐠 𝑫𝒐𝒘𝑵 = 𝒍𝒐𝒈𝑲𝒐𝒘  
 
Equation 6 











Where log Dow is the distribution coefficient octanol-water (log Kow) adjusted to 
the dissociation of the compound at a given pH; pKa is the dissociation constant of the 
compound (Lin et al., 2010). 
Log Dow was related to Kd using Equation 8 (Lin et al., 2010): 
Equation 8 
𝐥𝐨𝐠 𝑲𝒅 𝑴𝒐𝒅. = 𝟎. 𝟕𝟒 × 𝐥𝐨𝐠 𝑫𝒐𝒘 + 𝟎. 𝟏𝟓  
4.3.1.2. Variation from theoretical concentration (% VTC) 
In order to evaluate extent of desorption for each API, the theoretical concentration 
was calculated at each DF, including undiluted sample (DF1), and subtracted from 
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experimental data. The results were recalculated as the percentage of variation from the 
theoretical concentration (%VTC) for normalisation, as shown in Equation 9:  
Equation 9 
%𝑽𝑻𝑪 = (𝑪𝒆𝒙𝒑 − 𝑪𝒕𝒉 𝑪𝑫𝑭𝟏) × 𝟏𝟎𝟎⁄   
Where Cexp is the API experimental concentration in water, Cth is the API 
theoretical concentration in water and CDF1 was the API concentration in water at DF 1. 
 
4.4. Results and discussion 
4.4.1. Sorption 
The API distribution in undiluted samples (DF 1) is presented in Figure 21 as a 




Figure 21 Percentage (%) of APIs in solution after spiking at no dilution (DF 1); the compounds are ordered 
per increase of API log Kow, as indicated in the top bar. The error bars show the standard deviation (ACT, 
acetaminophen; ACE, acebutolol; NVR, nevirapine; CBZ, carbamazepine; VSL, valsartan; DCF, diclofenac; 
AMI, amitriptyline). 
These data were used as the initial concentration for the calculation of the 
theoretical concentration after dilution and the log Kd (Table 9). 
Table 9 Measured concentration of APIs in undiluted solution (DF1) and experimental solid-water distribution 
coefficient values. 
DF 1 ACT ACE NVR CBZ VLS DCF AMI 
µg L-1 102.39 92.05 73.05 83.68 84.42 91.20 46.58 
API
















































Log Kd [L kg-1] -1.70 2.27 2.90 2.62 2.60 2.32 3.39 
* ACT, acetaminophen; ACE, acebutolol; NVR, nevirapine; CBZ, carbamazepine; VSL, valsartan; DCF, diclofenac; 
AMI, amitriptyline. 
At the experimental pH of 7.5, the acidic and basic APIs are calculated to be fully 
ionised, and the compounds defined as neutral, ACT (pKa 9.38), NVR (pKa 2.8) and 
CBZ (pKa 13.2), may be considered fully unionised. The measured sorption behaviour 
was consistent with the chemical properties of each compound: charge, lipophilicity, and 
structure, and in accord with previous studies (Jelic et al., 2011; Silva et al., 2011; 
Verlicchi et al., 2012). 
The low log Kow (0.3) of the neutral ACT predicts little sorption, which agrees with 
previously published studies (Li et al., 2015; Lin et al., 2010; Martínez-Hernández et al., 
2014). The neutral CBZ and NVR, log Kow of 2.7 and 2.5 respectively, show a similar 
sorption trend. Sorption was greatest for AMI, consistent with its high lipophilicity (log 
Kow 4.9) and the influence of the positive charge. In fact, the lipophilic interactions are 
reported to be most important, whilst the charge on the ionised functional group exercises 
a secondary control on the distribution processes (Franco and Trapp, 2008; Githinji et al., 
2011; Martínez-Hernández et al., 2014; Silva et al., 2011). The low sorption of ACE was 
supported by its log Kow (1.7), which confirmed the secondary impact of the positive 
charge in determining the sorption behaviour. DCF and VLS, however, adsorbed less 
strongly than expected per their relatively high log Kow (3.6 and 4.3, respectively). This 
was likely due to the degree of repulsion of the negative charge on both the API and 
sorbent competing with lipophilic attraction (Delle Site, 2001; Paul et al., 2014).  
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The log Kd obtained at DF1 were compared with values available in the literature 
(Table 10) (Al-Khazrajy and Boxall, 2016; Bai et al., 2008; Hernandez-Ruiz et al., 2012b; 
Lahti and Oikari, 2011; Li et al., 2015; Lin et al., 2010; Loffler et al., 2005; Maoz and 
Chefetz, 2010; Martínez-Hernández et al., 2014; Maskaoui et al., 2007; Maskaoui and 
Zhou, 2010; Stein et al., 2008; Svahn and Bjorklund, 2015; Yamamoto et al., 2009; Zhou 
and Broodbank, 2014). The data show the importance of the sorbent quality (i.e. protein-
like or humic-like organic matter) in determining the extent of API sorption. Wastewater 
is mainly composed of proteinaceous material which binds organic contaminants more 
weakly than humic-like substances typical of freshwater (Hernandez-Ruiz et al., 2012b; 
Peng et al., 2014; Wang et al., 2016). The characterization of the synthetic wastewater 
used during this study confirmed the predominance of proteinaceous components (Figure 
9) and the Kd exp. were consistent with its comparative binding strength. In fact, the log 
Kd of -1.70 L kg
-1 for ACT was in the range of values obtained for suspended solids (SS) 
(-2.2 and 0.5) in a simulated sewage system (Hajj-Mohamad et al., 2017). Also, the log 
Kd for CBZ (2.62 L kg
-1) obtained in this study corresponded to the value reported by 
Maoz and Chefetz (Maoz and Chefetz, 2010) for DOM extracted from bulk sewage 
sludge (2.64 L kg-1), and in the range obtained by Lahti and Oikari (Lahti and Oikari, 
2011) for sediments from wastewater effluent (2.00-3.42 L kg-1) (Table 4). CBZ sorption 
to humic-like substances revealed a much larger log Kd in contrast of up to 6.66 L kg
-1 
(Table 4). The proteinaceous composition of the SW could explain the lack of ACE 
sorption despite the positive charge, consistent with the range (log Kd of 0.5 - 1.0 L kg
-1) 
obtained by Lahti and Oikari (Lahti and Oikari, 2011) for particulate matter derived from 
wastewater treatment works effluent, considerably less than 3.28 L kg-1, obtained by Lin 
et al. for freshwaters, typically characterized by the presence of humic-like substances 
(Lin et al., 2010). However, the repulsion of negative charges on the dissociated acidic 
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compounds is more important in sorption processes than the sorbent quality. This was 
shown by the log Kd exp. 2.13 L kg
-1 for DCF obtained for synthetic humic-like SS by Ra 
et al. (2008) that was close to the value of 2.32 L kg1 obtained in this study (Table 9).   
4.4.2. Trend of dissolved concentration of APIs as a function of dilution 
The variation in concentration of the dissolved APIs with dilution is shown in 
Figure 22. Desorption is expressed as the percentage of variation from the theoretical 
concentration (%VTC) against DF. The extent of the deviation, as a dilution effect, varied 
between compounds, determined by the relative influence of compound functionality and 
lipophilicity.  
Maximum deviation was measured at low DF, namely DF 2, whilst at higher DF 
the concentrations of APIs are similar to the theoretical values. The highest %VTC 
occurred for AMI (27.7%), followed by CBZ (12.4%), NVR (11.8%), ACE (7.7%), DCF 
(4.2%), ACT (1.3%), and VSL (-3.2%). 
Figure 22 shows the behaviour of the compounds separated by functionality. The 
compound ACT showed no variation from the theoretical concentration at each dilution 
factor (Figure 22A), which was expected as sorption was insignificant (Figure 22). ACT 
(pKa 9.38) was neutral at the experimental pH so functionality would not have influenced 
sorption. The low log Kow (0.3 L Kg
-1) indicates negligible lipophilicity, consistent with 
the low retention shown by the wastewater sorbents. As such, ACT behaved 
conservatively at each DF. The neutral compounds NVR and CBZ show a similar trend 
of deviation from predicted concentration (+10 %VTC at DF2). The two APIs were both 
neutral at the experimental pH and their log Kow values are similar (2.50 and 2.67 L Kg
-
1, respectively), which explains the similar trend, and highlights the role of lipophilicity 
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in controlling the sorption of APIs to and from the wastewater sorbents. CBZ and NVR 
have similar molecular structures that could be the cause of the notable persistence of the 
former (Andreozzi et al., 2004), and, if true also for the latter, would help explain the 
ubiquitous presence of NVR in impact zones (K’oreje et al., 2016, 2012; Ngumba et al., 
2016).  
Figure 22B shows the trend in the deviation from the theoretical concentration for 
the basic compounds AMI and ACE. AMI shows the largest %VTC (27.7%) amongst 
the compounds investigated, which is concomitant with the largest log Kow value (4.9). 
ACE is a cation at the experimental pH, but the lipophilicity (log Kow 1.7) appeared to be 




Figure 22 Percentage of variation from theoretical concentration of A: neutral compounds acetaminophen 
(ACT), Nevirapine (NVR), and carbamazepine (CBZ); B: basic compounds Acebutolol (ACE) and 
Amitriptyline (AMI); C: acidic compounds Valsartan (VLS) and Diclofenac (DCF); at DF from 1 to 10. 
Figure 22C shows the behaviour of the acidic compounds VLS and DCF. As 
previously discussed, these acidic compounds showed little sorption, despite the large 
log Kow, likely due to repulsion between the negative charge on the compound and the 
negative net charge of the organic matter sorbents (Refaey et al., 2017). Also, little 
desorption was measured for DCF (10%VTC) and none for VLS. The former behaviour 
was likely determined by strong binding of electrical forces involving charge transfer 
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(~40 kJ mol-1), which regards the moiety of negative charged compounds that once 
adsorbed would be unlikely reversible (Martínez-Hernández et al., 2014). 
Lipophilicity was the main parameter determining the behaviour of the neutral and 
cationic APIs, whilst the negative charge on the anionic APIs strongly interfered with the 
sorption/desorption processes. This trend is shown in Figure 23A, which depicts the 
relationships between log Kow and the %VTC of neutral and cationic APIs, on the right 
of the black line, and acidic compounds, on the left. Figure 23B shows the correlation of 
the %VTC and the log Kow of the neutral and positively charged compounds with the 
coefficient of determination (R2) greater than 0.950 in 7 of the 9 DFs.  
 
Figure 23 A shows the relationships between the log Kow of neutral and positively charged APIs on the right of 
the black line at the percentage of variation from theoretical concentration (%VTC) of 2, and the lack of 
relationship of the acidic compounds, on left side; B shows the correlation of the neutral and positively charged 
compounds versus dilution. 
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4.4.3. Modelled versus experimental Kd 
The log Kd values for the APIs were obtained from experimental data (log Kd exp.) 
and a theoretical model (log Kd mod.) (Lin et al., 2010). Additionally, literature solid-water 
distribution coefficients (log Kd lit.) were collected (Table 4), and the upper and lower 
values added to Table 2 for comparison. 
Although the log Kd mod. at DF 1 did not exactly match the experimental values, the 
data were within the range of reported values from the literature, which demonstrated the 
validity of the model (Table 10). The calculated log Kd for AMI was closest to the 
experimental value (DF 1), but did not correspond to the reported range of values from 
the literature. However, the log Kd lit. values for AMI originated from a single study and 
related to distribution to sediments, whilst the ranges for other compounds related to more 
relevant sorbents, namely DOM, colloids and suspended solids. As previously discussed, 
the sorbent type and quality strongly affect distribution processes and, therefore, the Kd 
values.  
A general increase of log Kd occurred at DF 8 and 10 for all APIs, especially NVR, 
CBZ, VLS and AMI, where this was up to one order of magnitude (Table 10). These 
increases were related with increased concentration of dissolved organic carbon (DOC) 
at the DF of 8 and 10, as depicted by the plot of theoretical and experimental DOC in 
Figure 24. As the DOC concentration is a representative measure of the concentration of 
DOM, it follows that the dissolution of organic matter from particulate organic matter 
(POM) increments the cation exchange capacity because of the increase in specific 
surface area, and therefore sorption. Therefore, the decrease of API concentration at the 
DF of 8 and 10 is likely due to an interplay of dilution and additional sorption to the 
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proportionally increased DOM, with respect to the expected concentration from the 
theoretical calculation. 
Table 10  Modelled (Log Kd mod.), reported values from the literature (log Kd lit.), and experimental (Log Kd 
exp.) distribution coefficient values for the APIs investigated in this study, including DFs (Al-Khazrajy and 
Boxall, 2016; Bai et al., 2008; Hernandez-Ruiz et al., 2012; Lahti and Oikari, 2011; Li et al., 2015; Lin et al., 
2010; Loffler et al., 2005; Maoz and Chefetz, 2010; Martínez-Hernández et al., 2014; Maskaoui et al., 2007; 
Maskaoui and Zhou, 2010; Stein et al., 2008; Svahn and Bjorklund, 2015; Yamamoto et al., 2009; Zhou and 
Broodbank, 2014) (See Table S3 for the list of values and respective references). 
Log Kd [L/kg] DF ACT ACE NVR CBZ VLS DCF AMI 
Log Kd mod. / 0.40 1.42 2.00 2.13 2.85 3.15 3.79 
Log Kd lit. / -0.3 - 2.4 0.5 - 3.3 n. a. -1.5 - 6.7 n. a. 0.9 - 6.9 0.9 - 2.4 
Log Kd exp. 1.0 -1.70 2.27 2.90 2.62 2.60 2.32 3.39 
 
1.2 -2.12 0.48 2.78 2.49 2.74 2.08 3.37 
 
1.4 -2.06 0.94 2.82 2.47 2.68 2.42 3.35 
 
1.6 -2.32 2.21 2.76 1.77 2.88 2.06 3.32 
 
1.8 -2.27 2.09 2.75 1.78 3.02 2.21 3.36 
 
2.0 -2.34 2.44 2.65 2.33 3.08 1.61 3.21 
 
2.2 -1.80 2.24 2.73 2.40 3.14 2.19 3.32 
 
4.4 -2.54 2.94 2.32 3.10 3.47 3.04 3.12 
 
8.0 -2.80 2.96 3.57 2.51 4.18 3.56 4.16 
 
10.0 -3.19 2.61 3.39 3.16 4.32 3.57 4.22 















Experimental DOC concentration(mg/l) 
Theoretical DOC concentration (mg/l)
 
Figure 24 Theoretical and experimental dissolved organic carbon (DOC) concentrations recorded at each DF; 
and the increase from theoretical concentration at DF 8 and 10. 
4.4.4. Implication of API desorption within the impact zone for ERA  
ERA guidelines do not include a protocol for evaluating ecological risk posed by 
the direct discharge of API-containing untreated wastewater (EMA, 2006). Although 
from a human health and environment perspective such practices should not occur, the 
fact is that across LLMIC such discharges are widespread. Phase 1 of the ERA guideline 
is aimed at estimating exposure within the aquatic environment only. It does not consider 
the route of administration, API form, metabolism and excretion. If the PEC is calculated 
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above 0.01 µg l-1, then a phase 2 analysis, which includes the generation of environmental 
fate and effect data, should be performed. However, in the phase 2 tier B environmental 
fate analysis, the PEC calculation considers the distribution of APIs to the sewage sludge 
accordingly to the experimental log Koc, defined as the log Kd value normalized to 
organic content in sewage sludge as from the OECD 106 protocol (OECD, 2000).  
Equation 3 may not be applicable to discharges of poorly or untreated wastewater 
where wastewater treatment is limited or does not occur. In fact, as from the obtained 
evidence, highly lipophilic neutral or positively charged APIs desorb more readily with 
dilution (Figure 23), and omitting desorption could lead to potential underestimation of 
APIs PEC. Municipal and industrial wastewater are considered the primary source of 
APIs to the environment, while poor or absent wastewater treatment is widespread 
globally (Malik et al., 2015). This study has identified clear trends in API environmental 
cycling during wastewater dilution which are not addressed in current APIs 
environmental risk assessment legislation, and which could have consequences for the 
estimation of precise environmental concentrations.  
4.5. Conclusions  
Inadequate wastewater treatment and consequent direct discharge of untreated 
wastewater to surface waters is a global problem. This study presents data on the sorption 
of APIs to untreated wastewater sorbents, and their deviation from theoretical 
concentrations during dilution in freshwaters, for the evaluation of exposure 
concentrations, using APIs representative of LLMICs. 
The measured sorption behaviour was consistent with the chemical properties of 
each compound: charge, lipophilicity, and structure. ACT was not adsorbed because of 
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its low lipophilicity and lack of charge, while the behaviour of NVR and CBZ was 
similar, consistent with the proximity of their log Kow values and chemical structure. The 
behaviour of the basic compounds, AMI and ACE, indicated that primary control of 
sorption was lipophilicity with a secondary role for the positively-charged functional 
group. In contrast, sorption of the acidic compounds, DCF and VLS, was low due to 
repulsion between the negatively-charged compound and the similar net charge on the 
sorbent surface sites. The measured log Kd values were consistent with reported values 
for the types of sorbent studied.  
Dilution caused significant positive deviation from theoretical concentrations of 
the neutral and basic APIs at low dilution factors, and showed a high correlation to the 
lipophilicity, with the positive charge playing a secondary role. The negatively-charged 
compounds did not show significant desorption (i.e. 0 % loss for VLS and < 10 % for 
DCF). This behaviour was attributed to irreversible binding of the negatively-charged 
functional group to positively-charged sites on the sorbent. In addition to dilution, the 
concomitant increase in DOM concentration at the higher DF (i.e. 8 and 10) appeared to 
result in further sorption of APIs.  
As a conclusive reflection, the possibility of de-conjugation of conjugates as 
metabolites could be summed up to the mechanistic desorption magnitude described in 
the results. 
This study has identified clear trends in API environmental cycling during 
wastewater dilution which are not addressed in current APIs environmental risk 





5. IMPACT OF THE WASTEWATER-MIXING ZONE ON 
ATTENUATION OF PHARMACEUTICALS IN NATURAL 
WATERS: IMPLICATIONS FOR AN IMPACT ZONE 






This experimental chapter was published as: Bagnis, S., Fitszsimons, M. F., 
Snape, J., Tappin, A., Comber, S., 2019. Impact of the wastewater-mixing zone on 
attenuation of pharmaceuticals in natural waters: implications for an impact zone 
inclusive environmental risk assessment. Sci. Total Environ. 658, 42–50; and it is 






The direct discharge of untreated wastewater has been identified as an important 
source of environmental contamination by active pharmaceutical ingredients and other 
‘down-the-drain’ chemicals in developing countries. It necessitates the development of 
an environmental risk assessment approach for the resulting impact zone. This study was 
designed to investigate the impact of low level of dilution (<10) on the natural attenuation 
processes of distribution and degradation within the impact zone. Dilution of the 
untreated wastewater resulted in increased desorption and corresponding environmental 
concentrations. The presence/absence of the microbial population in the batches affected 
the degree of sorption depending on the compound charge (i.e. positive or negative), 
highlighting an experimental technical bias. The degradation half-lives of acebutolol and 
diclofenac increased with increasing dilution and resulted in higher environmental 
persistence. The modelling of the biochemical oxygen demand (BOD) allowed an 
estimate of the temporal end boundary of the impact zone to be predicted as 24 h. 
Therefore, it was concluded that most of the investigated compounds would persist 
beyond the end of the impact zone as defined by the return to environmental BOD 
concentrations. It is proposed that, within environmental risk assessment protocols, the 
impact zone should be considered as a semi-natural wastewater treatment area in such a 









5.1. Introduction  
Wastewater management is an acute challenge in low and low-middle income 
countries (LLMICs) where increased volumes of wastewater generated by rapid 
urbanisation have not been matched by upgrades of sewerage infrastructures resulting in 
direct discharge of untreated wastewater (DDUW) to surface waters (Malik et al., 2015; 
Nansubuga et al., 2016). This results in serious pollution of a waterway to such a 
downstream distance that a combination of dilution and biogeochemical processes such 
as degradation, volatilisation and sorption render the anthropogenic discharges non-toxic. 
This area downstream of the DDUW has been defined as an “impact zone”, beginning at 
the DDUW entry point and ending where easily measurable determinants such as 
biochemical oxygen demand (BOD), ammonia, and dissolved oxygen levels, critical to 
ecological health, have returned to environmental background concentrations 
(A.I.S.E./CESIO, 1995; Bagnis et al., 2018a). Whilst DDUW are known to contain high 
nutrient concentrations and BOD, the presence of emerging contaminants such as active 
pharmaceuticals ingredients (APIs) is of increasing concern (Keller et al., 2014). This 
applies particularly to LLMICs where from a pharmaceutical point of view, LLMICs are 
also experiencing an increase in consumption of medicines, as well as relocation of 
pharmaceutical production plants to these regions (Kookana et al., 2014). 
The impact zone of DDUW has been linked to higher environmental concentrations 
of APIs than in high income countries with more advanced wastewater treatment plants 
(Kookana et al., 2014; Malik et al., 2015) and API concentrations up to mg L-1 have been 
detected in impact zones of LLMICs from Africa to Asia (Ashfaq et al., 2017; Madikizela 
et al., 2017; Ngumba et al., 2016; Shimizu et al., 2013).  
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To regulate any discharge effectively, it is necessary to be able to define impact 
zones in order to minimise their extent and plan future wastewater treatment 
requirements. Furthermore it is necessary to fully understand the fate of chemicals within 
an impact zone as they are unlikely to behave the same as BOD or ammonia, often used 
to define such zones.  Furthermore, current environmental risk assessment (ERA) 
guidance for APIs has been developed assuming that sewage is subject to treatment prior 
to discharge (EMA, 2006), and thus, given that the DDUW does not comply with this 
assumption, the environmental conditions in the impact zone require a dedicated ERA 
approach (Bagnis et al., 2018a). This can only be achieved by understanding the 
mechanisms of natural attenuation that APIs undergo, such as sorption and 
biodegradation, and the resulting degree of exposure within the impact zone boundaries 
and beyond. 
Additionally, an important mechanism related to the natural attenuation of 
chemicals in wastewater is dilution (Keller et al., 2014). Many environmental risk 
assessment and management strategies are overly reliant on the paradigm that dilution 
reduces a chemical’s concentration such that it positively contributes to the reduction of 
environmental risk in a directly proportional way. In the current ERA protocol, the 
default ratio of river flow to treated wastewater is set to 10 (EMA, 2006; European 
Comission Joint Research Centre, 2003). However, despite the conservative nature of the 
ERA protocol, this dilution factor is overestimated in at least 53 countries, many of which 
are LLMICs severely affected by DDUW (Keller et al., 2014). Such an assumption may 
therefore be resulting in under estimates of downstream concentrations of chemicals and 
given the fact that  chemicals are not actually transformed by dilution, this premise is 
often criticized (Van Breukelen, 2007).  
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A highly important factor often overlooked are the questions as to what the impacts 
of dilution are on other key processes, such as sorption and biodegradation, which are 
currently poorly understood but are critical to the derivation of a scientifically robust risk 
assessment or for use within the development of water quality models (Bagnis et al., 
2018a; Hajj-Mohamad et al., 2017). 
The practicalities of measuring APIs in impact zones of LLMICs with substantial 
inputs of untreated wastewater are highly challenging. The number of environmental 
variables are high and sample collection, preservation and analysis is often not possible 
locally. Therefore, it is necessary to develop and adopt laboratory simulations which 
provide the opportunity to control important variables such as wastewater quality and 
characteristics, dilution and API concentration and thus provides the ability to generate 
vitally important fate data upon which to base future risk assessment approaches. 
This study focuses on the fate and behaviour of APIs within a simulated impact 
zone through the recreation of conditions of dissolved organic carbon – DOC (considered 
a surrogate of BOD), suspended solids and microbiological inoculums on a laboratory 
scale. Additionally, it investigates the effects of dilution on the main natural attenuation 
processes controlling the concentration of APIs in the impact zone and beyond, i.e. 
distribution and biodegradation. Given that there is the potential for some APIs to persist 
beyond the impact zone defined by parameters such as BOD, for example, owing to either 
high concentrations discharged or being more recalcitrant than the observed BOD, it is 
essential to be able to quantify the extent as part of any risk assessment procedure. The 
overarching aim is to contribute to the development of an approach of environmental risk 
assessment for APIs within and beyond the impact zone generated by DDUW. Further 
contributing to the novelty of this research is the development of a simple model based 
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on simulated BOD concentrations (derived from experimentally derived DOC values) to 
predict API concentrations outside of the BOD derived impact zone, leading to a draft 
protocol for the assessment of the environmental risk posed by APIs in LLMICs with 
limited or poor wastewater treatment. 
5.2. Materials and methods 
All glassware and plasticware were cleaned prior to use (2 % v/v Decon, ≥ 24 h; 
10 % v/v HCl, ≥ 24 h) and rinsed with ultra-high purity water (UHP) with resistivity 
above 18.2 MΩ cm (Merck Millipore). 
5.2.1. Active pharmaceutical ingredients  
The APIs chosen for this study were the neutral acetaminophen (ACT), 
carbamazepine (CBZ), and nevirapine (NVR), the acidic diclofenac (DCF) and valsartan 
(VLS), and the basic acebutolol (ACE) and amitriptyline (AMI). These compounds 
represent APIs with different structure and functionalities (neutral, acidic and basic) 
which are commonly consumed in LLMICs (Bagnis et al., 2018a). The chemicals were 
purchased at the highest purity available, either from Sigma-Aldrich (acebutolol 
hydrochloride, amitriptyline hydrochloride, nevirapine, valsartan, and acetaminophen) or 
Fisher Scientific (carbamazepine and diclofenac sodium salt). 
5.2.2. Synthetic wastewater 
Wastewater composition varies considerably according to both time and location 
(Tchobanoglous et al., 2003), presenting challenges in its standardisation for experiments 
(Boeije et al., 1999). Therefore, a surrogate of synthetic wastewater is needed to achieve 
experimental reproducibility as well as to ensure there are no background API 
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concentrations present. Also, in order to perform an ERA for chemicals, some form of 
standardization is needed to facilitate inter- and intra-lab replication. Therefore, a 
synthetic medium is a logical starting point for such complex studies (Bagnis et al., 
2018a). The experimental design was informed by OECD standards tests for chemicals 
in the environment, which are also standardized in some respect, and was optimised by 
a through critical evaluation of synthetic wastewaters reported in the literature (Bagnis 
et al., 2018a; O’Flaherty et al., 2013). Thus, a synthetic wastewater (SW) was prepared 
to achieve controlled and reproducible experimental conditions (Boeije et al., 1999). In 
this study, sodium azide (NaN3) was added to sterilized batches, whilst inoculum (5 mL; 
consisting of fresh wastewater influent collected at the local wastewater treatment plant 
of South West Water, Plymouth, England, UK) was added to all other batches (OECD, 
1992). The batches containing the inoculum were pre-conditioned for 3 days before the 
experiments began (OECD, 1992). 
5.2.3. Experimental approach 
Dilution factors (DF) of 1, 2, 4 and 10 for untreated SW were prepared in triplicate 




Figure 25 Experimental design aimed at measuring the effect of synthetic wastewater dilution on the 
natural attenuation of the active pharmaceutical ingredients (APIs); I. the biotic batch in three replicates A, B, 
and C spiked with 100 µg L-1 of each API and 5 ml of inoculum; D, the control batch added with 5 ml of 
inoculum; the abiotic batches E, F, and G spiked with 100 µg L-1 of each API, 5 ml of sterilized inoculum, and 
0.02% NaN3;II. the dilution factors (DF) of 1, 2, 4 and 10; only 1 and 2 applied to the abiotic batch; III. the 
sampling schedule over the experimental duration of 50 days. 
The SW was buffered at pH 7.5, which is typical for both wastewater and receiving 
waters. Inoculum was added to each replicate and left for 72 h before addition of 7 APIs, 
each to a final concentration of 100 µg L-1 as a representative concentration for impact 
zones of LLIMCs (K’oreje et al., 2016, 2012; Madikizela et al., 2017; Ngumba et al., 
2016). The flasks were wrapped in aluminium foil to avoid photodegradation and 
continuously stirred. The temperature was 21 °C during the experimental period. After 
an equilibration time of approximately 4 hours, batches were diluted with UHP at a DF 
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of 1, 2, 4, and 10. Samples were collected at several time points over 50 days for API and 
DOC determination. An identical abiotic experiment was performed for DF 1 and 2 only, 
and run for 20 days to determine the sorption component only and/or hydrolysis in order 
to quantify loss through biodegradation (Figure 25). This second batch was kept sterile 
by adding sodium azide (0.02%). 
5.2.4. Analytical procedures 
Samples were collected in 15 mL centrifuge tubes (Fisher Scientific) and 
centrifuged for 10 minutes at 4000 rpm. The supernatant was filtered through 0.7 µm 
GF/F filters (Whatman) in order to allow for solid phase extraction (SPE) and 
preconcentration without interference from suspended solids present at high levels in the 
simulated untreated wastewater. For analysis of DOC, an aliquot was diluted 20 times 
(owing to the high levels present) acidified (HCl, 6 M) and frozen at -20 °C for 
preservation prior to analysis (Badr et al., 2003). 
Concentrations of APIs were measured according to Bagnis et al. (2018). Briefly, 
aqueous samples were passed through a SPE cartridge for sample clean-up and to 
optimise analyte resolution, mass detection and quantification. The SPE cartridges 
(OASIS HLB, 200 mg polymeric sorbent; 6 mL barrel volume; Waters, UK) were 
activated with 5 mL of methanol (Thermo Fisher Scientific, Optima LC/MS) and 5 mL 
of UHP. A 5 mL sample aliquot was then loaded onto the cartridge at a flow rate of 3 mL 
min-1, followed by 1 mL of UHP. The APIs were eluted with 5 mL of methanol amended 
with formic acid (2 %). The eluent was evaporated to dryness under a gentle stream of 
nitrogen gas then reconstituted with 1 ml of methanol : UHP at a 1 : 10 ratio. 
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Chromatographic separations were measured by high performance liquid 
chromatography (HPLC) coupled with a high-resolution mass spectrometry (HR-MS) 
orbitrap-based system (Thermo Scientific), using a reversed phase column (XBridge 
BEH C18 2.5 µm 2.1 x 50 mm Column XP, Waters) maintained at 50 oC. A gradient 
elution programme was employed, starting at 100 % UHP amended with 0.1 % formic 
acid, progressing to 100 % methanol after 5.5 minutes. The parameters used for high 
resolution mass spectrometric detection are described in Bagnis et al. (2018). 
The dissolved organic carbon (DOC) analyses were performed using high-
temperature catalytic oxidation (TOC-5000A - Shimadzu) according to the method of 
Badr et al. (2003). 
5.2.5. Calculations 
Biodegradation rates were assumed to follow first-order kinetics (Schwarzenbach 
et al., 2003). The 50 % dissipation time (DT50) was modelled as a surrogate measure of 





Where I is the intercept and IC is the initial concentration after dilution in µg L-1 
and K is the slope of the equation of the line obtained from the linear trend line of the 
biodegradation starting at the first sample taken after dilution; the dissipation time is 
expressed in days. 
BOD was not directly determined owing to practicalities of sample size and time 
constraints. However, reliable datasets are available that provide a strong correlation 
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between measured DOC and BOD for untreated municipal wastewater (Comber et al., 
2018; Kwak et al., 2013). Based on data from over 100 UK wastewater treatment works 
crude sewage the following relationship was derived from a DOC vs BOD correlation of 






5.3. Results and discussion 
5.3.1. Effects of dilution on natural attenuation 
Three out of the seven APIs investigated, namely ACE, DCF and ACT showed 
effective biodegradation within the simulated impact zone. The biodegradation rate of 
ACE and DCF was strongly affected by the dilution, showing an overall increase of 
persistence (longer half-life) at increased dilution. This inverse correlation is well 
described by the half-life dissipation time (DT50) of DCF and ACE (Table 1). 
Table 11 The 50 % dissipation time (DT50), in days, of the active pharmaceutical ingredients (APIs) 
acetobutol (ACE) and diclofenac (DCF) caused by biodegradation only, calculated after each applied dilution 
factor (DF), namely 1, 2, 4 and 10; mean of each experimental replicate (3) and standard deviation (STD). 
DT50 
(Days) 
DF1 DF2 DF4 DF10 
 Mean STD Mean STD Mean STD Mean STD 
DCF 38.55 17.98 20.93 2.10 36.36 18.07 116.22 80.40 




ACE biodegraded over fifteen days then reached a pseudo-plateau with a much 
slower rate of biodegradation (Figure 26A). The removal rate at no dilution (DF 1) was 
approximately 78 % after 14 days. This was similar to Lin et al. (2010) who ascribed the 
disappearance of the compound to sorption processes. However, based on the tests 
carried out here and examining the data for the abiotic tests here (Figure 26B), it appears 
that the sorption of ACE was much less significant than biodegradation (Lin et al., 2010). 
Lin et al. (2010) suggested that their results were most likely due to experimental 
artefacts which might explain such difference between the two studies. Nonetheless, the 
progressive dilution from DF 1 to 10 reduced the original concentration of the API, but 
also the biodegradation rate (Figure26A) and therefore the removal of ACE from the 
solution. In this case, the progressive increase of dilution concurrently reduced the 
degrading microbial biomass present in the system, which might explain the trend. This 
observation is consistent with previously reported studies for other compounds in 
continuous input studies (Landa et al., 1994). 
In the case of DCF the increasing dilution specifically affected its biodegradation 
profile. In fact, at zero dilution (DF1) the biodegradation curve of DCF showed 
immediate removal after addition (Figure 26C), whilst a progressive increase in the lag 
phase prior to biodegradation was observed at DF 2 and 4, lasting respectively 14 and 28 
days. At a dilution factor of 10 the DCF concentration remained constant after dilution, 
for the duration of the whole test (50 days), thus rendering the compound highly 
persistent. It is worth noting that, although DCF is generally described as fairly 
biodegradable in wastewater treatment works (Joss et al., 2006; Kruglova et al., 2014), 
in soils (Al-Rajab et al., 2010) and in aqueous environments (Jiskra and Hollender, 2008; 
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Poirier-Larabie et al., 2016), different environmental conditions can lead to varying 
degrees of persistence (Baena-Nogueras et al., 2017). 
These data strongly suggest that while dilution decreases the concentration of a chemical 
in the solution, it can increase its persistence. The latter is most likely caused by the 
concomitant dilution of the bacterial community and the substrate concentration 
represented by increasing lag phase of acclimation of the bacteria responsible for the 
contaminant biodegradation (Maier et al., 2009; Swinnen et al., 2004). Such a lag phase 
is a measure of the resilience of the degrader to such an environmental stress before 
returning to the conditions necessary to catabolise the contaminant (Ramadan et al., 
1990). Furthermore, it has been shown that such a dilution effect might be related to the 
dilution of other wastewater components such as salts, which indirectly affect the species 
lag phase duration prior to degradation of the contaminant (Robinson et al., 2001). The 
reduced removal from dilution of wastewater influent in a wastewater treatment plant has 
been reported (Joss et al., 2006) and is considered as a factor to be avoided to increase 
effluent treatment efficiency. 
The disappearance of ACT in the abiotic batch was extensive, being 40-50 % within 20 
days (Figure26F), but the degradation rate was much slower than in the combined 
sorption-biodegradation batch (Figure 26E), where removal by biodegradation occurred 
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Figure 26 Sorption-biodegradation and the sorption/hydrolysis only respectively of acebutolol (ACE) (A, B); 
diclofenac (DCF) (C, D); acetaminophen (ACT) (E, F) in untreated wastewater at several dilution factors (DF). 
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As such, dilution did not visibly influence the biodegradation rate of ACT since the 
latter was faster than the experimental time designed for batch equilibration. In the study 
of Lin et al. (2010)  consumption of 50 µg L-1 was completed with half-life (DT50) of 2.1 
days, compared with 3 days for Yamamoto et al. (2009), and 38 days for Baena-Nogueras 
et al. (2017). 
The slower disappearance rate observed in such experiments could be explained by 
the use of river water, which has a lower dissolved organic matter (DOM) concentration 
and lower microbial biomass as well as different bacterial communities than untreated 
wastewater. Such differences highlight the likely variable rates of biodegradation for 
APIs entering the environment in wastewater as treated effluent or untreated sewage 
(Tappin et al., 2014, 2012). 
CBZ, NVR, VLS, and AMI were persistent over the 50 days of the experiment 
(Figure 27A, C, E, G), consistent with their known metabolic stability (Nassar et al., 
2004; Siddiqui et al., 2011). The only effective natural attenuation processes occurring 
in the impact zone for these APIs were sorption and dilution.  
The neutral species NVR and CBZ have a similar chemical structure which can 
explain their comparable behaviour (Bagnis et al., 2018b). Their sorption was moderate 
(10-20 %), consistent with their similar lipophilicity (log Kow 2.7 and 2.5 for NVR and 
CBZ, respectively); no further losses were observed in either the biotic and abiotic 
batches (Figure 27A, B). Whilst sorption and dilution were the main factors controlling 
attenuation of CBZ and NVR in both biotic and abiotic batches. A positive deviation 
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Figure 27 Sorption-biodegradation and the sorption only respectively of carbamazepine (CBZ) (A, B); nevirapine (NVR) (C, D); valsartan (VLS) (E, F); amitriptyline (AMI) (G, H)  in 
untreated wastewater at several dilution factors (DF) 1, 2, 4 and 10. 
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The high frequency of detection of NVR in the environment (K’oreje et al., 2016; 
Madikizela et al., 2017; Ngumba et al., 2016) has been attributed to both its widespread 
use and to poor removal efficiency in wastewater treatment plants (Madikizela et al., 
2017). The work of Vankova et al.(2010) provides the only available information on the 
biodegradability of NVR and the results of this study were consistent with that study, 
which suggested high recalcitrance in wastewater treatment works. Due to the almost 
identical behaviour of CBZ, further investigation to evaluate its applicability as a possible 
marker for sewage contamination (Lim et al., 2017) is recommended, especially targeted 
to African countries where it is widely consumed (Madikizela et al., 2017). 
Little information is available about the natural attenuation of VLS (Bergheim et 
al., 2014; Mandaric et al., 2019). The distribution of ionisable APIs is controlled by both 
lipophilicity and charge, expressed by the ionization constant (pKa). In general, the 
concentration values for the different dilutions, reported for the ionisable compounds 
used in this study, corresponded to the expected calculated arithmetical value plus 
desorption, when the latter occurred, in accordance with the compound lipophilicity and 
speciation (Bagnis et al., 2018a). The results for VLS contrasted with reported data,  
which described a relatively fast biodegradation with consequent detection of 
transformation products such as valsartan acid, de-alkylated valsartan and amino-
valsartan (Helbling et al., 2010; Kern et al., 2010). These differences highlight the 
variability in behaviour of this API with the experimental conditions employed. While 
only a few studies on the persistence of AMI have been documented, these report high 
persistence in both water (Baena-Nogueras et al., 2017) and agricultural soils (Li et al., 
2013), in agreement with the data from this study (Figure 27G). 
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It is worth noting that the results of this work showed a different degree of sorption 
between the biotic and the abiotic experiments (Figure 26 and Figure 27). For instance, 
the anionic VLS showed approximately 20 % of sorption in the abiotic experiment 
compared with no sorption under biotic conditions (Figure 27E and F). The same 
behaviour was observed for the negatively charged DCF (Figure 26C and D). In contrast, 
the positively charged AMI had lower sorption under abiotic conditions (Figure 27G and 
H). In fact, at DF 1, 80 % the compound was adsorbed in the biotic batch as opposed to 
50 % in the abiotic one. Such behaviour has been ascribed to the difference of specific 
surface area for ionic exchange determined by the presence/absence of a bacterial biofilm 
on the sorbent surface (Carlson and Silverstein, 1998; Headley et al., 1998; Wunder et 
al., 2011). The bacterial extracellular polymeric substances are composed of anionic (e.g. 
—COOˉ, —SHˉ, —SO4
ˉ, HPO4
ˉ), cationic (e.g. —NH3
+), and apolar (e.g. aromatic) 
functional groups, which at the experimental pH (7.5) are predominantly negatively 
charged (Wunder et al., 2011). This translates to additional surface sites for exchange of 
positively charged compounds and the repulsion of negatively charged ones; thus, 
respectively increasing and decreasing sorption. Such differences between the 
environmentally more realistic biotic system and the artificial abiotic system highlights 
a technical bias in the experimental evaluation of the distribution of ionisable chemicals, 
such as APIs. 
5.3.2. APIs persistence through the impact zone 
Data from the experiments was used to model the environmental concentrations of 
APIs within and beyond the impact zone and to determine its extent. The end of the 
impact zone is defined as the point at which BOD reaches background environmental 
levels (< 1 – 8 mg L-1) (Schwarzenbach et al., 2003). Therefore, the experimental DOC 
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was measured and used in the mathematical model (2) derived from the linear correlation 
of DOC and BOD (R2=0.86) obtained from a large set of experimental data for untreated 
wastewater (Kwak et al., 2013). Through this correlation it was possible to estimate the 
temporal end boundary of the impact zone.  
According to the model, BOD decreased most rapidly in the first day (Figure 28), 
achieving a plateau which constitutes the recalcitrant or slowly degrading organic load 
present in the mixture (dashed red line in Figure 28) (Dignac et al., 2000). The percentage 
of refractory DOC in wastewater can be highly variable, but roughly comprised 10-30 % 
of the initial amount (Dignac et al., 2000; Reynolds, 2002), consistent with the generated 
data (Figure 28). The recalcitrant DOM could not be excluded from the simple modelling 
approach adopted in this study and therefore the plateau was considered as the lowest 
level of observable BOD, and consequently marked the end of the impact zone 
(A.I.S.E./CESIO, 1995). The end of the impact zone was calculated to be reached in 
approximately 24 hours irrespective of dilution. 
The modelled data suggested that six of the seven APIs investigated in this study 
would persist through the impact zone and occur at the initial observed concentration 
beyond its end boundary. Furthermore, although ACT was quickly biodegraded, the high 
rate of input and patterns of use could lead to pseudo-persistence in the natural 
environment, leading to the occurrence in concerning concentrations (> 0.01 µg L-1) 





Figure 28 Evolution of the biochemical oxygen demand (BOD) along the experimental time of 50 days 
for the dilution factors DF 1, 2, 4 and 10; the dashed red line corresponds to the threshold of the 30% of the 
combination of recalcitrant dissolved organic matter (DOM) and biomass. 
Nonetheless, it must be highlighted that uncertainties are likely to be associated 
with both the model applied for the calculation of BOD and the calculation of the 24h 
estimate when applied to a real environmental setting. These uncertainties are related to 
the environmental complexity of each individual scenario which translate in likely 
varying DOM composition and consequently variable rates of consumption; therefore, 
further studies are necessary for the development of a more accurate model. 
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5.3.3. Implications for an environmental risk assessment approach 
This work provides novel, robust data that could inform for the future development 
of an ERA approach for the impact zone with regard to APIs. The data presented here 
suggests that natural attenuation in the impact zone receiving untreated or poorly-treated 
wastewaters might not be enough to significantly restrict the environmental burden of 
APIs within its boundaries. In fact, even at the highest rate of biodegradation, the initial 
concentration of APIs in the impact zone could be expected beyond its end boundary. 
According to this investigation, while low levels of dilution (< 10) reduce the API 
concentration, the rate of biodegradation also slows increasing the risk of environmental 
persistence and likely occurrence of the API beyond the impact zone boundary. The 
dilution level of down-the-drain chemicals in surface waters is highly dependent on local 
hydrological conditions, such as seasonal runoff variability and so this must also be 
considered in the evaluation of the risk (Keller et al., 2014). Therefore, further studies 
are necessary to evaluate this important factor contributing to the environmental exposure 
of APIs in the impact zone. 
Based on the data presented here, it is possible to propose a possible preliminary 
ERA approach. In phase 1 of the European ERA a predicted environmental concentration 
(PEC) above 0.01 µg L-1 triggers a tier of tests to refine the understanding of the APIs 
environmental fate (EMA, 2006). Such calculations assume no biodegradation or loss (to 
sludge or atmosphere) within the wastewater treatment plant. In the case of DDUW the 
API concentrations would likely exceed such exposure threshold and as a consequence 
the development of a dedicated phase with the risk assessment is proposed (Figure 29; 
proposed as phase 2.2). It does not aim to reproduce the current ERA for APIs but is 
strongly informed by such protocols and compliments it to take account of DDUW. The 
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new phase of the ERA would be parallel to the current phase 2, renamed in Figure 29 as 
phase 2.1, for the evaluation of the PEC for APIs beyond the impact zone generated by 
the DDUW. This phase is divided in two parts, tier A and B, as for phase 2.1. Tier A is 
based on the modelling methodology used in this study and therefore constrains the 
impact zone at 24 h. In accordance with the guidelines for the ERA, the experimental 
studies necessary to evaluate environmental fate should be based on protocols issued by 
the European Commission, the Organization for Economic Co-operation and 
Development (OECD) or the International Organization for Standardization (ISO) 
(EMA, 2006). The PEC beyond the impact zone would therefore be used to evaluate the 
environmental risk using the PNEC calculated as from the actual protocol (EMA, 2006).  
 
Figure 29 A workflow diagram depicting the protocol to predict environmental concentrations (PEC) in 
the environmental risk assessment for pharmaceuticals assuming influent treatment in wastewater treatment 
plant (WWTP) in phase 2.1 (current phase 2), tier A and B, and in the case of direct discharge of untreated 
wastewater (DDUW), Phase 2.2, tier A and B. 
If a risk is still evident further refinement of the PEC would be necessary in tier B, 
taking into account parent compounds PEC and PNEC as well as the most relevant 
metabolic fraction (≥ 10 % of amount excreted) (EMA, 2006). In this case, an appropriate 
model should be developed for the impact zone in the same fashion as SimpleTreat model 
in EUSES (EMA, 2006). 
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The approach proposed here would quantify and manage the risk posed by the 
environmental occurrence of APIs to LLMICs where dilution occurs at factors below 10, 
such is the case of 53 countries worldwide. 
5.4. Conclusions 
According to the results of this investigation, the dilution significantly affects the 
biodegradation rate of DCF and ACE and this might be true for other APIs. ACT instead 
behaves consistently with previously reported data and it is quickly biodegraded in the 
wastewater solution regardless the degree of dilution. The other compounds here 
investigated show high persistence along the experimental timescale. The temporal 
modelling of the extent of the impact zone allow an estimate of its end at about 24 hours 
after discharge in the environment, without influence by dilution. The model applied to 
the APIs natural attenuation data of this study shows a persistence beyond the end of the 
impact zone. Thus, an ERA approach is proposed, considering the impact zone as a semi-
natural wastewater treatment area. The extent of the zone may be modelled with the aim 
of estimating the APIs concentrations beyond its end, after which the traditional ERA 










6.  CHARACTERIZATION OF THE NAIROBI RIVER 
CATCHMENT IMPACT ZONE AND OCCURRENCE OF 
PHARMACEUTICALS: IMPLICATIONS FOR AN IMPACT 








The largely uncontrolled release of active pharmaceuticals ingredients (APIs) 
within untreated wastewater discharged to waterbodies associated with many rapidly 
urbanising centres is of growing concern owing to potential antimicrobial resistance, 
endocrine disruption and potential toxicity.  A sampling campaign has been undertaken 
to assess the source, occurrence, magnitude and risk associated with APIs and other 
chemicals within the Nairobi/Athi river basin, in Kenya, East Africa. The catchment 
showed an extensive downstream impact zone estimated to extend 75 km, mostly derived 
from the direct discharge of untreated wastewater from the urban centre of Nairobi city. 
The exact extent of the downstream boundary of the impact zone was unclear owing to 
the inputs of untreated wastewater sources from the continuous urbanized areas along the 
river, which counteracted the natural attenuation caused by dilution and degradation. The 
most frequently detected APIs and chemicals were caffeine, carbamazepine, 
trimethoprim, nicotine, and sulfamethoxazole. Paracetamol, caffeine, sulfamethoxazole, 
and trimethoprim alone contributed 86% of the total amount of APIs analysed and 
detected along the Nairobi/Athi catchment. The main APIs sources were attributed to the 
informal settlements and the industrial area in Nairobi City, as well as the Dandora 
landfill. Also, farming or agricultural sites upstream of the city were likely sources of 
veterinary APIs. It was shown that there is a potential environmental risk of API 
ecotoxicological impacts beyond the end of the impact zone, and a medium and high risk 









In the past decade there has been a global increase of production and consumption 
of APIs in low and low-middle income countries (LLMICs) where the direct discharge 
of untreated wastewater (DDUW) is prevalent (Kookana et al., 2014). In particular, 
recent investigations have highlighted the widely-spread occurrence of high 
concentrations of APIs in pan-African “impact zones”, unequivocally ascribed to the 
poor African wastewater treatment coverage and efficiency (Agunbiade and Moodley, 
2014; K’oreje et al., 2016, 2012; Madikizela et al., 2017; Matongo et al., 2015; Ngumba 
et al., 2016; Schoeman et al., 2015; Wang et al., 2014; Wood et al., 2015).  A relatively 
well studied example of such contaminated areas in Africa is the Nairobi River 
catchment, flowing through the capital city of Kenya, Nairobi (K’oreje et al., 2012; Mbui 
et al., 2016; Ngumba et al., 2016). Nairobi was established in the early 1990’s with a 
population of 250,000 and was reputed as a city with high environmental standards, at 
the point that was named as “the green city in the sun”. However, due to rapid 
urbanization and population growth (3,149,000 officially, but potentially double this in 
reality) its reputation has changed, and owing to inadequate management of solid wastes 
and wastewater treatment, the water bodies comprising the Nairobi catchment are 
severely polluted (Mbui et al., 2016; Mobegi et al., 2016). The wastewater generated in 
the city’s informal settlements and from the centre is mostly directly discharged in the 
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Nairobi River basin without treatment, leading to a large-scale “impact zone” 
characterized by the occurrence of high concentrations of APIs (K’oreje et al., 2016, 
2012; Ngumba et al., 2016) together with other emerging and traditional organic 
contaminants (Kithiia, 2007; Kithiia and Ongwenyi, 1997; Mbui et al., 2016; Mobegi et 
al., 2016; Njuguna, 1979). The water within the catchment is a critical resource, for 
irrigation, industry, for potable water after treatment and in some cases, a direct source 
of drinking water for the very poor.    
In this study, the Nairobi/Athi catchment was investigated to understand the nature 
and extent of the “impact zone” generated by the DDUW as follows: (I) The extent of 
the impact zone was assessed, through the use of analytical techniques traditionally 
adopted for monitoring the surface water quality and proposed by Bagnis et al., (2019) 
for modelling purposes; (II) The occurrence and concentration of a large set of APIs and 
other chemicals in the impact zone and wider catchment has been quantified; (III) A 
traditional environmental risk assessment was then performed at the furthest sampling 
point downstream, assumed as the end of the impact zone. The overarching aim was the 
provision of scientific sound data for the development of an impact zone environmental 
risk assessment approach.  
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6.2. Study area and sampling 
The sampling area was located in the Nairobi capital province (1,661 m altitude 
and 696 km2 of urban area) which is located in the Nairobi/Athi River catchment (Figure 
30). The Athi River is the second largest river basin in Kenya, after the Tana River. This 
river collects its water from the flanks of the Rift valley, the Aberdare ranges and the 
Ngong hills. After flowing through vast arid areas of Kenya it discharges its waters in 
the Indian Ocean at the town of Malindi. This river also receives waters from the Nairobi 
River, its main tributary. The two main tributaries of the Nairobi River are the Mathare 
and the Ngong River, which drain Nairobi city centre and the surrounding urbanized 
zones, including informal settlements, industrial areas and agricultural lands (Kithiia, 
2007). 
The Mathare and Ngong Rivers are the main tributaries of the Nairobi River and 
all of them flow through Nairobi city (Figure 30). The two tributaries flow through large 
informal settlements areas (Mathare and Kibera), the latter also through the city’s 
industrial area. The Nairobi and Ngong Rivers flow next to the large 30 solid acres 












Figure 30 The Nairobi River catchment, the sampling points and the main sites of interest. The water 
flow is eastwards. “Eff” is the wastewater treatment plant effluent discharge point. 
Downstream the city the quality of the Nairobi River water is affected by the 
effluent from the Dandora wastewater treatment stabilization ponds (WWTP) which treat 
approximately 27% of the city’s population wastewater. Afterwards, the Nairobi River 
discharges into the Athi River which, after the Fourteen Falls, proceeds to the Indian 
Ocean. Also, two other minor tributaries of the Athi River were sampled before their 
confluence, namely Thiririka and Nango Rivers (Figure 30). 
Despite the sampling exercise being planned to occur during the dry season, most 
of the samples (19 out of 26) were collected during the wet season which started 
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unusually early in mid-March (Figure 30). The sampling campaign comprised a total of 
26 sampling points: five along the Mathare River, five along the Ngong River, eight along 
the Nairobi River, one from the effluent of WWTP, five along the Athi River, and one 
each from the Thiririka and Nango Rivers at the confluence with the Athi River. The last 
sample was collected at 75 kilometres downstream of the city, measured from the first 
upstream sample collected at the Nairobi River. 
The source of DDUW was identified as  diffuse point sources, such as small pipes 
from informal settlements, but also significant discharges were occurring from the 
industrial area (Ngumba et al., 2016).  
The samples were collected in 500 ml amber glass bottles and stored on ice and 
then overnight at 4 °C, and the sample preparation was completed within 24h. 
6.3. Calculations 
 The biochemical oxygen demand (BOD5) was estimated from the correlation of a 











6.4. Source apportionment of APIs 
The Principal Component Analysis (PCA) statistical procedure, validated by 
Larsen and Baker (2003), was adopted to estimate the source apportionment of the APIs 
relative to the sampling points along the main stream of the Nairobi/Athi River (Na1 to 
Na8 and At4 to At5) as representative for the whole catchment, and the effluent from the 
wastewater treatment plant (Eff) as a source for comparison (Figure 30). 
Briefly, with the aim of explaining the variability of the APIs in a minimum number 
of factors, the data were reduced to Principal Components (PCs) through a factor analysis 
performed by means of SPSS Statistics 24 (IBM). The analysis was performed setting a 
Kaiser normalization and a varimax rotation to simplify further the interpretation of the 
factors. 
All the factors originated through the computation are orthogonal to each other 
reducing the covariance. The first PC corresponds to the component loadings (CL) 
relative to the linear combination of the original concentration values, and it accounts for 
the greatest variability. All the other components are in decreasing order of variability. 
As default, all the components with eigen values less than 1 were excluded. The source 
emission of each API is indicated by the CL which express the relationship between the 
PC and the chemical (Dai et al., 2016; Larsen and Baker, 2003).  
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The most loaded factor scores (> 0.500) for each API were originally considered 
amongst PCs, with some exceptions in a second analysis comparing the PC with the 
original concentrations. Thus, the pattern of each PC was critically analysed against 
literature information to determine the source apportionment. 
6.5. Environmental risk assessment 
An environmental risk assessment (ERA) was performed using the measured 
concentrations at the furthest downstream sampling point along the impact zone. The 
assessment was performed through the risk quotient (2) of the measured environmental 
concentrations (MEC) of the APIs detected and predicted no effect concentrations 







 [MEC] and [PNEC] being reported in the same units generating a ratio for the risk. 




6.6. Results and discussion 
6.6.1. Impact zone characterization 
The rivers physico-chemical parameters at each sampling point are shown in Table 
12 (metadata in A3). The distance of each sampling point was measured relative to each 
river’s first upstream sampling point. A concise description of the sampling area and the 
respective elevation is also provided in Table 12. The mean of the physico-chemical 
parameters are: pH 8.5, conductivity 570.2 µs cm-1, TDS 245.9 ppm, and temperature 
23.7 °C. The temperature varied accordingly to the time of sampling, the lowest in the 
early morning and increasing along the day until the afternoon (21-29 °C). The altitude 
difference from the highest point of sample collection (Na1) to the lowest (At5) was of 
416m. The BOD5 was modelled from the TOC concentration (Bagnis et al., 2019). Also, 
the protein-like dissolved organic matter (PL-DOM) was estimated as a marker of sewage 
contamination. 
The BOD5 recorded at the sample points along the Nairobi/Athi catchment allowed 
an estimate of the extent of the impact zone generated by the diffuse DDUW in the 
Nairobi and Athi River catchments (Table 12). Such estimates were based on the 
definition of impact zone as the area between the discharge point of untreated wastewater 
and the downstream point at which the concentration of BOD5 returns to the expected 
environmental range (Bagnis et al., 2018a; Bagnis et al., 2019). 
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The sampling points on the Nairobi and Mathare Rivers upstream of the city centre 
showed very high BOD5 of 1136 mg L
-1 and 1349 mg L-1 respectively, and concentrations 
of PL-DOM of 0.3 mg L-1 and 2.0 mg L-1 respectively, the latter suggesting a higher 
contribution from sewage inputs to the Mathare River (Table 12). The range of BOD5 
values recorded at these sampling points were nearly three times above typical values for 
typical high strength crude sewage (Tchobanoglous et al., 2003),  but are in the observed 
range for industrial effluents (e.g. dyes and pharmaceutical factories) (Lokhande et al., 
2011; Pittwell, 1988), which suggest the presence of industrial sources of pollution 
upstream the Nairobi city centre. However, we do not have evidence of the presence of 
industrial facilities in the area upstream these sampling points, and additional studies 
would be necessary to ascertain their presence and nature.
158 
 
Table 12. A short description of each sampling point area, elevation and the physic-chemical parameters pH, conductivity, total dissolved solids (TDS) and temperature. Also, the biochemical 
oxygen demand (BOD5) and the protein-like dissolved organic matter (PL-DOM) are furnished; WWD, wastewater discharge. 
















At1 Athi Downstream Nairobi national park 0 1507 8.1 195 129 25.7 389.4 0.9 
At2 Athi Upstream a tanning plant WWD 13.1 1472 8.8 198 130 28.3 267.8 0.7 
At3 Athi Downstream a tanning plant WWD 23.2 1472 9.6 920 609 26.3 624.2 8.9 
At4 Athi Upstream Fourteen Falls 48.3 1428 8.1 302 199 22 160.3 1.2 
At5 Athi Fourteen Falls 59.3 1392 8 342 224 23.5 292.2 0.9 
Eff WWTP Effluent WWTP / 1480 8.8 1099 723 26 520.8 2.8 
Ma1 Mathare Upstream city centre 0 1781 7.4 530 359 21.2 1349.0 2.0 
Ma2 Mathare Dam 2.2 1770 8.3 420 276 24.7 197.4 0.6 
Ma3 Mathare Downstream dam 4.8 1734 7.3 153 101 22.1 901.8 0.6 
Ma4 Mathare Middle of Mathare slum 11.6 1627 8.4 486 320 21.3 297.2 3.7 
Ma5 Mathare Confluence to Nairobi River 19.5 1563 7.8 624 412 20.7 292.7 3.8 
Na1 Nairobi Upstream city centre 0 1808 7.6 362 239 20.1 1136.2 0.3 
Na2 Nairobi Upstream city centre 5.0 1728 8 1050 728 21 490.6 5.4 
Na3 Nairobi City centre 9.9 1680 7.9 768 508 26.2 454.2 4.0 
Na4 Nairobi 
Between city centre and junction with 
Mathare River 
15.5 1628 7.3 928 616 28.9 638.2 13.2 
Na5 Nairobi Confluence to Mathare River 21.0 1568 8.2 618 409 22.3 292.0 3.4 
Na6 Nairobi Confluence to Ngong River 25.7 1500 8 597 394 23.1 1421.4 2.8 
Na7 Nairobi Upstream WWTP 32.4 1491 8.5 788 522 27 515.2 0.6 
Na8 Nairobi Downstream WWTP 39.38 1459 8.6 935 615 25 503.5 2.9 
Ng1 Ngong Upstream Kibera Slum 0 1714 7.3 94 62.3 19.5 191.9 0.6 
Ng2 Ngong Middle Kibera Slum 5.7 1702 7.6 551 364 22 1115.4 4.5 
Ng3 Ngong Industrial area 11.2 1632 7.8 769 508 25.3 822.3 5.3 
Ng4 Ngong Quarry area 21.2 1547 7.8 817 539 25.2 508.5 3.6 
Ng5 Ngong Confluence to Nairobi River 24.0 1500 8.2 796 526 24 373.5 4.1 
Nn1 Nango Confluence into Athi River / 1432 7.7 313 205 22.7 249.9 0.3 
Th1 Thiririka Confluence into Nairobi River / 1430 7.7 171 112 22.5 206.2 0.5 
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The highest level of PL-DOM (13.2 mg L-1) was observed along the Nairobi River 
at sampling point Na4 (Table 12), located between the city centre and the confluence to 
the Mathare River (Figure 30), which highlighted high inputs of sewage contamination 
from the densely populated city centre. Afterwards, the PL-DOM concentration steadily 
decreased until sampling point Na8 located after the effluent discharge point from the 
WWTP, where a slight increase was observed, consistent with the WWTP effluent 
discharge. The estimated BOD5 transect along the Nairobi River showed a trend similar 
to the PL-DOM, with an exception of the sampling point before the confluence with the 
Ngong River (Na6), where the highest concentration was recorded (1421 mg L-1). 
The Mathare River flows through the city’s informal settlements and showed an 
increasing contamination along its length where the concentrations of BOD5 and PL-
DOM were elevated and followed a similar trend (Table 12).  
The first upstream sampling point collected along the Ngong River (Ng1) showed 
a relatively low BOD5 (192 mg L
-1), whilst the highest BOD5 concentration was recorded 
just after the informal settlement of Kibera (Ng2) (1115 mg L-1). The BOD5 concentration 
steadily decreased until the confluence with the Nairobi River most likely as an effect of 
dilution (Table 12). The PL-DOM showed an increase to a maximum at Kibera, then kept 
steady along the length of the river, suggesting continuous input of sewage all along the 
river which counteracted any dilution or attenuation. Another important contribution to 
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this impact zone is the extensive industrial area located on the north side of the Ngong 
River (Figure 30). 
The Athi River water quality showed an abrupt increase of PL-DOM at sampling point 
At3, most likely caused by the contribution of an upstream wastewater discharge point 
from a tannery.  Thereafter, the PL-DOM concentrations gradually started to decrease, 
and, after the confluence with the Nairobi River, at the last sampling point (At5), the 
concentration had decreased to 0.9 mg L-1. The BOD5 within the Athi River were 
relatively low compared to the rest of the catchment (Table 12). Also, the two smaller 
influents, Thirika and Nango Rivers, showed both BOD5 and PL-DOM at the lowest 
concentrations detected in the catchment, and no influence on the receiving stream water 
quality.  
Overall, a relatively rapid increase of PL-DOM and BOD5 along the transect upstream 
and within the urban centre and a rapid decrease thereafter was observed. This was most 
likely caused by the dilution from rainwater runoff and to an unknown degree, other 
natural attenuation factors, such as (bio) degradation. The whole sampling area along the 
Nairobi/Athi catchment was heavily impacted by BOD5 from numerous industrial and 
landfill sources as well as diffuse sewage pollution. There is no a clear end of such impact 
zone as the concentration of BOD5 at the last downstream sampling point (75km from 
the first upstream site) was still  greater than 8 mg L-1, considered as the threshold for the 
“severely polluted” categorization of water affected by wastewater pollution (Koncagul 
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et al., 2017). However, it could be considered an overestimation if there was a significant 
proportion of recalcitrant DOM in solution, leading to a positive bias in predicted BOD, 
as suggested by the modelling approach of Bagnis et al., (2018a). If this was the case, 
then the end of the impact zone could be assumed to be at sampling point At5 for ERA 
purposes. 
6.6.2. Frequency of APIs detection 
The samples were collected in 27 locations along the catchment and analysed for 
the occurrence of 55 APIs belonging to 19 therapeutic categories (Figure 31). Forty-five 
out of the fifty-five compounds under scrutiny were detected in at least one sampling 
location, and at least one representative for each of the nineteen therapeutic classes was 
detected along the entire catchment. 
The APIs with the highest frequency of detection (>90%) were caffeine, 
carbamazepine, and trimethoprim, detected in 100% of the sampling points, and nicotine 





Figure 31 Frequency of detection of the 55 active pharmaceutical ingredients (APIs) at the 27 sampling 
points (100%) grouped per therapeutic class. 
Even though the stimulant caffeine is not strictly an API it was added to the list 
because of its extensive  removal (100%) by conventional wastewater treatment (Sui et 
al., 2010) that suits it as a marker for DDUW contamination (Dai et al., 2016; Verlicchi 
et al., 2012). In fact, its detection in all of the sampling points suggested extensive 
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human-impacted contamination by sewage along the catchment. Also, other human 
derived stimulants such as nicotine and its main metabolite cotinine were also frequently 
detected (81.5% and 78 % respectively) supporting the case for untreated wastewater 
pollution. However, it must also be recognized that the large areas allocated to coffee 
crops cultivation distributed at the latitudes and altitudes of the Nairobi region, and the 
presence of tobacco factories in the industrial area of Nairobi, might contribute to the 
occurrence of these active compounds in surface waters (Barjolle et al., 2017).  
In a similar fashion, the antiepileptic drug carbamazepine is also used as a marker 
for sewage contamination, because of its poor removal and stability, and it was detected 
at all of the sampling points (100%). This widespread detection is likely due to a 
combination of sewage contamination and its well-known intrinsic high persistence 
(Durán-Álvarez et al., 2015; Gasser et al., 2011; Kruglova et al., 2014). In the same 
therapeutic class were the less frequently detected gabapentin (56%) and pregabalin 
(26%). 
The antibiotics trimethoprim and sulfamethoxazole were detected at high 
frequency. These compounds were consistently reported as the most frequently detected 
antibiotics in each United Nations region by aus der Beek et al. in 2016, with the highest 
maximum concentrations in African countries. Three out of the thirteen antibiotics 
investigated in this work, namely trimethoprim, sulfamethoxazole, and ciprofloxacin 
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were detected in a frequency higher than fifty percent; and seven, namely metronidazole, 
clarithromycin, lincomycin, erythromycin, oxytetracycline, tetracycline, and 
enrofloxacin in between 10 and 50 % of samples; but cloxacin was detected in less than 
10% of the samples collected and tylosin and sulfadiazine not detected at all (Figure 31).   
The antifungal fluconazole was detected at a frequency of 89% of the sampling 
points, followed by clotrimazole (37%) and miconazole (3.7%) belonging to the same 
therapeutic class. The remaining two antifungals itraconazole and ketoconazole were not 
detected. 
The API amitriptyline was the most frequently detected in the antidepressant 
therapeutic class (85%), whilst desvenlafaxine and venlafaxine were detected at five 
sampling points each (19%) and fluoxetine at two locations (7.4%). The antidepressant 
citalopram was not detected. 
Six APIs belonging to the class of antihistamine were investigated. The APIs 
cetirizine (63%) and fexofenadine (55.6%)were detected at a similar frequency; 
Ketotifen was detected at only two sampling locations (7%); whilst the antihistamines 
diphenhydramine and loratidine were not detected at all.  
In the class of the analgesic the compound paracetamol was found in seventeen out 
of the 27 sampling locations (63%) followed by lidocaine (56%) and naproxen (33%). 
Paracetamol (also known as acetaminophen) has been recognized as the most frequently 
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detected API globally (Barra Caracciolo et al., 2015), even though it is quickly 
catabolized by microorganisms and consistently removed from water and wastewater 
(Baena-Nogueras et al., 2017; Lin et al., 2010; Yamamoto et al., 2009), and therefore 
absent in samples collected away from any source. Naproxen has a similar environmental 
behaviour and is quickly eliminated from the aqueous environment (Grenni et al., 2018).  
The beta-blocker atenolol was detected at 60% of the sampling points, whilst 
propranolol was not detected. The antimalarial artemisinin was detected in fifteen sites 
out of the 27 (56%).  
All the other compounds not listed so far fell below the detection frequency of 50%. 
A total of 11 compounds out of the total 55 were not detected, namely tylosin, 
sulfadiazine, citalopram, itraconazole, ketoconazole, diphenhydramine, propranolol, 
miconazole, loratidine, temazepam, and tramadol; 3, namely cloxacillin, triamterene, 
raloxifene were detected only at one site; 3, namely fluoxetine, ketotifen, verapamil, in 
only 2 sites; and 3, namely oseltamivir, diltiazem, hydrocodone were detected only at 
three 3 sampling points. Of these compounds only one, namely fluoxetine, is listed in the 
Kenyan list of essential medicines (Kenya Essential Medicines List, 2016), which might 
explain their low frequencies of detection.  
As an exclusion criterion the compounds not detected or detected in less than 3 
sampling points at concentrations <10 ng L-1 in the impact zone were excluded from 
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further statistical analyses as the risk is considered irrelevant in the EU ERA protocol 
(EMA, 2018) (A4). 
6.6.3. Catchment APIs distribution 
The Ngong River showed the highest mean and max concentrations of total sum of 
APIs (Ng2), respectively 31,160 and 55,193 ng L-1 (Figure 30 and 31), which were the 
highest reported along the catchment for the investigated APIs.  
 
Figure 32 Sum of the 56 APIs at each river sampling point (e.g. Sampling point 1 of Ngong = Ng1; 
Sampling point 1 of Nairobi = Na1, etc., ) and river mean; the wastewater treatment plant effluent concentration 
is furnished individually as last right column. 
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The total concentration of APIs increased from 3052 ng L-1 at the sampling point 
Ng1, upstream the informal settlement of Kibera, to the max total concentration of around 
55,000 ng L-1 at 5.6 km downstream the slum (Ng2). The subsequent sample was 
collected in the middle of the industrial area and other informal settlements, Ng3, and 
showed the second highest total concentration of APIs along this river (52,792 ng L-1). 
The total concentrations at the last two samples, Ng4 and Ng5, decreased to less than half 
the maximum concentration, respectively 21,000 and 23,776 ng L-1. Such decrease is 
very likely due to a combination of reduced input and dilution caused by recent rainfall 
runoff from the surrounding area. Also, it is likely that (bio) degradation played a role in 
the decrease of concentrations of the compounds more rapidly catabolised by 
microorganisms. The pH of the Ngong River increased towards the confluence to the 
Nairobi River. 
The average total APIs concentrations of the Nairobi was 18,560 ng L-1 and its 
maximum concentration was of 41,954 ng L-1 recorded at the sampling point Na4 located 
after the city centre and before the confluence with the Mathare River (Figure 32). The 
samples collected upstream (Na1, Na2) and in the city centre (Na3) showed a 
significantly lower concentration with respect to the samples collected downstream (Na4, 
Na5, Na6). The last two sampling locations showed total concentrations similar to the 
upstream ones (Na7, Na8), showing a natural recovery of the river water quality with 
regard to APIs. 
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The Mathare River showed relatively less API contamination at locations upstream 
of the city (Ma1, Ma2, Ma3), whilst it was the third highest river for average total amount 
of APIs (9913 ng L-1) owing to two very polluted sites (25,156 ng L-1 at Ma4, and 20,343 
ng L-1 at Ma5). These last two sampling points are locate in proximity of the Mathare 
informal settlement and the Dandora landfill (Figure 30) which might explain the sudden 
increase of APIs. 
The Thiririka River was sampled before the confluence with the Nairobi as it could 
potentially be contaminated by APIs from the upstream urban centre of Githurai located 
adjacent to Nairobi and therefore contributes to the impact zone. However the results 
showed a relatively low total concentration of pharmaceuticals (653 ng L-1). 
The Athi River showed an average total APIs concentration of 2064 ng L-1 and a 
maximum total APIs concentration of 3255 ng L-1. The first three sampling locations 
have no influence from the sources of APIs within the city centre. After the sampling 
point At3 the water quality is influenced by the confluence with the Nairobi River. 
However, the maximum total APIs concentration was detected at the sampling location 
At5 (3255 ng L-1), which was likely influenced by the waters coming from the Nango 
River (5674 ng L-1).   
The sample collected from the effluent of the Dandora WWTP showed a 
concentration much lower than the averages observed in the rivers, which confirms the 
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importance of the wastewater treatment in reducing the environmental occurrence of 
APIs (Comber et al., 2018). 
6.6.4. APIs individual contribution and occurrence patterns  
The analgesic paracetamol was the compound with the highest contribution to the 
contamination by APIs (47.4%) (Figure 33), and the API occurring in the largest 
concentration in the Ngong River (maximum 31,003 ng L-1), the Nairobi River (max 
24,541 ng L-1), and the Mathare River (maximum 14,180 ng L-1) (Figure 34). These high 
concentrations contrasted its relatively low frequency of detection (Figure 31) 
highlighting its well-known rapid biodegradation (Baena-Nogueras et al., 2017; Bagnis 
et al., 2019; Lin et al., 2010; Yamamoto et al., 2009), which together with dilution, 
significantly contributed to its decrease of  occurrence in the environment and absence at 
sampling locations far from the source. Paracetamol was detected in other waterbodies 
of the African continent at concentrations in the same order of magnitude as those 
recorded in this study (Table 13). 
Sulfamethoxazole was the second most abundant API detected in the catchment 
(15.8%) (Figure 33), occurring as the most abundant API in the Athi River (max 1530 
ng L-1, At5), and showed the second maximum concentration in the River Ngong (11250 
ng L-1, Ng2) (Figure 34). This compound is used in large amounts globally and widely 
detected in water compartments, and according to the ERA performed by Straub (2015) 
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the Nairobi/Athi catchment reported the highest global MEC in a previous study (K’
oreje et al., 2012) (Table 13). The well-known wide detection of sulfamethoxazole is 
owed partly to the highly variable removal rate, caused by the transformation of its 
metabolites Na-sulfamethoxazole and Glu-sulfamethoxazole back to sulfamethoxazole 
in WWTP’s, which often results in a net negative removal (Göbel et al., 2004). The 
increase of concentration at the last sampling point with respect to the previous might be 
caused by a combination of transformation and the contribution of non-identified point 
sources. Regardless, once in the environment the main mechanism of removal is 
biodegradation, whilst photodegradation is significant only on a surface shallow layer 
(Straub, 2016). 
The stimulant caffeine showed the third highest contribution (18.1%) and 
maximum concentration in the River Ngong (10891 ng L-1). This compound was detected 
in South African water bodies in comparable concentrations (Agunbiade and Moodley, 




Figure 33 Percentage contribution of each API (sum of each sampling point concentration) to the total 
concentration of APIs detected along the Nairobi/Athi catchment. The slice “others” contains the compounds 
occurring for less than 1%, for ease of analyses. 
The antibiotic trimethoprim also showed an important environmental load relative 
to the total APIs (4.3%) and it was detected at all sampling sites. The maximum 
concentration (3345 ng L-1) was recorded downstream of the Dandora landfill, suggesting 
a leachate contribution from this potential secondary environmental source of APIs, as 
previously observed in other studies (Clarke et al., 2015; Masoner et al., 2014). This 
antibiotic was previously detected by other studies concerning African water bodies, with 




Figure 34 Maximum concentration detected in nanograms per litre of each active pharmaceutical 
ingredient (API) in each River and wastewater treatment ponds (WWTP) effluent. 
These four compounds alone contribute for the 85.6% of the total amount of APIs 
detected along the Nairobi/Athi catchment. Two of these are antibiotics might strongly 
contribute to the reported occurrence of antibiotic resistant environmental pools (Subirats 
et al., 2017). 
The other compounds with a contribution higher than 1% were the antibiotic 
metronidazole (2.4%), the antifungals clotrimazole (1.5%) and fluconazole (1.2%), the 
stimulant cotinine (1.3%), and the antimalarial artemisinin (2.3%). All the APIs 
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contributing to less than 1% were grouped in one category that contributes to the 5.1% 
of the total (Figure 33). 
In Table 13 are reported the concentrations of a list of APIs detected both in this 
study and in other studies on the African continent. For all of them the concentrations of 
reported APIs are generally similar. Carbamazepine, however, shows concentrations 
much larger in the study of K’oreje et al., (2016) than this study, both performed in the 
same catchment. This is probably because of the different sampling periods, in fact the 
latter study was performed during a dry season, whilst this work was performed during a 
wet season, which results in a high dilution from rainfall runoff, reducing the 
concentration of APIs. Also ciprofloxacin was detected in much higher concentrations in 
the study of Agunbiade and Moodley, (2014), though referring to a different water body 
in South Africa. 
Table 13 APIs detected at the highest concentration (ng L-1) and frequency comparison with previous 
studies on the African continent (n.a., not available). 









Carbamazepine 172 n.a. n.a. n.a. >4000 
Caffeine 10890 n.a. 33200 >10000 n.a. 
Trimethoprim 3346 2650 290 n.a. >6000 
Nicotine 872 n.a. n.a. n.a. n.a. 
Sulfamethoxazole 11250 13765 5320 >8000 >20000 
Paracetamol 31003 n.a. 1740 16060 >15000 
Amitriptyline 54 n.a. n.a. n.a. n.a. 




6.6.5. APIs source apportionment 
The PCA analysis was performed with the purpose to reduce the complexity of the 
APIs dataset along the Nairobi/Athi River and to allow an easier estimate of the sources 
of APIs; It resulted in four PCs listed in Table 14. 
The first principal component (PC1) showed the highest variance (46%) and was 
interpreted as the diffuse discharge of untreated wastewater. This is because the PC was 
highly weighted by APIs and protein-like DOM (PL-DOM) (Table 14). In fact, PC1 was 
heavily weighted by caffeine, nicotine, and paracetamol which are typically detected in 
untreated wastewater but completely or highly removed in wastewater treatment plants 
(Comber et al., 2018; Rosal et al., 2010; Sui et al., 2010).  Despite their high recalcitrance 
to degradation in wastewater treatment plant, carbamazepine, atenolol, and 
sulfamethoxazole can be also amenable to untreated wastewater discharge as well for the 
high concentrations (Castiglioni et al., 2006; Comber et al., 2018; Rajab et al., 2013; 
Rosal et al., 2010). Additionally, in this investigation atenolol is completely absent in the 
WWTP effluent whilst occurring in river waters, strengthening the direct discharge of 




Table 14 The four principal components (PC1, PC2, PC3, PC4) with the active pharmaceutical 
ingredients (APIs) and the protein-like DOM (PL-DOM) as variables along the Nairobi/Athi River sampling 
points. Also, the table includes the estimate source and relative variance. 
 
PC 1 PC 2 PC 3 PC4 
Amitriptyline  0.876 -0.090 -0.226 0.000 
Artemisinin -0.347 -0.246 -0.067 -0.495 
Atenolol 0.729 0.583 0.202 -0.121 
Caffeine 0.538 0.774 0.199 -0.079 
Carbamazepine 0.397 0.160 0.840 -0.028 
Cetirizine 0.067 0.347 0.847 -0.180 
Cimetidine 0.797 0.320 0.319 0.069 
Ciprofloxacin -0.142 -0.127 -0.136 0.902 
Clotrimazole 0.544 0.497 0.435 0.136 
Cotinine 0.956 0.173 0.098 -0.093 
Enrofloxacin -0.090 -0.249 -0.215 0.909 
Fluconazole 0.066 0.111 0.915 -0.228 
Gabapentin 0.500 -0.340 0.574 -0.367 
Metronidazole -0.098 0.974 0.065 -0.074 
Naproxen 0.750 -0.381 0.436 -0.055 
Nicotine 0.959 0.082 0.211 -0.010 
Paracetamol 0.735 0.553 0.238 0.051 
Sulfamethoxazole 0.948 0.116 0.109 -0.176 
Tetracycline -0.140 0.077 -0.143 0.972 
Trimethoprim 0.003 0.980 0.136 -0.02 
PL-DOM 0.876 -0.157 0.377 -0.126 












Variance (%) 46 17 16 9 
Despite the information available in the literature about the degradability of the 
antidepressant amitriptyline is scarce, there is evidence of high persistence (Baena-
Nogueras et al., 2017; Bagnis et al., 2019; Li et al., 2013). But, similar to atenolol, its 
detection in the river waters and the absence in the effluent of the Dandora wastewater 
treatment plant and the high PC weight (0.88) suggested a contribution of its occurrence 
from DDUW (S.4). Also clotrimazole, cotinine, naproxen, cimetidine and gabapentin 
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showed high loading. These compounds were in high concentration in the sampling area 
between Na4 and Na6 which correspond to the area after the city centre and the suburban 
area downstream. 
The second principal component (PC2) contributes 17% of the total variance. 
This profile was highly weighted by the APIs atenolol, caffeine, clotrimazole, 
metronidazole, paracetamol, and trimethoprim. Because of the little significance of PL-
DOM to this PC, it was assumed the source of these APIs was linked to poorly defined 
point sources along the river. The maximum concentration of trimethoprim was recorded 
at a downstream sampling point (Na6) with respect to the highest concentration of PL-
DOM (Na4) (A5). The Na6 sampling area corresponded with the tract of river flowing 
next to the Dandora Landfill, whose leachate runoff might be deemed as a point source 
of trimethoprim (Clarke et al., 2015; Masoner et al., 2014). However, also the presence 
of other sources was considered likely, such as hospitals or veterinary clinics.  
The third principal component (PC3) contributed to 16% of the total variance. 
This PC represented the effluent from the WWTP as it is weighted by only the APIs that 
were detected in the effluent sample namely carbamazepine, cetirizine, fluconazole, and 
gabapentin, and moderately weighted by PL-DOM as well, typical of WWTP effluents.  
The fourth principal component (PC4) contributes to the 9% of the total 
variance. This component was highly weighted only by the veterinary antibiotics 
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ciprofloxacin, tetracycline and enrofloxacin, which were detected at the sampling point 
Na1 in relatively high concentrations (A5). These APIs represented sources from farming 
use upstream of the city since they are also used for veterinary purposes (Alexandrino et 
al., 2017; Granados-chinchilla and Rodríguez, 2017; Peng et al., 2016). However, 
collecting information about these sources was out of the scope of this work and further 
investigation could be useful to confirm their origin. 
6.6.6. Surface water ERA beyond the end of the impact zone  
The data furnished a broad and detailed picture of the extent of the contamination 
by the direct discharge of untreated wastewater in the Nairobi/Athi catchment and the 
occurrence of APIs at a point far from the source (At5). The EMA protocol for 
environmental risk assessment for medicinal active compounds was applied at the last 
downstream sampling point, assuming that such impact zone acted as a semi-natural 
wastewater treatment plant as proposed by Bagnis et al., (2019). In ≤ 0.1 insignificant; ≤ 
1 low; ≤ 10 moderate; > 10 high. The APIs with a MEC <10 ng L-1 (FASS, 2019), and log Kow 




Table 15 are furnished the measured environmental concentrations (MEC) and 
PNEC of the 14 APIs detected at the sampling point At5, the MEC and PNEC quotient 
results, and the risk index level as follows: ≤ 0.1 insignificant; ≤ 1 low; ≤ 10 moderate; > 10 
high. The APIs with a MEC <10 ng L-1 (FASS, 2019), and log Kow <4.5  were considered as 




Table 15 Environmental risk assessment (ERA) calculated from the measured environmental 
concentrations (MEC) of the APIs detected at the last sampling point At5 (ng L-1) and predicted no effect 
concentrations (PNEC) available in the literature. The environmental risk index is as follows: ≤ 0.1 insignificant; 
≤ 1 low; ≤ 10 moderate; > 10 high. The APIs with a MEC <10 ng L-1 (FASS, 2019), and log Kow <4.5  were 
considered as unlikely to represent a risk (EMA, 2006). 
ERA 
API* MEC PNEC RQ RISK REFERENCE 
SFX 1529.2 560 2.73 Moderate AMR Industry Alliance, 2018; 
Straub, 2016 
MTR 182 130 1.4 Insignificant Bengtsson-Palme and Larsson, 
2016 
FLC 112.2 250 0.45 Moderate AMR Industry Alliance, 2018 
TRM 64.6 500 0.13 Low Straub, 2013  
CTN 87.5 1000 0.09 Insignificant Gosset et al. 2017 
PAR 45.8 814 0.06 Insignificant Minguez et al. 2015 
AMI 12.8 720 0.02 Insignificant Minguez et al. 2015 
ART 465.6 19000 0.02 Insignificant Jessing et al. 2009 




CBZ 55.2 100000 0 Insignificant Minguez et al. 2015 
GAB 54.6 100000 0 Insignificant Minguez et al. 2015 




LDC <10 820000 
 
Unlikely AstraZeneca, 2017 
NCT <10 100 
 
Unlikely Oropesa et a. 2017 
* AMI, amitriptyline; ART. artemisinin; CFF, caffeine; CRB, carbamazepine; CTN, cotinine; 
FXF, fexofenadine; FLC, fluconazole; GAB, gabapentin; LDC, lidocaine; MTR, metronidazole; NCT, 
nicotine; PAR, paracetamol; SFX, sulfamethoxazole; TRM, trimethoprim; n.a., not available. 
The PNEC were selected or calculated from the available literature (AMR Industry 
Alliance, 2018; Bengtsson-Palme and Larsson, 2016; Chen and Ying, 2015; Gosset et 
al., 2017; Jessing et al., 2009; Minguez et al., 2014; Oropesa et al., 2017; Straub, 2016, 
2013). Fexofenadine, nicotine, lidocaine were detected at concentrations below 10 ng L-
1 and, according to the protocol of ERA for medicines of the EMA (2006), are unlikely 
to represent a risk for the environment. The log Kow for these APIs is below 4.5, 
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respectively 2.8, 1.2, 2.3 (Drugbank, 2018h), and therefore there is no need for an 
additional step involving the assessment of persistence, bio-accumulation and toxicity 
(EMA, 2006). Fluconaxole presented a quotient of 0.45 which is interpreted as a 
moderate risk. Sulfamethoxazole also showed a moderate risk as the ratio of MEC and 
PNEC was above 1 (2.73) but below 10. TRM showed a low risk, whilst the other APIs 
do not present a significant risk. 
Therefore, despite the natural attenuation of APIs occurring along the impact zone 
it was shown the likelihood of an environmental risk of some APIs ecotoxicological 
effects beyond its end boundary.  
6.7. Conclusions 
Based on the data reported above the following conclusions may be drawn regarding the 
occurrence and potential impacts of APIs within the Nairobi catchment: 
 The Nairobi/Athi catchment showed an extensive downstream impact zone mostly 
derived from the DDUW from the urban centre of Nairobi city.  
 The impact zone extended downstream to a distance far from the city. However, its 
downstream boundary was unclear owing to the inputs of untreated wastewater sources 
from the continuous urbanized areas along the river, which counteract the natural 
attenuation caused by dilution and degradation.  
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 The most frequently detected APIs and chemicals were caffeine, carbamazepine, 
trimethoprim, nicotine, and sulfamethoxazole. 
 Paracetamol, caffeine, sulfamethoxazole, and trimethoprim alone contributed 86% of the 
total amount of APIs detected along the Nairobi/Athi catchment. 
 The main API sources were attributed to the informal settlements and the industrial area 
in Nairobi City, as well as the Dandora landfill. Also, farming or agricultural sites 
upstream of the city were likely sources of veterinary APIs. 
 It is shown that there is a potential environmental risk of API ecotoxicological impacts 

















The overall goal of this project was to provide novel and scientifically sound information 
about the effects of natural attenuation processes on the exposure to active 
pharmaceutical ingredients in the impact zone generated by the direct discharge of 
untreated wastewater into surface waters and beyond its boundaries, and to furnish an 
approach to environmental risk assessment. 
The aims outlined in the introduction of the thesis were successfully achieved. The 
assessment of the effect of low levels of dilution (<10) of the sewage effluent mixed with 
receiving water on the partitioning of APIs, namely sorption and desorption was 
described in the relative section and provides sound information on the mechanics driving 
the distribution of APIs between sorbents and solution, providing some useful endpoints 
for prediction of environmental concentrations. 
Similarly the effect of low levels of dilution (<10) of the sewage effluent mixed with 
receiving water on the biodegradation rates of selected APIs provided novel insight on 
the role of the dilution on this natural attenuation process, furnishing a new perspective 
on an aspect rarely considered in the environmental assessment of chemicals. 
The development of a model to determine the extent of the impact zone based on BOD 
consumption, predicted from DOC concentrations, furnished a very first hint on the 
approach for developing a model of the impact zone. 
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The above mentioned laboratory study and novel approaches were validated through a 
fieldwork real case study which aimed at the characterization of the extent of a real 
impact zone and the occurrence of APIs in a real environment. 
The information generated is of pivotal importance for the development of an 
environmental risk assessment approach for such areas. In fact, in consideration of the 
high amount of wastewater generated globally and discharged in the environment with 
poor or no treatment, it is urgent the need of tools able to predict the risk coming from 
the exposure to active pharmaceutical ingredients, and to be extended to other classes of 
chemicals.  
As such, from an environmental risk assessment perspective, the impact zone is 
suggested to be treated as a semi-natural wastewater treatment area and, also, it is 
proposed the development of a model to allow the prediction of environmental 
concentrations of APIs beyond the downstream boundaries of the impact zone. In fact, 
as prove by the data gathered from the Nairobi catchment fieldwork, beyond the impact 
zone boundaries there could still be a considerable environmental risk. This should be 
considered even more seriously in the prediction of an increase of use of pharmaceuticals 
in the developing world. 
Therefore, further studies will be necessary to generate laboratory and field data to be 
used for increasing the understanding of such impacted areas and to allow the 
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development of tools for the correct evaluation of the environmental risk caused by 
pharmaceuticals. An important aspect to address in future studies could be the generation 
of a classification of different impact zone based on hydrological river conditions in order 
to provide scenarios for modelling, similarly for instance, to traditional models used for 
the modelling of pesticides environmental concentrations. Another subject requiring 
additional studies is the role of biofilms in the impact zone on removing APIs, but also 
as sensitive environmental pool for the propagation of antibiotic resistance genes, a 
subject already raised to the scientific community attention (Subirats et al., 2017). The 
use of river water withdrawn from the impact zone for irrigation purposes is important 
for the transfer of APIs and other organic contaminants in agricultural fields and 
consequently posing at risk to exposure the consumers in addition to the local ecosystem, 















A1. Direct aqueous injection-high-performance liquid 
chromatography/tandem mass spectrometry – list of target APIs 
COMPOUND THERAPEUTIC CLASS 
AMITRIPTYLINE Antidepressant 




CEPHALEXIN Antibiotic (Cephalosporin) 
CETERIZINE Antihistamine 
CIMETIDINE Histamine H2 receptor antagonist 
CIPROFLOXACIN Antibiotic (Fluoroquinolone) 
CITALOPRAM Antidepressant 
CLARITHROMYCIN Antibiotic (Macrolide) 
CLOTRIMAZOLE Antifungal 
CLOXACILLIN Antibiotic (Penicillin) 
CODEINE Opioid pain medication 
DESVENLAFAXINE Antidepressant 
DIAZEPAM Benzodiazepine 
DILTIAZEM Calcium channel blocker 
DIPHENHYDRAMINE Antihistamine 
ENROFLOXACIN Antibiotic (Fluoroquinolone) 



















NOREISTHERONE Oral contraceptive 
NORFLUOXETINE Antidepressant/ metabolite of Fluoxetine 
OSELTAMIVIR Antiviral 
OXAZEPAM Benzodiazepine 




RALOXIFENE Selective estrogen receptor modulator 






SULFADIAZINE Antibiotic (Sulfonamide) 
SULFAMETHOXAZOLE Antibiotic (Sulfonamide) 
TEMAZEPAM Benzodiazepine 
TETRACYCLINE Antibiotic (Tetracycline) 
TRAMADOL Opioid pain medication 
TRIAMTERENE Diuretic 
TRICLOSAN Antifungal 
TRIMETHOPRIM Antibiotic (Sulfonamide) 
TYLOSIN Antibiotic (Macrolide) 
VENLAFAXINE Antidepressant 








A2. Methodology limit of detection (LOD) and Limit of quantification 
(LOQ) 
 
API SURFACE WATER 
  LOD LOQ 
  ng/L ng/L 
  n=10 n=10 
AMITRIPTYLINE 5.83 11.66 
ARTEMISININ 5.75 11.51 
ATENOLOL 3.01 6.02 
CAFFEINE 11.23 22.46 
CARBAMAZEPINE 0.70 1.40 
CETERIZINE 10.92 21.84 
CIMETIDINE 1.75 3.51 
CIPROFLOXACIN 25.83 51.65 
CITALOPRAM 0.78 1.56 
CLARITHROMYCIN 13.46 26.92 
CLOTRIMAZOLE 116.03 232.05 
CLOXACILLIN 56.72 113.45 
CODEINE 10.32 20.64 
COTININE 6.97 13.95 
DESVENLAFAXINE 5.33 10.66 
DIAZEPAM 0.78 1.56 
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DILTIAZEM 0.50 1.00 
DIPHENHYDRAMINE 8.46 16.92 
ENROFLOXACIN 4.23 8.45 
ERYTHROMYCIN 1.57 3.13 
FEXOFENADINE 4.64 9.29 
FLUOXETINE 7.00 13.99 
FLUCONAZOLE 5.49 10.98 
GABAPENTIN 7.70 15.40 
HYDROCODONE 1.65 3.30 
ITRACONAZOLE 29.22 58.44 
KETOCONAZOLE 2.19 4.38 
KETOTIFEN 0.56 1.12 
LIDOCAINE 1.33 2.66 
LINCOMYACIN 1.27 2.55 
LORATADINE 10.31 20.62 
METFORMIN 9.21 18.42 
METRONIDAZOLE 5.79 11.59 
MICONAZOLE 4.73 9.45 
NAPROXEN 17.92 35.85 
NICOTINE 2.37 4.74 
NOREISTHERONE 6.57 13.14 
OSELTAMIVIR 4.80 9.61 
OXYTETRACYCLINE 8.10 16.20 
PARACETAMOL 21.68 43.36 
PREGABALIN 10.50 21.00 
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PROPRANOLOL 7.43 14.86 
RALOXIFENE 4.55 9.10 
RANITIDINE 2.34 4.68 
SALBUTAMOL 5.17 10.34 
SITAGLIPTIN 4.17 8.33 
SULFADIAZINE 127.97 255.94 
SULFAMETHOXAZOLE 1.76 3.52 
TEMAZEPAM 17.64 35.27 
TETRACYCLINE 12.83 25.65 
TRAMADOL 6.69 13.38 
TRIAMTERENE 2.39 4.78 
TRIMETHOPRIM 0.88 1.75 
TYLOSIN 33.89 67.77 
VENLAFAXINE 4.92 9.85 



























NA1 Nairobi Upstream city centre 1808 S 01 16 34.7 E 036 44 01.7 7.6 362 2.39 20.1 Dry 
NA2 Nairobi Upstream city centre 1728 S 01 16 02.7 E 036 46 28.8 8.0 1050 128 21.0 Dry 
MA1 Gathare Upstream city centre 1781 S 01 14 50.2 E 036 44 06.5 7.4 530 359 21.2 Dry 
MA2 Gathare Dam 1770 S 01 14 33.9 E 036 45 17.2 8.3 420 276 24.7 Dry 
MA3 Mathare Downstream dam 1734 S 01 14 51.9 E 036 46 38.2 7.3 153 101 22.1 Dry 
NA3 Nairobi City centre 1680 S 01 16 33.5 E 036 49 00.6 7.9 768 508 26.2 Dry 
NA4 Nairobi Between city centre and junction with 
Mathare River 
1628 S 01 17 02.2 E 036 51 41.6 7.3 928 616 28.9 Dry 
MA4 Mathare Close to Thika road 1627 S 01 15 47.7 E 036 50 35.2  8.4 486 320 21.3 Wet 
MA5 Mathare Junction to Nairobi River 1563 S 01 14 36.7 E 036 53 47.5 7.8 624 412 20.7 Wet 
NA5 Nairobi Junction to Mathare River 1568 S 01 14 37.9  E 036 53 47.2 8.2 618 409 22.3 Wet 
NA6 Nairobi Junction to Ngong River 1500 S 01 14 38.2 E 036 57 13.3 8.0 597 394 23.1 Wet 
NG5 Ngong Junction to Nairobi River 1500 S 01 14 40.8 E 036 57 12.4 8.2 796 526 24.0 Wet 
NG4 Ngong Quarry area 1547 S 01 15 59.2 E 036 56 06.6 7.8 817 539 25.2 Wet 
NG3 Ngong Industrial area  1632 S 01 18 47.9 E 036 51 56.8 7.8 769 508 25.3 Wet 
NG2 Ngong Middle Kibera Slum 1702 S 01 18 52.7 E 036 47 21.4 7.6 551 364 22.0 Wet 
NG1 Ngong Upstream Kibera Slum  1714 S 01 18 59.0 E 036 46 28.5 7.3 94 62.3 19.5 Wet 
NA7 Nairobi Upstream WWTP 1491 S 01 14 42.8 E 036 59 18.3 8.5 788 522 27.0 Wet 
NA9 Nairobi Downstream WWTP 1459 S 01 13 34.8 E 037 01 34.3 8.6 935 615 25.0 Wet 
EFF WWTP Effluent WWTP 1480 S 01 13 38.4 E 037 01 29.7 8.8 1099 723 26.0 Wet 
TH1 Thiririka Confluence into Nairobi River 1430 S 01 11 35.5 E 037 06 58.2 7.7 171 112 22.5 Wet 
AT4 Athi Upstream fourteen falls  1428 S 01 06 59.0 E 037 10 31.2 8.1 302 199 22.0 Wet 
NN1 Nango Confluence into Athi River 1432 S 01 07 12.8 E 037 10 32.3 7.7 313 205 22.7 Wet 
AT3 Athi Downstream the tanning plant 1472 S 01 19 55.3 E 037 03 41.2 9.6 920 609 26.3 Wet 
AT2 Athi Upstream the tanning plant 1472 S 01 22 50.0  E 037 02 35.4 8.8 198 130 28.3 Wet 
AT1 Athi Downstream Nairobi national park 1507 S 01 26 37.7 E 036 57 53.7 8.1 195 129 25.7 Wet 
AT5 Athi Fourteen falls 1392 S 01 04 37.7 E 037 15 10.6 8.0 342 224 23.5 Wet 
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A4. List of APIs excluded from the analysis since not detected or detected 
in less than 3 sampling points at concentration <10 ng L-1. 
API Criterium API Criterium 
Citalopram Not detected Loratidine Not detected 
Cloxacillin Not detected Oseltamivir Not detected 
Desvenlafaxine Not detected Raloxifene Not detected 
Diltiazem <3 sp Sulfadiazine Not detected 
Diphenhydramine Not detected Temazepam Not detected 
Fluoxetine <3 sp Tramadol Not detected 
Hydrocodone <3 sp Triamterene <3 sp 
Itraconazole Not detected Tylosin Not detected 
Ketoconazole Not detected Venlafaxine Not detected 
Ketotifen Not detected Verapamil Not detected 
Lincomycin Not detected Propranolol Not detected 














A5. List of the concentration of each API used in the principal component analysis at each sampling site and the concentration 
of the protein-like dissolved organic matter (PL-DOM). 
*SP: sampling sites; APIs: active pharmaceutical ingredients; AMI: Amitriptyline; ART: Artemisinin; ATN: Atenolol; CAF: Caffeine; CBZ: Carbamazepine; CTR: Ceterizine; CMT: Cimetidine; CPR: Ciprofloxacin; CLT: Clotrimazole; 
CTN: Cotinine; ENR: Enrofloxacin; FLC: Fluconazole; GAB: Gabapentin; MET: Metronidazole; NPX: Naproxen; NCT: Nicotine; PAR: Paracetamol; SFX: Sulfamethoxazole; TET: Tetracycline; TRM: Trimethoprim; PL-DOM: Protein-like 
dissolved organic matter 
 
SP\APIs* (ng L-1) AMI ART ATN CAF CBZ CTR CMT CPR CLT CTN ENR FLC GAB MET NPX NCT PAR SFX TET TRM PL-DOM (mg L-1) 
Na1 14 0 0 182 62 0 6 623 0 16 389 37 0 0 0 9 0 183 487 28 394 
Na2 35 633 35 1187 81 101 0 224 0 436 115 247 179 0 41 236 7531 3636 0 159 4435 
Na3 34 0 40 956 49 62 18 0 0 219 14 162 135 0 0 78 0 2449 0 70 3317 
Na4 54 0 119 6433 172 124 86 74 528 821 9 302 369 0 124 872 24541 6890 0 286 10089 
Na5 0 474 65 4708 71 172 38 145 0 238 0 155 147 537 0 207 13396 1697 0 2007 3202 
Na6 21 0 93 7309 127 162 45 105 678 381 0 358 0 1059 0 233 22770 3093 152 3346 2473 
Na7 24 400 79 5824 121 92 0 120 0 214 0 211 193 699 0 104 2645 2305 0 1596 636 
Na8 0 0 37 1723 125 143 17 103 0 77 0 338 258 206 0 24 0 1929 0 599 3002 
At4 14 498 4 239 42 0 0 131 0 71 0 66 60 0 17 7 0 883 0 40 1052 
At5 13 466 0 634 55 0 0 0 0 88 0 112 55 182 0 8 46 1529 0 65 827 
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